id	sid	tid	token	lemma	pos
iajs-3451	1	1	128	128	NUM
iajs-3451	1	2	this	this	DET
iajs-3451	1	3	work	work	NOUN
iajs-3451	1	4	is	be	AUX
iajs-3451	1	5	licensed	license	VERB
iajs-3451	1	6	under	under	ADP
iajs-3451	1	7	a	a	DET
iajs-3451	1	8	creative	creative	ADJ
iajs-3451	1	9	commons	common	NOUN
iajs-3451	1	10	attribution	attribution	NOUN
iajs-3451	1	11	4.0	4.0	NUM
iajs-3451	1	12	international	international	ADJ
iajs-3451	1	13	license	license	NOUN
iajs-3451	1	14	ihjpas	ihjpa	NOUN
iajs-3451	1	15	.	.	PUNCT
iajs-3451	2	1	37	37	NUM
iajs-3451	2	2	(	(	PUNCT
iajs-3451	2	3	2	2	NUM
iajs-3451	2	4	)	)	PUNCT
iajs-3451	2	5	2024	2024	NUM
iajs-3451	2	6	ibn	ibn	PROPN
iajs-3451	2	7	al	al	PROPN
iajs-3451	2	8	-	-	PUNCT
iajs-3451	2	9	haitham	haitham	PROPN
iajs-3451	2	10	journal	journal	PROPN
iajs-3451	2	11	for	for	ADP
iajs-3451	2	12	pure	pure	ADJ
iajs-3451	2	13	and	and	CCONJ
iajs-3451	2	14	applied	applied	ADJ
iajs-3451	2	15	sciences	sciences	PROPN
iajs-3451	2	16	journal	journal	PROPN
iajs-3451	2	17	homepage	homepage	NOUN
iajs-3451	2	18	:	:	PUNCT
iajs-3451	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3451	2	20	pissn	pissn	ADJ
iajs-3451	2	21	:	:	PUNCT
iajs-3451	2	22	1609	1609	NUM
iajs-3451	2	23	-	-	SYM
iajs-3451	2	24	4042	4042	NUM
iajs-3451	2	25	,	,	PUNCT
iajs-3451	2	26	eissn	eissn	NOUN
iajs-3451	2	27	:	:	PUNCT
iajs-3451	2	28	2521	2521	NUM
iajs-3451	2	29	-	-	SYM
iajs-3451	2	30	3407	3407	NUM
iajs-3451	2	31	evaluation	evaluation	NOUN
iajs-3451	2	32	of	of	ADP
iajs-3451	2	33	several	several	ADJ
iajs-3451	2	34	hematologic	hematologic	NOUN
iajs-3451	2	35	and	and	CCONJ
iajs-3451	2	36	serological	serological	ADJ
iajs-3451	2	37	parameters	parameter	NOUN
iajs-3451	2	38	in	in	ADP
iajs-3451	2	39	rheumatoid	rheumatoid	NOUN
iajs-3451	2	40	arthritis	arthritis	NOUN
iajs-3451	2	41	patients	patient	NOUN
iajs-3451	2	42	zahraa	zahraa	VERB
iajs-3451	2	43	jabbar	jabbar	PROPN
iajs-3451	2	44	diwan	diwan	PROPN
iajs-3451	2	45	1	1	NUM
iajs-3451	2	46	*	*	PUNCT
iajs-3451	2	47	and	and	CCONJ
iajs-3451	2	48	wasan	wasan	PROPN
iajs-3451	2	49	addai	addai	PROPN
iajs-3451	2	50	almarsomy	almarsomy	VERB
iajs-3451	2	51	2	2	NUM
iajs-3451	2	52	1,2	1,2	NUM
iajs-3451	2	53	department	department	NOUN
iajs-3451	2	54	of	of	ADP
iajs-3451	2	55	biology	biology	NOUN
iajs-3451	2	56	,	,	PUNCT
iajs-3451	2	57	college	college	NOUN
iajs-3451	2	58	of	of	ADP
iajs-3451	2	59	science	science	NOUN
iajs-3451	2	60	for	for	ADP
iajs-3451	2	61	women	woman	NOUN
iajs-3451	2	62	,	,	PUNCT
iajs-3451	2	63	university	university	NOUN
iajs-3451	2	64	of	of	ADP
iajs-3451	2	65	baghdad	baghdad	PROPN
iajs-3451	2	66	,	,	PUNCT
iajs-3451	2	67	baghdad	baghdad	PROPN
iajs-3451	2	68	,	,	PUNCT
iajs-3451	2	69	iraq	iraq	PROPN
iajs-3451	2	70	*	*	PUNCT
iajs-3451	2	71	corresponding	correspond	VERB
iajs-3451	2	72	author	author	NOUN
iajs-3451	2	73	.	.	PUNCT
iajs-3451	3	1	received	receive	VERB
iajs-3451	3	2	:	:	PUNCT
iajs-3451	3	3	29	29	NUM
iajs-3451	3	4	april	april	PROPN
iajs-3451	3	5	2023	2023	NUM
iajs-3451	3	6	accepted	accept	VERB
iajs-3451	3	7	:	:	PUNCT
iajs-3451	3	8	31	31	NUM
iajs-3451	3	9	may	may	PROPN
iajs-3451	3	10	2023	2023	NUM
iajs-3451	3	11	published	publish	VERB
iajs-3451	3	12	:	:	PUNCT
iajs-3451	3	13	20	20	NUM
iajs-3451	3	14	april	april	PROPN
iajs-3451	3	15	2024	2024	NUM
iajs-3451	3	16	doi.org/10.30526/37.2.3451	doi.org/10.30526/37.2.3451	NOUN
iajs-3451	3	17	abstract	abstract	ADJ
iajs-3451	3	18	rheumatoid	rheumatoid	NOUN
iajs-3451	3	19	arthritis	arthritis	NOUN
iajs-3451	3	20	(	(	PUNCT
iajs-3451	3	21	ra	ra	NOUN
iajs-3451	3	22	)	)	PUNCT
iajs-3451	3	23	is	be	AUX
iajs-3451	3	24	a	a	DET
iajs-3451	3	25	chronic	chronic	ADJ
iajs-3451	3	26	inflammatory	inflammatory	ADJ
iajs-3451	3	27	disease	disease	NOUN
iajs-3451	3	28	that	that	PRON
iajs-3451	3	29	primarily	primarily	ADV
iajs-3451	3	30	affects	affect	VERB
iajs-3451	3	31	the	the	DET
iajs-3451	3	32	synovial	synovial	ADJ
iajs-3451	3	33	joints	joint	NOUN
iajs-3451	3	34	and	and	CCONJ
iajs-3451	3	35	produces	produce	VERB
iajs-3451	3	36	recurring	recur	VERB
iajs-3451	3	37	inflammation	inflammation	NOUN
iajs-3451	3	38	of	of	ADP
iajs-3451	3	39	the	the	DET
iajs-3451	3	40	synovial	synovial	ADJ
iajs-3451	3	41	membrane	membrane	NOUN
iajs-3451	3	42	,	,	PUNCT
iajs-3451	3	43	which	which	PRON
iajs-3451	3	44	ultimately	ultimately	ADV
iajs-3451	3	45	causes	cause	VERB
iajs-3451	3	46	joint	joint	ADJ
iajs-3451	3	47	degeneration	degeneration	NOUN
iajs-3451	3	48	,	,	PUNCT
iajs-3451	3	49	deformity	deformity	NOUN
iajs-3451	3	50	,	,	PUNCT
iajs-3451	3	51	and	and	CCONJ
iajs-3451	3	52	disability	disability	NOUN
iajs-3451	3	53	.	.	PUNCT
iajs-3451	4	1	the	the	DET
iajs-3451	4	2	current	current	ADJ
iajs-3451	4	3	study	study	NOUN
iajs-3451	4	4	included	include	VERB
iajs-3451	4	5	110	110	NUM
iajs-3451	4	6	blood	blood	NOUN
iajs-3451	4	7	samples	sample	NOUN
iajs-3451	4	8	collected	collect	VERB
iajs-3451	4	9	from	from	ADP
iajs-3451	4	10	patients	patient	NOUN
iajs-3451	4	11	infected	infect	VERB
iajs-3451	4	12	with	with	ADP
iajs-3451	4	13	rheumatoid	rheumatoid	NOUN
iajs-3451	4	14	arthritis	arthritis	NOUN
iajs-3451	4	15	(	(	PUNCT
iajs-3451	4	16	60	60	NUM
iajs-3451	4	17	)	)	PUNCT
iajs-3451	4	18	and	and	CCONJ
iajs-3451	4	19	50	50	NUM
iajs-3451	4	20	blood	blood	NOUN
iajs-3451	4	21	samples	sample	NOUN
iajs-3451	4	22	from	from	ADP
iajs-3451	4	23	controls	control	NOUN
iajs-3451	4	24	.	.	PUNCT
iajs-3451	5	1	the	the	DET
iajs-3451	5	2	results	result	NOUN
iajs-3451	5	3	showed	show	VERB
iajs-3451	5	4	that	that	SCONJ
iajs-3451	5	5	investigation	investigation	NOUN
iajs-3451	5	6	of	of	ADP
iajs-3451	5	7	some	some	DET
iajs-3451	5	8	hematological	hematological	ADJ
iajs-3451	5	9	tests	test	NOUN
iajs-3451	5	10	revealed	reveal	VERB
iajs-3451	5	11	a	a	DET
iajs-3451	5	12	high	high	ADJ
iajs-3451	5	13	significant	significant	ADJ
iajs-3451	5	14	erythrocyte	erythrocyte	NOUN
iajs-3451	5	15	sedimentation	sedimentation	NOUN
iajs-3451	5	16	rate	rate	NOUN
iajs-3451	5	17	(	(	PUNCT
iajs-3451	5	18	esr	esr	PROPN
iajs-3451	5	19	)	)	PUNCT
iajs-3451	5	20	for	for	ADP
iajs-3451	5	21	the	the	DET
iajs-3451	5	22	patient	patient	ADJ
iajs-3451	5	23	group	group	NOUN
iajs-3451	5	24	compared	compare	VERB
iajs-3451	5	25	to	to	ADP
iajs-3451	5	26	the	the	DET
iajs-3451	5	27	control	control	NOUN
iajs-3451	5	28	group	group	NOUN
iajs-3451	5	29	(	(	PUNCT
iajs-3451	5	30	28.25	28.25	NUM
iajs-3451	5	31	±	±	NUM
iajs-3451	5	32	2.72	2.72	NUM
iajs-3451	5	33	,	,	PUNCT
iajs-3451	5	34	16.24	16.24	NUM
iajs-3451	5	35	±	±	NUM
iajs-3451	5	36	1.83	1.83	NUM
iajs-3451	5	37	)	)	PUNCT
iajs-3451	5	38	,	,	PUNCT
iajs-3451	5	39	respectively	respectively	ADV
iajs-3451	5	40	.	.	PUNCT
iajs-3451	6	1	but	but	CCONJ
iajs-3451	6	2	it	it	PRON
iajs-3451	6	3	is	be	AUX
iajs-3451	6	4	non	non	ADJ
iajs-3451	6	5	-	-	ADJ
iajs-3451	6	6	significant	significant	ADJ
iajs-3451	6	7	for	for	ADP
iajs-3451	6	8	patients	patient	NOUN
iajs-3451	6	9	for	for	ADP
iajs-3451	6	10	(	(	PUNCT
iajs-3451	6	11	wbc	wbc	PROPN
iajs-3451	6	12	,	,	PUNCT
iajs-3451	6	13	rbc	rbc	PROPN
iajs-3451	6	14	,	,	PUNCT
iajs-3451	6	15	and	and	CCONJ
iajs-3451	6	16	plt	plt	NOUN
iajs-3451	6	17	)	)	PUNCT
iajs-3451	6	18	was	be	AUX
iajs-3451	6	19	(	(	PUNCT
iajs-3451	6	20	7.34	7.34	NUM
iajs-3451	6	21	±	±	NUM
iajs-3451	6	22	0.25	0.25	NUM
iajs-3451	6	23	,	,	PUNCT
iajs-3451	6	24	4.71	4.71	NUM
iajs-3451	6	25	±	±	NUM
iajs-3451	6	26	0.08	0.08	NUM
iajs-3451	6	27	,	,	PUNCT
iajs-3451	6	28	and	and	CCONJ
iajs-3451	6	29	248.26	248.26	NUM
iajs-3451	6	30	±	±	NUM
iajs-3451	6	31	9.18	9.18	NUM
iajs-3451	6	32	)	)	PUNCT
iajs-3451	6	33	,	,	PUNCT
iajs-3451	6	34	while	while	SCONJ
iajs-3451	6	35	the	the	DET
iajs-3451	6	36	control	control	NOUN
iajs-3451	6	37	group	group	NOUN
iajs-3451	6	38	was	be	AUX
iajs-3451	6	39	(	(	PUNCT
iajs-3451	6	40	6.73	6.73	NUM
iajs-3451	6	41	±0.19	±0.19	NOUN
iajs-3451	6	42	,	,	PUNCT
iajs-3451	6	43	4.96	4.96	NUM
iajs-3451	6	44	±0.10	±0.10	NOUN
iajs-3451	6	45	,	,	PUNCT
iajs-3451	6	46	and	and	CCONJ
iajs-3451	6	47	263.64	263.64	NUM
iajs-3451	6	48	±8.26	±8.26	NOUN
iajs-3451	6	49	)	)	PUNCT
iajs-3451	6	50	,	,	PUNCT
iajs-3451	6	51	respectively	respectively	ADV
iajs-3451	6	52	.	.	PUNCT
iajs-3451	7	1	as	as	ADV
iajs-3451	7	2	well	well	ADV
iajs-3451	7	3	as	as	ADP
iajs-3451	7	4	the	the	DET
iajs-3451	7	5	result	result	NOUN
iajs-3451	7	6	of	of	ADP
iajs-3451	7	7	the	the	DET
iajs-3451	7	8	rheumatoid	rheumatoid	NOUN
iajs-3451	7	9	arthritis	arthritis	NOUN
iajs-3451	7	10	factor	factor	NOUN
iajs-3451	7	11	(	(	PUNCT
iajs-3451	7	12	rh	rh	PROPN
iajs-3451	7	13	)	)	PUNCT
iajs-3451	7	14	level	level	NOUN
iajs-3451	7	15	,	,	PUNCT
iajs-3451	7	16	there	there	PRON
iajs-3451	7	17	was	be	VERB
iajs-3451	7	18	a	a	DET
iajs-3451	7	19	significant	significant	ADJ
iajs-3451	7	20	increase	increase	NOUN
iajs-3451	7	21	in	in	ADP
iajs-3451	7	22	patients	patient	NOUN
iajs-3451	7	23	with	with	ADP
iajs-3451	7	24	positive	positive	ADJ
iajs-3451	7	25	rf	rf	NUM
iajs-3451	7	26	45	45	NUM
iajs-3451	7	27	(	(	PUNCT
iajs-3451	7	28	75.00	75.00	NUM
iajs-3451	7	29	%	%	NOUN
iajs-3451	7	30	)	)	PUNCT
iajs-3451	7	31	and	and	CCONJ
iajs-3451	7	32	negative	negative	ADJ
iajs-3451	7	33	rf	rf	ADJ
iajs-3451	7	34	15	15	NUM
iajs-3451	7	35	(	(	PUNCT
iajs-3451	7	36	25.00	25.00	NUM
iajs-3451	7	37	%	%	NOUN
iajs-3451	7	38	)	)	PUNCT
iajs-3451	7	39	.	.	PUNCT
iajs-3451	8	1	while	while	SCONJ
iajs-3451	8	2	the	the	DET
iajs-3451	8	3	result	result	NOUN
iajs-3451	8	4	for	for	ADP
iajs-3451	8	5	the	the	DET
iajs-3451	8	6	c	c	NOUN
iajs-3451	8	7	-	-	PUNCT
iajs-3451	8	8	reactive	reactive	ADJ
iajs-3451	8	9	protein	protein	NOUN
iajs-3451	8	10	(	(	PUNCT
iajs-3451	8	11	crp	crp	NOUN
iajs-3451	8	12	)	)	PUNCT
iajs-3451	8	13	test	test	NOUN
iajs-3451	8	14	for	for	ADP
iajs-3451	8	15	patients	patient	NOUN
iajs-3451	8	16	was	be	AUX
iajs-3451	8	17	positive	positive	ADJ
iajs-3451	8	18	26	26	NUM
iajs-3451	8	19	(	(	PUNCT
iajs-3451	8	20	43.33	43.33	NUM
iajs-3451	8	21	%	%	NOUN
iajs-3451	8	22	)	)	PUNCT
iajs-3451	8	23	and	and	CCONJ
iajs-3451	8	24	negative	negative	ADJ
iajs-3451	8	25	34	34	NUM
iajs-3451	8	26	(	(	PUNCT
iajs-3451	8	27	56.67	56.67	NUM
iajs-3451	8	28	%	%	NOUN
iajs-3451	8	29	)	)	PUNCT
iajs-3451	8	30	.	.	PUNCT
iajs-3451	9	1	keywords	keyword	NOUN
iajs-3451	9	2	:	:	PUNCT
iajs-3451	9	3	rheumatoid	rheumatoid	VERB
iajs-3451	9	4	arthritis	arthritis	NOUN
iajs-3451	9	5	,	,	PUNCT
iajs-3451	9	6	serologic	serologic	ADJ
iajs-3451	9	7	test	test	NOUN
iajs-3451	9	8	,	,	PUNCT
iajs-3451	9	9	cbc	cbc	PROPN
iajs-3451	9	10	test	test	NOUN
iajs-3451	9	11	,	,	PUNCT
iajs-3451	9	12	autoimmune	autoimmune	ADJ
iajs-3451	9	13	disease	disease	NOUN
iajs-3451	9	14	,	,	PUNCT
iajs-3451	9	15	rf	rf	NOUN
iajs-3451	9	16	factor	factor	NOUN
iajs-3451	9	17	.	.	PUNCT
iajs-3451	10	1	1	1	X
iajs-3451	10	2	.	.	X
iajs-3451	10	3	introduction	introduction	NOUN
iajs-3451	10	4	rheumatoid	rheumatoid	NOUN
iajs-3451	10	5	arthritis	arthritis	NOUN
iajs-3451	10	6	is	be	AUX
iajs-3451	10	7	a	a	DET
iajs-3451	10	8	disordered	disordered	ADJ
iajs-3451	10	9	inflammation	inflammation	NOUN
iajs-3451	10	10	resulting	result	VERB
iajs-3451	10	11	from	from	ADP
iajs-3451	10	12	a	a	DET
iajs-3451	10	13	chronic	chronic	ADJ
iajs-3451	10	14	autoimmune	autoimmune	ADJ
iajs-3451	10	15	response	response	NOUN
iajs-3451	10	16	,	,	PUNCT
iajs-3451	10	17	that	that	PRON
iajs-3451	10	18	affects	affect	VERB
iajs-3451	10	19	both	both	CCONJ
iajs-3451	10	20	small	small	ADJ
iajs-3451	10	21	and	and	CCONJ
iajs-3451	10	22	large	large	ADJ
iajs-3451	10	23	joints	joint	NOUN
iajs-3451	10	24	in	in	ADP
iajs-3451	10	25	the	the	DET
iajs-3451	10	26	body	body	NOUN
iajs-3451	10	27	.	.	PUNCT
iajs-3451	11	1	without	without	ADP
iajs-3451	11	2	treatment	treatment	NOUN
iajs-3451	11	3	,	,	PUNCT
iajs-3451	11	4	this	this	DET
iajs-3451	11	5	disease	disease	NOUN
iajs-3451	11	6	significantly	significantly	ADV
iajs-3451	11	7	shortens	shorten	VERB
iajs-3451	11	8	the	the	DET
iajs-3451	11	9	patient	patient	NOUN
iajs-3451	11	10	's	's	PART
iajs-3451	11	11	life	life	NOUN
iajs-3451	11	12	,	,	PUNCT
iajs-3451	11	13	so	so	SCONJ
iajs-3451	11	14	it	it	PRON
iajs-3451	11	15	also	also	ADV
iajs-3451	11	16	indirectly	indirectly	ADV
iajs-3451	11	17	results	result	VERB
iajs-3451	11	18	in	in	ADP
iajs-3451	11	19	death	death	NOUN
iajs-3451	12	1	[	[	X
iajs-3451	12	2	1	1	NUM
iajs-3451	12	3	-	-	SYM
iajs-3451	12	4	3	3	NUM
iajs-3451	12	5	]	]	PUNCT
iajs-3451	12	6	.	.	PUNCT
iajs-3451	13	1	the	the	DET
iajs-3451	13	2	pathogenesis	pathogenesis	NOUN
iajs-3451	13	3	of	of	ADP
iajs-3451	13	4	rheumatoid	rheumatoid	NOUN
iajs-3451	13	5	arthritis	arthritis	NOUN
iajs-3451	13	6	may	may	AUX
iajs-3451	13	7	be	be	AUX
iajs-3451	13	8	heterogeneous	heterogeneous	ADJ
iajs-3451	13	9	and	and	CCONJ
iajs-3451	13	10	have	have	VERB
iajs-3451	13	11	complex	complex	ADJ
iajs-3451	13	12	manifestations	manifestation	NOUN
iajs-3451	13	13	,	,	PUNCT
iajs-3451	13	14	as	as	SCONJ
iajs-3451	13	15	autoantibodies	autoantibody	NOUN
iajs-3451	13	16	are	be	AUX
iajs-3451	13	17	a	a	DET
iajs-3451	13	18	feature	feature	NOUN
iajs-3451	13	19	of	of	ADP
iajs-3451	13	20	positive	positive	ADJ
iajs-3451	13	21	rheumatoid	rheumatoid	NOUN
iajs-3451	13	22	arthritis	arthritis	NOUN
iajs-3451	13	23	,	,	PUNCT
iajs-3451	13	24	as	as	SCONJ
iajs-3451	13	25	they	they	PRON
iajs-3451	13	26	are	be	AUX
iajs-3451	13	27	a	a	DET
iajs-3451	13	28	biomarker	biomarker	NOUN
iajs-3451	13	29	of	of	ADP
iajs-3451	13	30	an	an	DET
iajs-3451	13	31	erosive	erosive	ADJ
iajs-3451	13	32	disorder	disorder	NOUN
iajs-3451	13	33	of	of	ADP
iajs-3451	13	34	the	the	DET
iajs-3451	13	35	joint	joint	ADJ
iajs-3451	13	36	surface	surface	NOUN
iajs-3451	13	37	.	.	PUNCT
iajs-3451	14	1	also	also	ADV
iajs-3451	14	2	,	,	PUNCT
iajs-3451	14	3	many	many	ADJ
iajs-3451	14	4	changes	change	NOUN
iajs-3451	14	5	may	may	AUX
iajs-3451	14	6	occur	occur	VERB
iajs-3451	14	7	before	before	ADP
iajs-3451	14	8	the	the	DET
iajs-3451	14	9	clinical	clinical	ADJ
iajs-3451	14	10	onset	onset	NOUN
iajs-3451	14	11	of	of	ADP
iajs-3451	14	12	the	the	DET
iajs-3451	14	13	disease	disease	NOUN
iajs-3451	14	14	;	;	PUNCT
iajs-3451	14	15	this	this	DET
iajs-3451	14	16	stage	stage	NOUN
iajs-3451	14	17	may	may	AUX
iajs-3451	14	18	last	last	VERB
iajs-3451	14	19	for	for	ADP
iajs-3451	14	20	several	several	ADJ
iajs-3451	14	21	years	year	NOUN
iajs-3451	14	22	and	and	CCONJ
iajs-3451	14	23	may	may	AUX
iajs-3451	14	24	be	be	AUX
iajs-3451	14	25	characterized	characterize	VERB
iajs-3451	14	26	by	by	ADP
iajs-3451	14	27	the	the	DET
iajs-3451	14	28	appearance	appearance	NOUN
iajs-3451	14	29	of	of	ADP
iajs-3451	14	30	autoantibodies	autoantibody	NOUN
iajs-3451	14	31	without	without	ADP
iajs-3451	14	32	any	any	DET
iajs-3451	14	33	signs	sign	NOUN
iajs-3451	14	34	of	of	ADP
iajs-3451	14	35	arthritis	arthritis	NOUN
iajs-3451	14	36	[	[	X
iajs-3451	14	37	4	4	NUM
iajs-3451	14	38	]	]	PUNCT
iajs-3451	14	39	.	.	PUNCT
iajs-3451	15	1	we	we	PRON
iajs-3451	15	2	used	use	VERB
iajs-3451	15	3	the	the	DET
iajs-3451	15	4	measure	measure	NOUN
iajs-3451	15	5	of	of	ADP
iajs-3451	15	6	the	the	DET
iajs-3451	15	7	erythrocyte	erythrocyte	PROPN
iajs-3451	15	8	sedimentation	sedimentation	NOUN
iajs-3451	15	9	rate	rate	NOUN
iajs-3451	15	10	(	(	PUNCT
iajs-3451	15	11	esr	esr	PROPN
iajs-3451	15	12	)	)	PUNCT
iajs-3451	15	13	,	,	PUNCT
iajs-3451	15	14	which	which	PRON
iajs-3451	15	15	is	be	AUX
iajs-3451	15	16	a	a	DET
iajs-3451	15	17	laboratory	laboratory	NOUN
iajs-3451	15	18	indicator	indicator	NOUN
iajs-3451	15	19	for	for	ADP
iajs-3451	15	20	disease	disease	NOUN
iajs-3451	15	21	activity	activity	NOUN
iajs-3451	15	22	in	in	ADP
iajs-3451	15	23	clinical	clinical	ADJ
iajs-3451	15	24	medicine	medicine	NOUN
iajs-3451	15	25	and	and	CCONJ
iajs-3451	15	26	is	be	AUX
iajs-3451	15	27	still	still	ADV
iajs-3451	15	28	an	an	DET
iajs-3451	15	29	important	important	ADJ
iajs-3451	15	30	tool	tool	NOUN
iajs-3451	15	31	for	for	ADP
iajs-3451	15	32	tracking	track	VERB
iajs-3451	15	33	inflammatory	inflammatory	ADJ
iajs-3451	15	34	diseases	disease	NOUN
iajs-3451	15	35	,	,	PUNCT
iajs-3451	15	36	especially	especially	ADV
iajs-3451	15	37	rheumatoid	rheumatoid	VERB
iajs-3451	15	38	arthritis	arthritis	NOUN
iajs-3451	15	39	[	[	X
iajs-3451	15	40	5	5	NUM
iajs-3451	15	41	,	,	PUNCT
iajs-3451	15	42	6	6	NUM
iajs-3451	15	43	]	]	PUNCT
iajs-3451	15	44	.	.	PUNCT
iajs-3451	16	1	therefore	therefore	ADV
iajs-3451	16	2	,	,	PUNCT
iajs-3451	16	3	esr	esr	PROPN
iajs-3451	16	4	is	be	AUX
iajs-3451	16	5	a	a	DET
iajs-3451	16	6	vital	vital	ADJ
iajs-3451	16	7	component	component	NOUN
iajs-3451	16	8	of	of	ADP
iajs-3451	16	9	several	several	ADJ
iajs-3451	16	10	rheumatic	rheumatic	ADJ
iajs-3451	16	11	criteria	criterion	NOUN
iajs-3451	16	12	for	for	ADP
iajs-3451	16	13	determining	determine	VERB
iajs-3451	16	14	disease	disease	NOUN
iajs-3451	16	15	activity	activity	NOUN
iajs-3451	16	16	and	and	CCONJ
iajs-3451	16	17	improvement	improvement	NOUN
iajs-3451	16	18	,	,	PUNCT
iajs-3451	16	19	as	as	ADV
iajs-3451	16	20	well	well	ADV
iajs-3451	16	21	as	as	ADP
iajs-3451	16	22	a	a	DET
iajs-3451	16	23	laboratory	laboratory	NOUN
iajs-3451	16	24	activity	activity	NOUN
iajs-3451	16	25	sign	sign	NOUN
iajs-3451	16	26	for	for	ADP
iajs-3451	16	27	its	its	PRON
iajs-3451	16	28	treatment	treatment	NOUN
iajs-3451	16	29	[	[	X
iajs-3451	16	30	7	7	NUM
iajs-3451	16	31	,	,	PUNCT
iajs-3451	16	32	8	8	NUM
iajs-3451	16	33	]	]	PUNCT
iajs-3451	16	34	.	.	PUNCT
iajs-3451	17	1	the	the	DET
iajs-3451	17	2	erythrocyte	erythrocyte	PROPN
iajs-3451	17	3	sedimentation	sedimentation	NOUN
iajs-3451	17	4	rate	rate	NOUN
iajs-3451	17	5	(	(	PUNCT
iajs-3451	17	6	esr	esr	PROPN
iajs-3451	17	7	)	)	PUNCT
iajs-3451	17	8	is	be	AUX
iajs-3451	17	9	used	use	VERB
iajs-3451	17	10	to	to	PART
iajs-3451	17	11	track	track	VERB
iajs-3451	17	12	the	the	DET
iajs-3451	17	13	body	body	NOUN
iajs-3451	17	14	's	's	PART
iajs-3451	17	15	heightened	heighten	VERB
iajs-3451	17	16	inflammatory	inflammatory	ADJ
iajs-3451	17	17	activity	activity	NOUN
iajs-3451	17	18	[	[	X
iajs-3451	17	19	9	9	NUM
iajs-3451	17	20	,	,	PUNCT
iajs-3451	17	21	10	10	NUM
iajs-3451	17	22	]	]	PUNCT
iajs-3451	17	23	.	.	PUNCT
iajs-3451	18	1	although	although	SCONJ
iajs-3451	18	2	the	the	DET
iajs-3451	18	3	esr	esr	PROPN
iajs-3451	18	4	test	test	NOUN
iajs-3451	18	5	lacks	lack	VERB
iajs-3451	18	6	specificity	specificity	NOUN
iajs-3451	18	7	,	,	PUNCT
iajs-3451	18	8	which	which	PRON
iajs-3451	18	9	is	be	AUX
iajs-3451	18	10	the	the	DET
iajs-3451	18	11	only	only	ADJ
iajs-3451	18	12	negative	negative	ADJ
iajs-3451	18	13	of	of	ADP
iajs-3451	18	14	its	its	PRON
iajs-3451	18	15	use	use	NOUN
iajs-3451	18	16	in	in	ADP
iajs-3451	18	17	assessing	assess	VERB
iajs-3451	18	18	illness	illness	NOUN
iajs-3451	18	19	severity	severity	NOUN
iajs-3451	18	20	,	,	PUNCT
iajs-3451	18	21	it	it	PRON
iajs-3451	18	22	can	can	AUX
iajs-3451	18	23	be	be	AUX
iajs-3451	18	24	increased	increase	VERB
iajs-3451	18	25	in	in	ADP
iajs-3451	18	26	a	a	DET
iajs-3451	18	27	variety	variety	NOUN
iajs-3451	18	28	of	of	ADP
iajs-3451	18	29	disorders	disorder	NOUN
iajs-3451	18	30	through	through	ADP
iajs-3451	18	31	infections	infection	NOUN
iajs-3451	18	32	and	and	CCONJ
iajs-3451	18	33	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3451	18	34	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	VERB
iajs-3451	18	35	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	VERB
iajs-3451	18	36	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	18	37	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	18	38	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	18	39	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	18	40	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	1	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	2	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	3	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	4	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	5	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	6	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	7	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	8	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	9	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	10	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	11	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	12	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	13	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	14	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	15	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	16	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	17	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	18	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	19	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	20	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	21	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	22	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	23	https://orcid.org/0009-0006-1661-3276	https://orcid.org/0009-0006-1661-3276	PROPN
iajs-3451	19	24	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	mailto:zahraa.gtuf2102m@csw.uobaghdad.edu.iq	PROPN
iajs-3451	19	25	https://orcid.org/0000-0001-9831-6713	https://orcid.org/0000-0001-9831-6713	PROPN
iajs-3451	19	26	mailto:wasan.a@csw.uobaghdad.edu.iq	mailto:wasan.a@csw.uobaghdad.edu.iq	NOUN
iajs-3451	19	27	ihjpas	ihjpas	PROPN
iajs-3451	19	28	.	.	PUNCT
iajs-3451	20	1	37	37	NUM
iajs-3451	20	2	(	(	PUNCT
iajs-3451	20	3	2	2	NUM
iajs-3451	20	4	)	)	PUNCT
iajs-3451	20	5	2024	2024	NUM
iajs-3451	20	6	129	129	NUM
iajs-3451	20	7	inflammation	inflammation	NOUN
iajs-3451	20	8	in	in	ADP
iajs-3451	20	9	addition	addition	NOUN
iajs-3451	20	10	to	to	ADP
iajs-3451	20	11	autoimmune	autoimmune	ADJ
iajs-3451	20	12	diseases	disease	NOUN
iajs-3451	20	13	,	,	PUNCT
iajs-3451	20	14	as	as	ADP
iajs-3451	20	15	in	in	ADP
iajs-3451	20	16	the	the	DET
iajs-3451	20	17	present	present	ADJ
iajs-3451	20	18	results	result	NOUN
iajs-3451	20	19	,	,	PUNCT
iajs-3451	20	20	this	this	DET
iajs-3451	20	21	current	current	ADJ
iajs-3451	20	22	study	study	NOUN
iajs-3451	20	23	is	be	AUX
iajs-3451	20	24	compatible	compatible	ADJ
iajs-3451	20	25	with	with	ADP
iajs-3451	20	26	[	[	X
iajs-3451	20	27	11	11	NUM
iajs-3451	20	28	]	]	PUNCT
iajs-3451	20	29	,	,	PUNCT
iajs-3451	20	30	which	which	PRON
iajs-3451	20	31	concluded	conclude	VERB
iajs-3451	20	32	that	that	SCONJ
iajs-3451	20	33	esr	esr	PROPN
iajs-3451	20	34	values	value	NOUN
iajs-3451	20	35	can	can	AUX
iajs-3451	20	36	be	be	AUX
iajs-3451	20	37	raised	raise	VERB
iajs-3451	20	38	in	in	ADP
iajs-3451	20	39	ra	ra	PROPN
iajs-3451	20	40	and	and	CCONJ
iajs-3451	20	41	utilized	utilize	VERB
iajs-3451	20	42	as	as	ADP
iajs-3451	20	43	a	a	DET
iajs-3451	20	44	screening	screening	NOUN
iajs-3451	20	45	test	test	NOUN
iajs-3451	20	46	to	to	PART
iajs-3451	20	47	determine	determine	VERB
iajs-3451	20	48	the	the	DET
iajs-3451	20	49	intensity	intensity	NOUN
iajs-3451	20	50	of	of	ADP
iajs-3451	20	51	the	the	DET
iajs-3451	20	52	disease	disease	NOUN
iajs-3451	20	53	,	,	PUNCT
iajs-3451	20	54	although	although	SCONJ
iajs-3451	20	55	it	it	PRON
iajs-3451	20	56	has	have	VERB
iajs-3451	20	57	considerably	considerably	ADV
iajs-3451	20	58	poorer	poor	ADJ
iajs-3451	20	59	specificity	specificity	NOUN
iajs-3451	20	60	than	than	ADP
iajs-3451	20	61	crp	crp	PROPN
iajs-3451	20	62	and	and	CCONJ
iajs-3451	20	63	rf	rf	NOUN
iajs-3451	20	64	.	.	PUNCT
iajs-3451	21	1	the	the	DET
iajs-3451	21	2	reason	reason	NOUN
iajs-3451	21	3	for	for	ADP
iajs-3451	21	4	elevated	elevated	ADJ
iajs-3451	21	5	levels	level	NOUN
iajs-3451	21	6	of	of	ADP
iajs-3451	21	7	esr	esr	PROPN
iajs-3451	21	8	in	in	ADP
iajs-3451	21	9	ra	ra	PROPN
iajs-3451	21	10	may	may	AUX
iajs-3451	21	11	be	be	AUX
iajs-3451	21	12	an	an	DET
iajs-3451	21	13	increase	increase	NOUN
iajs-3451	21	14	in	in	ADP
iajs-3451	21	15	fibrinogen	fibrinogen	NOUN
iajs-3451	21	16	levels	level	NOUN
iajs-3451	21	17	,	,	PUNCT
iajs-3451	21	18	which	which	PRON
iajs-3451	21	19	makes	make	VERB
iajs-3451	21	20	the	the	DET
iajs-3451	21	21	red	red	ADJ
iajs-3451	21	22	blood	blood	NOUN
iajs-3451	21	23	cells	cell	NOUN
iajs-3451	21	24	sticky	sticky	ADJ
iajs-3451	21	25	and	and	CCONJ
iajs-3451	21	26	accelerate	accelerate	VERB
iajs-3451	21	27	the	the	DET
iajs-3451	21	28	sedimentation	sedimentation	NOUN
iajs-3451	21	29	process	process	NOUN
iajs-3451	21	30	[	[	X
iajs-3451	21	31	12	12	NUM
iajs-3451	21	32	]	]	PUNCT
iajs-3451	21	33	.	.	PUNCT
iajs-3451	22	1	however	however	ADV
iajs-3451	22	2	,	,	PUNCT
iajs-3451	22	3	the	the	DET
iajs-3451	22	4	rheumatoid	rheumatoid	NOUN
iajs-3451	22	5	factor	factor	NOUN
iajs-3451	22	6	(	(	PUNCT
iajs-3451	22	7	rf	rf	NOUN
iajs-3451	22	8	)	)	PUNCT
iajs-3451	22	9	is	be	AUX
iajs-3451	22	10	an	an	DET
iajs-3451	22	11	autoantibody	autoantibody	NOUN
iajs-3451	22	12	that	that	PRON
iajs-3451	22	13	targets	target	VERB
iajs-3451	22	14	the	the	DET
iajs-3451	22	15	immunoglobulin	immunoglobulin	NOUN
iajs-3451	22	16	g	g	PROPN
iajs-3451	22	17	(	(	PUNCT
iajs-3451	22	18	igg	igg	PROPN
iajs-3451	22	19	)	)	PUNCT
iajs-3451	22	20	fc	fc	PROPN
iajs-3451	22	21	,	,	PUNCT
iajs-3451	22	22	or	or	CCONJ
iajs-3451	22	23	crystallizable	crystallizable	ADJ
iajs-3451	22	24	fragment	fragment	NOUN
iajs-3451	22	25	.	.	PUNCT
iajs-3451	23	1	these	these	DET
iajs-3451	23	2	autoantibodies	autoantibody	NOUN
iajs-3451	23	3	target	target	VERB
iajs-3451	23	4	the	the	DET
iajs-3451	23	5	joints	joint	NOUN
iajs-3451	23	6	during	during	ADP
iajs-3451	23	7	inflammation	inflammation	NOUN
iajs-3451	23	8	.	.	PUNCT
iajs-3451	24	1	recently	recently	ADV
iajs-3451	24	2	,	,	PUNCT
iajs-3451	24	3	the	the	DET
iajs-3451	24	4	presence	presence	NOUN
iajs-3451	24	5	of	of	ADP
iajs-3451	24	6	anti	anti	ADJ
iajs-3451	24	7	-	-	ADJ
iajs-3451	24	8	citrullinated	citrullinate	VERB
iajs-3451	24	9	protein	protein	NOUN
iajs-3451	24	10	antibodies	antibodie	VERB
iajs-3451	24	11	(	(	PUNCT
iajs-3451	24	12	acpas	acpas	PROPN
iajs-3451	24	13	)	)	PUNCT
iajs-3451	24	14	has	have	AUX
iajs-3451	24	15	been	be	AUX
iajs-3451	24	16	associated	associate	VERB
iajs-3451	24	17	with	with	ADP
iajs-3451	24	18	rheumatoid	rheumatoid	NOUN
iajs-3451	24	19	arthritis	arthritis	NOUN
iajs-3451	24	20	.	.	PUNCT
iajs-3451	25	1	these	these	DET
iajs-3451	25	2	autoantibodies	autoantibody	NOUN
iajs-3451	25	3	target	target	VERB
iajs-3451	25	4	the	the	DET
iajs-3451	25	5	joints	joint	NOUN
iajs-3451	25	6	during	during	ADP
iajs-3451	25	7	inflammation	inflammation	NOUN
iajs-3451	25	8	by	by	ADP
iajs-3451	25	9	modifying	modify	VERB
iajs-3451	25	10	proteins	protein	NOUN
iajs-3451	25	11	in	in	ADP
iajs-3451	25	12	inflamed	inflame	VERB
iajs-3451	25	13	joints	joint	NOUN
iajs-3451	25	14	[	[	X
iajs-3451	25	15	13	13	NUM
iajs-3451	25	16	-	-	SYM
iajs-3451	25	17	15	15	NUM
iajs-3451	25	18	]	]	PUNCT
iajs-3451	25	19	.	.	PUNCT
iajs-3451	26	1	therefore	therefore	ADV
iajs-3451	26	2	,	,	PUNCT
iajs-3451	26	3	one	one	NUM
iajs-3451	26	4	of	of	ADP
iajs-3451	26	5	the	the	DET
iajs-3451	26	6	most	most	ADV
iajs-3451	26	7	important	important	ADJ
iajs-3451	26	8	diagnostic	diagnostic	ADJ
iajs-3451	26	9	criteria	criterion	NOUN
iajs-3451	26	10	for	for	ADP
iajs-3451	26	11	rheumatoid	rheumatoid	NOUN
iajs-3451	26	12	arthritis	arthritis	NOUN
iajs-3451	26	13	,	,	PUNCT
iajs-3451	26	14	according	accord	VERB
iajs-3451	26	15	to	to	ADP
iajs-3451	26	16	the	the	DET
iajs-3451	26	17	european	european	PROPN
iajs-3451	26	18	league	league	PROPN
iajs-3451	26	19	against	against	ADP
iajs-3451	26	20	rheumatism	rheumatism	NOUN
iajs-3451	26	21	(	(	PUNCT
iajs-3451	26	22	eular	eular	ADJ
iajs-3451	26	23	)	)	PUNCT
iajs-3451	26	24	,	,	PUNCT
iajs-3451	26	25	is	be	AUX
iajs-3451	26	26	rf	rf	VERB
iajs-3451	26	27	,	,	PUNCT
iajs-3451	26	28	in	in	ADP
iajs-3451	26	29	addition	addition	NOUN
iajs-3451	26	30	to	to	ADP
iajs-3451	26	31	anti	anti	ADJ
iajs-3451	26	32	-	-	ADJ
iajs-3451	26	33	citrullinated	citrullinate	VERB
iajs-3451	26	34	protein	protein	NOUN
iajs-3451	26	35	antibodies	antibodie	VERB
iajs-3451	26	36	(	(	PUNCT
iajs-3451	26	37	accpa	accpa	NOUN
iajs-3451	26	38	)	)	PUNCT
iajs-3451	26	39	as	as	ADP
iajs-3451	26	40	serological	serological	ADJ
iajs-3451	26	41	markers	marker	NOUN
iajs-3451	26	42	.	.	PUNCT
iajs-3451	27	1	several	several	ADJ
iajs-3451	27	2	studies	study	NOUN
iajs-3451	27	3	have	have	AUX
iajs-3451	27	4	suggested	suggest	VERB
iajs-3451	27	5	these	these	DET
iajs-3451	27	6	tests	test	NOUN
iajs-3451	27	7	as	as	ADP
iajs-3451	27	8	the	the	DET
iajs-3451	27	9	best	good	ADJ
iajs-3451	27	10	predictors	predictor	NOUN
iajs-3451	27	11	of	of	ADP
iajs-3451	27	12	rheumatoid	rheumatoid	NOUN
iajs-3451	27	13	arthritis	arthritis	NOUN
iajs-3451	27	14	and	and	CCONJ
iajs-3451	27	15	also	also	ADV
iajs-3451	27	16	of	of	ADP
iajs-3451	27	17	cartilage	cartilage	NOUN
iajs-3451	27	18	and	and	CCONJ
iajs-3451	27	19	bone	bone	NOUN
iajs-3451	27	20	destruction	destruction	NOUN
iajs-3451	27	21	[	[	X
iajs-3451	27	22	16	16	NUM
iajs-3451	27	23	-	-	SYM
iajs-3451	27	24	19	19	NUM
iajs-3451	27	25	]	]	PUNCT
iajs-3451	27	26	.	.	PUNCT
iajs-3451	28	1	as	as	ADV
iajs-3451	28	2	well	well	ADV
iajs-3451	28	3	as	as	ADP
iajs-3451	28	4	the	the	DET
iajs-3451	28	5	c	c	NOUN
iajs-3451	28	6	-	-	PUNCT
iajs-3451	28	7	reactive	reactive	ADJ
iajs-3451	28	8	protein	protein	NOUN
iajs-3451	28	9	(	(	PUNCT
iajs-3451	28	10	crp	crp	PROPN
iajs-3451	28	11	)	)	PUNCT
iajs-3451	29	1	,	,	PUNCT
iajs-3451	29	2	is	be	AUX
iajs-3451	29	3	a	a	DET
iajs-3451	29	4	cyclic	cyclic	ADJ
iajs-3451	29	5	protein	protein	NOUN
iajs-3451	29	6	with	with	ADP
iajs-3451	29	7	five	five	NUM
iajs-3451	29	8	links	link	NOUN
iajs-3451	29	9	that	that	PRON
iajs-3451	29	10	is	be	AUX
iajs-3451	29	11	detected	detect	VERB
iajs-3451	29	12	in	in	ADP
iajs-3451	29	13	blood	blood	NOUN
iajs-3451	29	14	plasma	plasma	NOUN
iajs-3451	29	15	and	and	CCONJ
iajs-3451	29	16	rises	rise	VERB
iajs-3451	29	17	in	in	ADP
iajs-3451	29	18	response	response	NOUN
iajs-3451	29	19	to	to	ADP
iajs-3451	29	20	inflammation	inflammation	NOUN
iajs-3451	29	21	predominantly	predominantly	ADV
iajs-3451	29	22	in	in	ADP
iajs-3451	29	23	the	the	DET
iajs-3451	29	24	liver	liver	NOUN
iajs-3451	29	25	,	,	PUNCT
iajs-3451	29	26	though	though	SCONJ
iajs-3451	29	27	it	it	PRON
iajs-3451	29	28	can	can	AUX
iajs-3451	29	29	also	also	ADV
iajs-3451	29	30	be	be	AUX
iajs-3451	29	31	made	make	VERB
iajs-3451	29	32	by	by	ADP
iajs-3451	29	33	fat	fat	ADJ
iajs-3451	29	34	and	and	CCONJ
iajs-3451	29	35	inflammatory	inflammatory	ADJ
iajs-3451	29	36	cells	cell	NOUN
iajs-3451	29	37	because	because	SCONJ
iajs-3451	29	38	it	it	PRON
iajs-3451	29	39	was	be	AUX
iajs-3451	29	40	initially	initially	ADV
iajs-3451	29	41	discovered	discover	VERB
iajs-3451	29	42	to	to	PART
iajs-3451	29	43	be	be	AUX
iajs-3451	29	44	a	a	DET
iajs-3451	29	45	material	material	NOUN
iajs-3451	29	46	in	in	ADP
iajs-3451	29	47	the	the	DET
iajs-3451	29	48	blood	blood	NOUN
iajs-3451	29	49	of	of	ADP
iajs-3451	29	50	individuals	individual	NOUN
iajs-3451	29	51	with	with	ADP
iajs-3451	29	52	acute	acute	ADJ
iajs-3451	29	53	inflammation	inflammation	NOUN
iajs-3451	29	54	that	that	SCONJ
iajs-3451	29	55	reacts	react	VERB
iajs-3451	29	56	with	with	ADP
iajs-3451	29	57	the	the	DET
iajs-3451	29	58	carbohydrate	carbohydrate	NOUN
iajs-3451	29	59	(	(	PUNCT
iajs-3451	29	60	c	c	NOUN
iajs-3451	29	61	)	)	PUNCT
iajs-3451	29	62	antibody	antibody	NOUN
iajs-3451	29	63	in	in	ADP
iajs-3451	29	64	the	the	DET
iajs-3451	29	65	pneumococcal	pneumococcal	ADJ
iajs-3451	29	66	capsule	capsule	NOUN
iajs-3451	29	67	.	.	PUNCT
iajs-3451	30	1	the	the	DET
iajs-3451	30	2	designation	designation	NOUN
iajs-3451	30	3	name	name	NOUN
iajs-3451	30	4	given	give	VERB
iajs-3451	30	5	to	to	ADP
iajs-3451	30	6	crp	crp	PROPN
iajs-3451	30	7	is	be	AUX
iajs-3451	30	8	due	due	ADJ
iajs-3451	30	9	to	to	ADP
iajs-3451	30	10	the	the	DET
iajs-3451	30	11	fact	fact	NOUN
iajs-3451	30	12	that	that	SCONJ
iajs-3451	30	13	crp	crp	PROPN
iajs-3451	30	14	is	be	AUX
iajs-3451	30	15	high	high	ADJ
iajs-3451	30	16	in	in	ADP
iajs-3451	30	17	persons	person	NOUN
iajs-3451	30	18	with	with	ADP
iajs-3451	30	19	underlying	underlie	VERB
iajs-3451	30	20	illnesses	illness	NOUN
iajs-3451	30	21	such	such	ADJ
iajs-3451	30	22	as	as	ADP
iajs-3451	30	23	advanced	advanced	ADJ
iajs-3451	30	24	cancer	cancer	NOUN
iajs-3451	30	25	,	,	PUNCT
iajs-3451	30	26	hepatitis	hepatitis	NOUN
iajs-3451	30	27	,	,	PUNCT
iajs-3451	30	28	arthritis	arthritis	NOUN
iajs-3451	30	29	,	,	PUNCT
iajs-3451	30	30	tissue	tissue	NOUN
iajs-3451	30	31	damage	damage	NOUN
iajs-3451	30	32	,	,	PUNCT
iajs-3451	30	33	viral	viral	ADJ
iajs-3451	30	34	or	or	CCONJ
iajs-3451	30	35	bacterial	bacterial	ADJ
iajs-3451	30	36	infection	infection	NOUN
iajs-3451	30	37	,	,	PUNCT
iajs-3451	30	38	and	and	CCONJ
iajs-3451	30	39	several	several	ADJ
iajs-3451	30	40	other	other	ADJ
iajs-3451	30	41	autoimmune	autoimmune	ADJ
iajs-3451	30	42	problems	problem	NOUN
iajs-3451	30	43	[	[	X
iajs-3451	30	44	20	20	NUM
iajs-3451	30	45	,	,	PUNCT
iajs-3451	30	46	21	21	NUM
iajs-3451	30	47	]	]	PUNCT
iajs-3451	30	48	.	.	PUNCT
iajs-3451	31	1	the	the	DET
iajs-3451	31	2	aim	aim	NOUN
iajs-3451	31	3	of	of	ADP
iajs-3451	31	4	the	the	DET
iajs-3451	31	5	current	current	ADJ
iajs-3451	31	6	study	study	NOUN
iajs-3451	31	7	is	be	AUX
iajs-3451	31	8	to	to	PART
iajs-3451	31	9	assess	assess	VERB
iajs-3451	31	10	the	the	DET
iajs-3451	31	11	levels	level	NOUN
iajs-3451	31	12	of	of	ADP
iajs-3451	31	13	some	some	DET
iajs-3451	31	14	hematological	hematological	ADJ
iajs-3451	31	15	parameters	parameter	NOUN
iajs-3451	31	16	,	,	PUNCT
iajs-3451	31	17	including	include	VERB
iajs-3451	31	18	erythrocyte	erythrocyte	PROPN
iajs-3451	31	19	sedimentation	sedimentation	NOUN
iajs-3451	31	20	rate	rate	NOUN
iajs-3451	31	21	(	(	PUNCT
iajs-3451	31	22	esr	esr	PROPN
iajs-3451	31	23	)	)	PUNCT
iajs-3451	31	24	,	,	PUNCT
iajs-3451	31	25	complete	complete	ADJ
iajs-3451	31	26	blood	blood	NOUN
iajs-3451	31	27	count	count	NOUN
iajs-3451	31	28	(	(	PUNCT
iajs-3451	31	29	cbc	cbc	PROPN
iajs-3451	31	30	)	)	PUNCT
iajs-3451	31	31	,	,	PUNCT
iajs-3451	31	32	and	and	CCONJ
iajs-3451	31	33	blood	blood	NOUN
iajs-3451	31	34	groups	group	NOUN
iajs-3451	31	35	in	in	ADP
iajs-3451	31	36	the	the	DET
iajs-3451	31	37	studied	study	VERB
iajs-3451	31	38	groups	group	NOUN
iajs-3451	31	39	(	(	PUNCT
iajs-3451	31	40	patients	patient	NOUN
iajs-3451	31	41	and	and	CCONJ
iajs-3451	31	42	controls	control	NOUN
iajs-3451	31	43	)	)	PUNCT
iajs-3451	31	44	,	,	PUNCT
iajs-3451	31	45	in	in	ADP
iajs-3451	31	46	addition	addition	NOUN
iajs-3451	31	47	to	to	ADP
iajs-3451	31	48	the	the	DET
iajs-3451	31	49	estimated	estimate	VERB
iajs-3451	31	50	serological	serological	ADJ
iajs-3451	31	51	tests	test	NOUN
iajs-3451	31	52	,	,	PUNCT
iajs-3451	31	53	including	include	VERB
iajs-3451	31	54	rheumatoid	rheumatoid	NOUN
iajs-3451	31	55	factor	factor	NOUN
iajs-3451	31	56	(	(	PUNCT
iajs-3451	31	57	rf	rf	NOUN
iajs-3451	31	58	)	)	PUNCT
iajs-3451	31	59	and	and	CCONJ
iajs-3451	31	60	creactive	creactive	ADJ
iajs-3451	31	61	protein	protein	NOUN
iajs-3451	31	62	in	in	ADP
iajs-3451	31	63	these	these	DET
iajs-3451	31	64	groups	group	NOUN
iajs-3451	31	65	.	.	PUNCT
iajs-3451	32	1	2	2	X
iajs-3451	32	2	.	.	X
iajs-3451	32	3	materials	material	NOUN
iajs-3451	32	4	and	and	CCONJ
iajs-3451	32	5	methods	method	NOUN
iajs-3451	32	6	the	the	DET
iajs-3451	32	7	present	present	ADJ
iajs-3451	32	8	study	study	NOUN
iajs-3451	32	9	included	include	VERB
iajs-3451	32	10	110,000	110,000	NUM
iajs-3451	32	11	blood	blood	NOUN
iajs-3451	32	12	samples	sample	NOUN
iajs-3451	32	13	collected	collect	VERB
iajs-3451	32	14	from	from	ADP
iajs-3451	32	15	patients	patient	NOUN
iajs-3451	32	16	with	with	ADP
iajs-3451	32	17	rheumatoid	rheumatoid	NOUN
iajs-3451	32	18	arthritis	arthritis	NOUN
iajs-3451	32	19	by	by	ADP
iajs-3451	32	20	a	a	DET
iajs-3451	32	21	rheumatology	rheumatology	NOUN
iajs-3451	32	22	clinic	clinic	NOUN
iajs-3451	32	23	in	in	ADP
iajs-3451	32	24	the	the	DET
iajs-3451	32	25	baghdad	baghdad	PROPN
iajs-3451	32	26	teaching	teaching	NOUN
iajs-3451	32	27	hospital	hospital	NOUN
iajs-3451	32	28	of	of	ADP
iajs-3451	32	29	iraq	iraq	PROPN
iajs-3451	32	30	from	from	ADP
iajs-3451	32	31	october	october	PROPN
iajs-3451	32	32	2022	2022	NUM
iajs-3451	32	33	to	to	ADP
iajs-3451	32	34	december	december	PROPN
iajs-3451	32	35	2022	2022	NUM
iajs-3451	32	36	.	.	PUNCT
iajs-3451	33	1	a	a	DET
iajs-3451	33	2	medical	medical	ADJ
iajs-3451	33	3	history	history	NOUN
iajs-3451	33	4	was	be	AUX
iajs-3451	33	5	collected	collect	VERB
iajs-3451	33	6	from	from	ADP
iajs-3451	33	7	each	each	DET
iajs-3451	33	8	patient	patient	NOUN
iajs-3451	33	9	(	(	PUNCT
iajs-3451	33	10	age	age	NOUN
iajs-3451	33	11	,	,	PUNCT
iajs-3451	33	12	sex	sex	NOUN
iajs-3451	33	13	,	,	PUNCT
iajs-3451	33	14	address	address	NOUN
iajs-3451	33	15	,	,	PUNCT
iajs-3451	33	16	and	and	CCONJ
iajs-3451	33	17	absence	absence	NOUN
iajs-3451	33	18	of	of	ADP
iajs-3451	33	19	other	other	ADJ
iajs-3451	33	20	diseases	disease	NOUN
iajs-3451	33	21	)	)	PUNCT
iajs-3451	33	22	.	.	PUNCT
iajs-3451	34	1	the	the	DET
iajs-3451	34	2	number	number	NOUN
iajs-3451	34	3	was	be	AUX
iajs-3451	34	4	21	21	NUM
iajs-3451	34	5	males	male	NOUN
iajs-3451	34	6	and	and	CCONJ
iajs-3451	34	7	39	39	NUM
iajs-3451	34	8	females	female	NOUN
iajs-3451	34	9	.	.	PUNCT
iajs-3451	35	1	the	the	DET
iajs-3451	35	2	ages	age	NOUN
iajs-3451	35	3	ranged	range	VERB
iajs-3451	35	4	from	from	ADP
iajs-3451	35	5	20	20	NUM
iajs-3451	35	6	to	to	PART
iajs-3451	35	7	69	69	NUM
iajs-3451	35	8	years	year	NOUN
iajs-3451	35	9	,	,	PUNCT
iajs-3451	35	10	and	and	CCONJ
iajs-3451	35	11	50	50	NUM
iajs-3451	35	12	healthy	healthy	ADJ
iajs-3451	35	13	persons	person	NOUN
iajs-3451	35	14	(	(	PUNCT
iajs-3451	35	15	21	21	NUM
iajs-3451	35	16	males	male	NOUN
iajs-3451	35	17	and	and	CCONJ
iajs-3451	35	18	29	29	NUM
iajs-3451	35	19	females	female	NOUN
iajs-3451	35	20	)	)	PUNCT
iajs-3451	35	21	were	be	AUX
iajs-3451	35	22	included	include	VERB
iajs-3451	35	23	for	for	ADP
iajs-3451	35	24	comparison	comparison	NOUN
iajs-3451	35	25	.	.	PUNCT
iajs-3451	36	1	5	5	NUM
iajs-3451	36	2	milliliters	milliliter	NOUN
iajs-3451	36	3	of	of	ADP
iajs-3451	36	4	blood	blood	NOUN
iajs-3451	36	5	samples	sample	NOUN
iajs-3451	36	6	were	be	AUX
iajs-3451	36	7	divided	divide	VERB
iajs-3451	36	8	into	into	ADP
iajs-3451	36	9	two	two	NUM
iajs-3451	36	10	test	test	NOUN
iajs-3451	36	11	tubes	tube	NOUN
iajs-3451	36	12	;	;	PUNCT
iajs-3451	36	13	3	3	NUM
iajs-3451	36	14	ml	ml	NOUN
iajs-3451	36	15	of	of	ADP
iajs-3451	36	16	blood	blood	NOUN
iajs-3451	36	17	samples	sample	NOUN
iajs-3451	36	18	were	be	AUX
iajs-3451	36	19	left	leave	VERB
iajs-3451	36	20	to	to	PART
iajs-3451	36	21	clot	clot	VERB
iajs-3451	36	22	at	at	ADP
iajs-3451	36	23	room	room	NOUN
iajs-3451	36	24	temperature	temperature	NOUN
iajs-3451	36	25	for	for	ADP
iajs-3451	36	26	10–15	10–15	NUM
iajs-3451	36	27	minutes	minute	NOUN
iajs-3451	36	28	and	and	CCONJ
iajs-3451	36	29	then	then	ADV
iajs-3451	36	30	centrifuged	centrifuge	VERB
iajs-3451	36	31	at	at	ADP
iajs-3451	36	32	2500	2500	NUM
iajs-3451	36	33	rpm	rpm	NOUN
iajs-3451	36	34	for	for	ADP
iajs-3451	36	35	15	15	NUM
iajs-3451	36	36	minutes	minute	NOUN
iajs-3451	36	37	to	to	PART
iajs-3451	36	38	obtain	obtain	VERB
iajs-3451	36	39	serum	serum	NOUN
iajs-3451	36	40	for	for	ADP
iajs-3451	36	41	crp	crp	PROPN
iajs-3451	36	42	,	,	PUNCT
iajs-3451	36	43	rf	rf	NOUN
iajs-3451	36	44	tests	test	NOUN
iajs-3451	36	45	,	,	PUNCT
iajs-3451	36	46	and	and	CCONJ
iajs-3451	36	47	2	2	NUM
iajs-3451	36	48	ml	ml	NOUN
iajs-3451	36	49	edta	edta	NOUN
iajs-3451	36	50	tubes	tube	NOUN
iajs-3451	36	51	for	for	ADP
iajs-3451	36	52	esr	esr	PROPN
iajs-3451	36	53	and	and	CCONJ
iajs-3451	36	54	blood	blood	NOUN
iajs-3451	36	55	grouping	group	VERB
iajs-3451	36	56	tests	test	NOUN
iajs-3451	36	57	[	[	X
iajs-3451	36	58	22	22	NUM
iajs-3451	36	59	]	]	PUNCT
iajs-3451	36	60	.	.	PUNCT
iajs-3451	37	1	3	3	X
iajs-3451	37	2	.	.	NOUN
iajs-3451	37	3	results	result	NOUN
iajs-3451	37	4	and	and	CCONJ
iajs-3451	37	5	discussion	discussion	NOUN
iajs-3451	37	6	3.1	3.1	NUM
iajs-3451	37	7	.	.	PUNCT
iajs-3451	38	1	erythrocyte	erythrocyte	PROPN
iajs-3451	38	2	sedimentation	sedimentation	NOUN
iajs-3451	38	3	rate	rate	NOUN
iajs-3451	38	4	(	(	PUNCT
iajs-3451	38	5	esr	esr	PROPN
iajs-3451	38	6	)	)	PUNCT
iajs-3451	38	7	,	,	PUNCT
iajs-3451	38	8	wbc	wbc	PROPN
iajs-3451	38	9	,	,	PUNCT
iajs-3451	38	10	rbc	rbc	PROPN
iajs-3451	38	11	and	and	CCONJ
iajs-3451	38	12	plt	plt	NOUN
iajs-3451	38	13	in	in	ADP
iajs-3451	38	14	rheumatoid	rheumatoid	NOUN
iajs-3451	38	15	arthritis	arthritis	NOUN
iajs-3451	38	16	patients	patient	NOUN
iajs-3451	38	17	and	and	CCONJ
iajs-3451	38	18	control	control	NOUN
iajs-3451	38	19	groups	group	NOUN
iajs-3451	38	20	the	the	DET
iajs-3451	38	21	current	current	ADJ
iajs-3451	38	22	results	result	NOUN
iajs-3451	38	23	show	show	VERB
iajs-3451	38	24	that	that	SCONJ
iajs-3451	38	25	the	the	DET
iajs-3451	38	26	hematologic	hematologic	ADJ
iajs-3451	38	27	indicators	indicator	NOUN
iajs-3451	38	28	had	have	VERB
iajs-3451	38	29	a	a	DET
iajs-3451	38	30	highly	highly	ADV
iajs-3451	38	31	significant	significant	ADJ
iajs-3451	38	32	(	(	PUNCT
iajs-3451	38	33	p≤0.01	p≤0.01	NOUN
iajs-3451	38	34	)	)	PUNCT
iajs-3451	38	35	value	value	NOUN
iajs-3451	38	36	for	for	ADP
iajs-3451	38	37	esr	esr	PROPN
iajs-3451	38	38	(	(	PUNCT
iajs-3451	38	39	28.25	28.25	NUM
iajs-3451	38	40	±	±	NUM
iajs-3451	38	41	2.72	2.72	NUM
iajs-3451	38	42	)	)	PUNCT
iajs-3451	38	43	for	for	ADP
iajs-3451	38	44	patients	patient	NOUN
iajs-3451	38	45	and	and	CCONJ
iajs-3451	38	46	(	(	PUNCT
iajs-3451	38	47	16.24	16.24	NUM
iajs-3451	38	48	±1.83	±1.83	PROPN
iajs-3451	38	49	)	)	PUNCT
iajs-3451	38	50	for	for	ADP
iajs-3451	38	51	control	control	NOUN
iajs-3451	38	52	,	,	PUNCT
iajs-3451	38	53	but	but	CCONJ
iajs-3451	38	54	there	there	PRON
iajs-3451	38	55	were	be	VERB
iajs-3451	38	56	no	no	DET
iajs-3451	38	57	significant	significant	ADJ
iajs-3451	38	58	differences	difference	NOUN
iajs-3451	38	59	for	for	ADP
iajs-3451	38	60	other	other	ADJ
iajs-3451	38	61	parameters	parameter	NOUN
iajs-3451	38	62	(	(	PUNCT
iajs-3451	38	63	wbc	wbc	PROPN
iajs-3451	38	64	,	,	PUNCT
iajs-3451	38	65	rbc	rbc	PROPN
iajs-3451	38	66	,	,	PUNCT
iajs-3451	38	67	and	and	CCONJ
iajs-3451	38	68	plt	plt	NOUN
iajs-3451	38	69	)	)	PUNCT
iajs-3451	38	70	(	(	PUNCT
iajs-3451	38	71	7.34	7.34	NUM
iajs-3451	38	72	±	±	NUM
iajs-3451	38	73	0.25	0.25	NUM
iajs-3451	38	74	,	,	PUNCT
iajs-3451	38	75	4.71	4.71	NUM
iajs-3451	38	76	±	±	NUM
iajs-3451	38	77	0.08	0.08	NUM
iajs-3451	38	78	,	,	PUNCT
iajs-3451	38	79	and	and	CCONJ
iajs-3451	38	80	248.26	248.26	NUM
iajs-3451	38	81	±9.18	±9.18	PROPN
iajs-3451	38	82	,	,	PUNCT
iajs-3451	38	83	respectively	respectively	ADV
iajs-3451	38	84	)	)	PUNCT
iajs-3451	38	85	for	for	ADP
iajs-3451	38	86	patients	patient	NOUN
iajs-3451	38	87	compared	compare	VERB
iajs-3451	38	88	with	with	ADP
iajs-3451	38	89	the	the	DET
iajs-3451	38	90	control	control	NOUN
iajs-3451	38	91	group	group	NOUN
iajs-3451	38	92	(	(	PUNCT
iajs-3451	38	93	6.73	6.73	NUM
iajs-3451	38	94	±0.19	±0.19	NOUN
iajs-3451	38	95	,	,	PUNCT
iajs-3451	38	96	4.96	4.96	NUM
iajs-3451	38	97	±0.10	±0.10	NOUN
iajs-3451	38	98	,	,	PUNCT
iajs-3451	38	99	263.64	263.64	NUM
iajs-3451	38	100	±8.26	±8.26	NOUN
iajs-3451	38	101	,	,	PUNCT
iajs-3451	38	102	respectively	respectively	ADV
iajs-3451	38	103	)	)	PUNCT
iajs-3451	38	104	table	table	NOUN
iajs-3451	38	105	1	1	NUM
iajs-3451	38	106	ihjpas	ihjpa	NOUN
iajs-3451	38	107	.	.	PUNCT
iajs-3451	39	1	37	37	NUM
iajs-3451	39	2	(	(	PUNCT
iajs-3451	39	3	2	2	NUM
iajs-3451	39	4	)	)	PUNCT
iajs-3451	39	5	2024	2024	NUM
iajs-3451	39	6	130	130	NUM
iajs-3451	39	7	table	table	NOUN
iajs-3451	39	8	1	1	NUM
iajs-3451	39	9	.	.	PUNCT
iajs-3451	39	10	comparison	comparison	NOUN
iajs-3451	39	11	between	between	ADP
iajs-3451	39	12	esr	esr	PROPN
iajs-3451	39	13	,	,	PUNCT
iajs-3451	39	14	wbc	wbc	PROPN
iajs-3451	39	15	,	,	PUNCT
iajs-3451	39	16	rbc	rbc	PROPN
iajs-3451	39	17	and	and	CCONJ
iajs-3451	39	18	plt	plt	NOUN
iajs-3451	39	19	parameters	parameter	NOUN
iajs-3451	39	20	of	of	ADP
iajs-3451	39	21	patients	patient	NOUN
iajs-3451	39	22	and	and	CCONJ
iajs-3451	39	23	control	control	NOUN
iajs-3451	39	24	groups	group	NOUN
iajs-3451	39	25	.	.	PUNCT
iajs-3451	40	1	group	group	NOUN
iajs-3451	40	2	mean	mean	VERB
iajs-3451	40	3	±	±	PROPN
iajs-3451	40	4	se	se	PROPN
iajs-3451	40	5	esr	esr	PROPN
iajs-3451	40	6	(	(	PUNCT
iajs-3451	40	7	mm	mm	PROPN
iajs-3451	40	8	/	/	SYM
iajs-3451	40	9	h	h	PROPN
iajs-3451	40	10	)	)	PUNCT
iajs-3451	40	11	wbc	wbc	PROPN
iajs-3451	40	12	rbc	rbc	PROPN
iajs-3451	40	13	plt	plt	PROPN
iajs-3451	40	14	(	(	PUNCT
iajs-3451	40	15	%	%	NOUN
iajs-3451	40	16	)	)	PUNCT
iajs-3451	40	17	patients	patient	NOUN
iajs-3451	40	18	28.25	28.25	NUM
iajs-3451	40	19	±2.72	±2.72	PROPN
iajs-3451	40	20	7.34	7.34	NUM
iajs-3451	40	21	±0.25	±0.25	NOUN
iajs-3451	40	22	4.71	4.71	NUM
iajs-3451	40	23	±0.08	±0.08	PROPN
iajs-3451	40	24	248.26	248.26	NUM
iajs-3451	40	25	±9.18	±9.18	PROPN
iajs-3451	40	26	control	control	NOUN
iajs-3451	40	27	16.24	16.24	NUM
iajs-3451	40	28	±1.83	±1.83	PROPN
iajs-3451	40	29	6.73	6.73	NUM
iajs-3451	40	30	±0.19	±0.19	NOUN
iajs-3451	40	31	4.96	4.96	NUM
iajs-3451	40	32	±0.10	±0.10	PROPN
iajs-3451	40	33	263.64	263.64	NUM
iajs-3451	40	34	±8.26	±8.26	PROPN
iajs-3451	40	35	t	t	NOUN
iajs-3451	40	36	-	-	PUNCT
iajs-3451	40	37	test	test	NOUN
iajs-3451	40	38	6.789	6.789	NUM
iajs-3451	40	39	*	*	PUNCT
iajs-3451	40	40	*	*	SYM
iajs-3451	40	41	0.643	0.643	NUM
iajs-3451	40	42	ns	ns	NUM
iajs-3451	40	43	0.252	0.252	NUM
iajs-3451	40	44	ns	ns	NUM
iajs-3451	40	45	24.935	24.935	NUM
iajs-3451	40	46	ns	ns	NUM
iajs-3451	40	47	p	p	NOUN
iajs-3451	40	48	-	-	PUNCT
iajs-3451	40	49	value	value	NOUN
iajs-3451	40	50	0.0001	0.0001	NUM
iajs-3451	40	51	0.0624	0.0624	NUM
iajs-3451	40	52	0.0571	0.0571	NUM
iajs-3451	40	53	0.224	0.224	NUM
iajs-3451	40	54	*	*	PUNCT
iajs-3451	40	55	*	*	PUNCT
iajs-3451	40	56	highly	highly	ADV
iajs-3451	40	57	significant	significant	ADJ
iajs-3451	40	58	at	at	ADP
iajs-3451	40	59	(	(	PUNCT
iajs-3451	40	60	p≤0.01	p≤0.01	NOUN
iajs-3451	40	61	)	)	PUNCT
iajs-3451	40	62	,	,	PUNCT
iajs-3451	40	63	ns=	ns=	ADJ
iajs-3451	40	64	non	non	ADJ
iajs-3451	40	65	-	-	ADJ
iajs-3451	40	66	significant	significant	ADJ
iajs-3451	40	67	.	.	PUNCT
iajs-3451	41	1	as	as	ADP
iajs-3451	41	2	in	in	ADP
iajs-3451	41	3	the	the	DET
iajs-3451	41	4	present	present	ADJ
iajs-3451	41	5	results	result	NOUN
iajs-3451	41	6	,	,	PUNCT
iajs-3451	41	7	this	this	DET
iajs-3451	41	8	current	current	ADJ
iajs-3451	41	9	study	study	NOUN
iajs-3451	41	10	is	be	AUX
iajs-3451	41	11	compatible	compatible	ADJ
iajs-3451	41	12	with	with	ADP
iajs-3451	41	13	[	[	X
iajs-3451	41	14	23	23	NUM
iajs-3451	41	15	]	]	PUNCT
iajs-3451	41	16	,	,	PUNCT
iajs-3451	41	17	which	which	PRON
iajs-3451	41	18	concluded	conclude	VERB
iajs-3451	41	19	that	that	SCONJ
iajs-3451	41	20	esr	esr	PROPN
iajs-3451	41	21	values	value	NOUN
iajs-3451	41	22	can	can	AUX
iajs-3451	41	23	be	be	AUX
iajs-3451	41	24	raised	raise	VERB
iajs-3451	41	25	in	in	ADP
iajs-3451	41	26	ra	ra	PROPN
iajs-3451	41	27	and	and	CCONJ
iajs-3451	41	28	utilized	utilize	VERB
iajs-3451	41	29	as	as	ADP
iajs-3451	41	30	a	a	DET
iajs-3451	41	31	screening	screening	NOUN
iajs-3451	41	32	test	test	NOUN
iajs-3451	41	33	to	to	PART
iajs-3451	41	34	determine	determine	VERB
iajs-3451	41	35	the	the	DET
iajs-3451	41	36	intensity	intensity	NOUN
iajs-3451	41	37	of	of	ADP
iajs-3451	41	38	the	the	DET
iajs-3451	41	39	disease	disease	NOUN
iajs-3451	41	40	,	,	PUNCT
iajs-3451	41	41	although	although	SCONJ
iajs-3451	41	42	it	it	PRON
iajs-3451	41	43	has	have	VERB
iajs-3451	41	44	considerably	considerably	ADV
iajs-3451	41	45	poorer	poor	ADJ
iajs-3451	41	46	specificity	specificity	NOUN
iajs-3451	41	47	than	than	ADP
iajs-3451	41	48	crp	crp	PROPN
iajs-3451	41	49	and	and	CCONJ
iajs-3451	41	50	rf	rf	NOUN
iajs-3451	41	51	and	and	CCONJ
iajs-3451	41	52	corresponds	correspond	VERB
iajs-3451	41	53	to	to	ADP
iajs-3451	41	54	[	[	X
iajs-3451	41	55	11	11	NUM
iajs-3451	41	56	]	]	PUNCT
iajs-3451	41	57	,	,	PUNCT
iajs-3451	41	58	whose	whose	DET
iajs-3451	41	59	result	result	NOUN
iajs-3451	41	60	of	of	ADP
iajs-3451	41	61	the	the	DET
iajs-3451	41	62	average	average	ADJ
iajs-3451	41	63	esr	esr	PROPN
iajs-3451	41	64	in	in	ADP
iajs-3451	41	65	the	the	DET
iajs-3451	41	66	patient	patient	NOUN
iajs-3451	41	67	group	group	NOUN
iajs-3451	41	68	was	be	AUX
iajs-3451	41	69	42.7	42.7	NUM
iajs-3451	41	70	±	±	NUM
iajs-3451	41	71	31	31	NUM
iajs-3451	41	72	,	,	PUNCT
iajs-3451	41	73	while	while	SCONJ
iajs-3451	41	74	in	in	ADP
iajs-3451	41	75	the	the	DET
iajs-3451	41	76	control	control	NOUN
iajs-3451	41	77	group	group	NOUN
iajs-3451	41	78	it	it	PRON
iajs-3451	41	79	was	be	AUX
iajs-3451	41	80	12.2	12.2	NUM
iajs-3451	41	81	±	±	NUM
iajs-3451	41	82	3.0	3.0	NUM
iajs-3451	41	83	.	.	PUNCT
iajs-3451	42	1	as	as	ADP
iajs-3451	42	2	for	for	ADP
iajs-3451	42	3	the	the	DET
iajs-3451	42	4	non	non	ADJ
iajs-3451	42	5	-	-	ADJ
iajs-3451	42	6	significant	significant	ADJ
iajs-3451	42	7	results	result	NOUN
iajs-3451	42	8	of	of	ADP
iajs-3451	42	9	the	the	DET
iajs-3451	42	10	wbc	wbc	PROPN
iajs-3451	42	11	,	,	PUNCT
iajs-3451	42	12	rbc	rbc	PROPN
iajs-3451	42	13	,	,	PUNCT
iajs-3451	42	14	and	and	CCONJ
iajs-3451	42	15	plt	plt	NOUN
iajs-3451	42	16	parameters	parameter	NOUN
iajs-3451	42	17	,	,	PUNCT
iajs-3451	42	18	they	they	PRON
iajs-3451	42	19	comply	comply	VERB
iajs-3451	42	20	with	with	ADP
iajs-3451	42	21	[	[	X
iajs-3451	42	22	12	12	NUM
iajs-3451	42	23	]	]	PUNCT
iajs-3451	42	24	.	.	PUNCT
iajs-3451	43	1	this	this	PRON
iajs-3451	43	2	may	may	AUX
iajs-3451	43	3	be	be	AUX
iajs-3451	43	4	due	due	ADJ
iajs-3451	43	5	to	to	ADP
iajs-3451	43	6	the	the	DET
iajs-3451	43	7	fact	fact	NOUN
iajs-3451	43	8	that	that	SCONJ
iajs-3451	43	9	most	most	ADJ
iajs-3451	43	10	of	of	ADP
iajs-3451	43	11	the	the	DET
iajs-3451	43	12	patients	patient	NOUN
iajs-3451	43	13	used	use	VERB
iajs-3451	43	14	anti	anti	ADJ
iajs-3451	43	15	-	-	ADJ
iajs-3451	43	16	rheumatic	rheumatic	ADJ
iajs-3451	43	17	drugs	drug	NOUN
iajs-3451	43	18	,	,	PUNCT
iajs-3451	43	19	including	include	VERB
iajs-3451	43	20	mtx	mtx	NOUN
iajs-3451	43	21	,	,	PUNCT
iajs-3451	43	22	as	as	SCONJ
iajs-3451	43	23	their	their	PRON
iajs-3451	43	24	primary	primary	ADJ
iajs-3451	43	25	medication	medication	NOUN
iajs-3451	43	26	or	or	CCONJ
iajs-3451	43	27	other	other	ADJ
iajs-3451	43	28	treatments	treatment	NOUN
iajs-3451	43	29	to	to	PART
iajs-3451	43	30	control	control	VERB
iajs-3451	43	31	this	this	DET
iajs-3451	43	32	disease	disease	NOUN
iajs-3451	43	33	.	.	PUNCT
iajs-3451	44	1	therefore	therefore	ADV
iajs-3451	44	2	,	,	PUNCT
iajs-3451	44	3	the	the	DET
iajs-3451	44	4	percentages	percentage	NOUN
iajs-3451	44	5	of	of	ADP
iajs-3451	44	6	some	some	DET
iajs-3451	44	7	results	result	NOUN
iajs-3451	44	8	for	for	ADP
iajs-3451	44	9	patients	patient	NOUN
iajs-3451	44	10	remained	remain	VERB
iajs-3451	44	11	normal	normal	ADJ
iajs-3451	44	12	and	and	CCONJ
iajs-3451	44	13	approached	approach	VERB
iajs-3451	44	14	the	the	DET
iajs-3451	44	15	control	control	NOUN
iajs-3451	44	16	group	group	NOUN
iajs-3451	44	17	.	.	PUNCT
iajs-3451	45	1	3.2	3.2	NUM
iajs-3451	45	2	.	.	PUNCT
iajs-3451	46	1	blood	blood	NOUN
iajs-3451	46	2	groups	group	NOUN
iajs-3451	46	3	in	in	ADP
iajs-3451	46	4	rheumatoid	rheumatoid	VERB
iajs-3451	46	5	arthritis	arthritis	NOUN
iajs-3451	46	6	patients	patient	NOUN
iajs-3451	46	7	and	and	CCONJ
iajs-3451	46	8	control	control	NOUN
iajs-3451	46	9	groups	group	NOUN
iajs-3451	46	10	the	the	DET
iajs-3451	46	11	results	result	NOUN
iajs-3451	46	12	showed	show	VERB
iajs-3451	46	13	that	that	SCONJ
iajs-3451	46	14	blood	blood	NOUN
iajs-3451	46	15	groups	group	NOUN
iajs-3451	46	16	were	be	AUX
iajs-3451	46	17	highly	highly	ADV
iajs-3451	46	18	significant	significant	ADJ
iajs-3451	46	19	(	(	PUNCT
iajs-3451	46	20	p≤0.01	p≤0.01	NOUN
iajs-3451	46	21	)	)	PUNCT
iajs-3451	46	22	in	in	ADP
iajs-3451	46	23	blood	blood	NOUN
iajs-3451	46	24	group	group	NOUN
iajs-3451	46	25	o	o	NOUN
iajs-3451	46	26	(	(	PUNCT
iajs-3451	46	27	28	28	NUM
iajs-3451	46	28	(	(	PUNCT
iajs-3451	46	29	46.67	46.67	NUM
iajs-3451	46	30	%	%	NOUN
iajs-3451	46	31	)	)	PUNCT
iajs-3451	46	32	)	)	PUNCT
iajs-3451	46	33	,	,	PUNCT
iajs-3451	46	34	which	which	PRON
iajs-3451	46	35	was	be	AUX
iajs-3451	46	36	the	the	DET
iajs-3451	46	37	most	most	ADV
iajs-3451	46	38	prevalent	prevalent	ADJ
iajs-3451	46	39	among	among	ADP
iajs-3451	46	40	rheumatoid	rheumatoid	NOUN
iajs-3451	46	41	patients	patient	NOUN
iajs-3451	46	42	,	,	PUNCT
iajs-3451	46	43	followed	follow	VERB
iajs-3451	46	44	by	by	ADP
iajs-3451	46	45	blood	blood	NOUN
iajs-3451	46	46	group	group	NOUN
iajs-3451	46	47	b	b	PROPN
iajs-3451	46	48	(	(	PUNCT
iajs-3451	46	49	15	15	NUM
iajs-3451	46	50	(	(	PUNCT
iajs-3451	46	51	25.00	25.00	NUM
iajs-3451	46	52	%	%	NOUN
iajs-3451	46	53	)	)	PUNCT
iajs-3451	46	54	)	)	PUNCT
iajs-3451	46	55	,	,	PUNCT
iajs-3451	46	56	blood	blood	NOUN
iajs-3451	46	57	group	group	NOUN
iajs-3451	46	58	a	a	X
iajs-3451	46	59	(	(	PUNCT
iajs-3451	46	60	13	13	NUM
iajs-3451	46	61	(	(	PUNCT
iajs-3451	46	62	21.67	21.67	NUM
iajs-3451	46	63	%	%	NOUN
iajs-3451	46	64	)	)	PUNCT
iajs-3451	46	65	)	)	PUNCT
iajs-3451	46	66	,	,	PUNCT
iajs-3451	46	67	then	then	ADV
iajs-3451	46	68	blood	blood	NOUN
iajs-3451	46	69	group	group	NOUN
iajs-3451	46	70	ab	ab	PROPN
iajs-3451	46	71	(	(	PUNCT
iajs-3451	46	72	4	4	NUM
iajs-3451	46	73	(	(	PUNCT
iajs-3451	46	74	6.67	6.67	NUM
iajs-3451	46	75	%	%	NOUN
iajs-3451	46	76	)	)	PUNCT
iajs-3451	46	77	)	)	PUNCT
iajs-3451	46	78	,	,	PUNCT
iajs-3451	46	79	and	and	CCONJ
iajs-3451	46	80	highly	highly	ADV
iajs-3451	46	81	significant	significant	ADJ
iajs-3451	46	82	for	for	ADP
iajs-3451	46	83	the	the	DET
iajs-3451	46	84	control	control	NOUN
iajs-3451	46	85	group	group	NOUN
iajs-3451	46	86	as	as	ADP
iajs-3451	46	87	21	21	NUM
iajs-3451	46	88	(	(	PUNCT
iajs-3451	46	89	42.00	42.00	NUM
iajs-3451	46	90	%	%	NOUN
iajs-3451	46	91	)	)	PUNCT
iajs-3451	46	92	,	,	PUNCT
iajs-3451	46	93	17	17	NUM
iajs-3451	46	94	(	(	PUNCT
iajs-3451	46	95	34.00	34.00	NUM
iajs-3451	46	96	%	%	NOUN
iajs-3451	46	97	)	)	PUNCT
iajs-3451	46	98	,	,	PUNCT
iajs-3451	46	99	8	8	NUM
iajs-3451	46	100	(	(	PUNCT
iajs-3451	46	101	16.00	16.00	NUM
iajs-3451	46	102	%	%	NOUN
iajs-3451	46	103	)	)	PUNCT
iajs-3451	46	104	,	,	PUNCT
iajs-3451	46	105	and	and	CCONJ
iajs-3451	46	106	4	4	NUM
iajs-3451	46	107	(	(	PUNCT
iajs-3451	46	108	8.00	8.00	NUM
iajs-3451	46	109	%	%	NOUN
iajs-3451	46	110	)	)	PUNCT
iajs-3451	46	111	,	,	PUNCT
iajs-3451	46	112	respectively	respectively	ADV
iajs-3451	46	113	,	,	PUNCT
iajs-3451	46	114	but	but	CCONJ
iajs-3451	46	115	there	there	PRON
iajs-3451	46	116	are	be	VERB
iajs-3451	46	117	no	no	DET
iajs-3451	46	118	differences	difference	NOUN
iajs-3451	46	119	between	between	ADP
iajs-3451	46	120	the	the	DET
iajs-3451	46	121	same	same	ADJ
iajs-3451	46	122	type	type	NOUN
iajs-3451	46	123	for	for	ADP
iajs-3451	46	124	each	each	PRON
iajs-3451	46	125	of	of	ADP
iajs-3451	46	126	the	the	DET
iajs-3451	46	127	study	study	NOUN
iajs-3451	46	128	groups	group	NOUN
iajs-3451	46	129	as	as	SCONJ
iajs-3451	46	130	shown	show	VERB
iajs-3451	46	131	in	in	ADP
iajs-3451	46	132	tables	table	NOUN
iajs-3451	46	133	1–2	1–2	NUM
iajs-3451	46	134	.	.	PUNCT
iajs-3451	46	135	table	table	NOUN
iajs-3451	46	136	2	2	NUM
iajs-3451	46	137	.	.	PUNCT
iajs-3451	46	138	distribution	distribution	NOUN
iajs-3451	46	139	of	of	ADP
iajs-3451	46	140	study	study	NOUN
iajs-3451	46	141	samples	sample	NOUN
iajs-3451	46	142	according	accord	VERB
iajs-3451	46	143	to	to	ADP
iajs-3451	46	144	blood	blood	NOUN
iajs-3451	46	145	groups	group	NOUN
iajs-3451	46	146	in	in	ADP
iajs-3451	46	147	patients	patient	NOUN
iajs-3451	46	148	and	and	CCONJ
iajs-3451	46	149	control	control	NOUN
iajs-3451	46	150	.	.	PUNCT
iajs-3451	47	1	group	group	NOUN
iajs-3451	48	1	no	no	INTJ
iajs-3451	48	2	a	a	DET
iajs-3451	48	3	no	no	NOUN
iajs-3451	48	4	.	.	PUNCT
iajs-3451	49	1	(	(	PUNCT
iajs-3451	49	2	%	%	INTJ
iajs-3451	49	3	)	)	PUNCT
iajs-3451	49	4	b	b	NOUN
iajs-3451	50	1	no	no	INTJ
iajs-3451	50	2	.	.	PUNCT
iajs-3451	51	1	(	(	PUNCT
iajs-3451	51	2	%	%	INTJ
iajs-3451	51	3	)	)	PUNCT
iajs-3451	52	1	ab	ab	PROPN
iajs-3451	52	2	no	no	INTJ
iajs-3451	52	3	.	.	PUNCT
iajs-3451	53	1	(	(	PUNCT
iajs-3451	53	2	%	%	INTJ
iajs-3451	53	3	)	)	PUNCT
iajs-3451	53	4	o	o	INTJ
iajs-3451	54	1	no	no	INTJ
iajs-3451	54	2	.	.	PUNCT
iajs-3451	55	1	(	(	PUNCT
iajs-3451	55	2	%	%	INTJ
iajs-3451	55	3	)	)	PUNCT
iajs-3451	55	4	p	p	X
iajs-3451	55	5	-	-	PUNCT
iajs-3451	55	6	value	value	NOUN
iajs-3451	55	7	patients	patient	NOUN
iajs-3451	55	8	60	60	NUM
iajs-3451	55	9	13	13	NUM
iajs-3451	55	10	(	(	PUNCT
iajs-3451	55	11	21.67	21.67	NUM
iajs-3451	55	12	%	%	NOUN
iajs-3451	55	13	)	)	PUNCT
iajs-3451	55	14	15	15	NUM
iajs-3451	55	15	(	(	PUNCT
iajs-3451	55	16	25.00	25.00	NUM
iajs-3451	55	17	%	%	NOUN
iajs-3451	55	18	)	)	PUNCT
iajs-3451	55	19	4	4	NUM
iajs-3451	55	20	(	(	PUNCT
iajs-3451	55	21	6.67	6.67	NUM
iajs-3451	55	22	%	%	NOUN
iajs-3451	55	23	)	)	PUNCT
iajs-3451	55	24	28	28	NUM
iajs-3451	55	25	(	(	PUNCT
iajs-3451	55	26	46.67	46.67	NUM
iajs-3451	55	27	%	%	NOUN
iajs-3451	55	28	)	)	PUNCT
iajs-3451	56	1	0.0002	0.0002	NUM
iajs-3451	56	2	*	*	PUNCT
iajs-3451	56	3	*	*	PUNCT
iajs-3451	56	4	control	control	NOUN
iajs-3451	56	5	50	50	NUM
iajs-3451	56	6	8	8	NUM
iajs-3451	56	7	(	(	PUNCT
iajs-3451	56	8	16.00	16.00	NUM
iajs-3451	56	9	%	%	NOUN
iajs-3451	56	10	)	)	PUNCT
iajs-3451	56	11	17	17	NUM
iajs-3451	56	12	(	(	PUNCT
iajs-3451	56	13	34.00	34.00	NUM
iajs-3451	56	14	%	%	NOUN
iajs-3451	56	15	)	)	PUNCT
iajs-3451	56	16	4	4	NUM
iajs-3451	56	17	(	(	PUNCT
iajs-3451	56	18	8.00	8.00	NUM
iajs-3451	56	19	%	%	NOUN
iajs-3451	56	20	)	)	PUNCT
iajs-3451	56	21	21	21	NUM
iajs-3451	56	22	(	(	PUNCT
iajs-3451	56	23	42.00	42.00	NUM
iajs-3451	56	24	%	%	NOUN
iajs-3451	56	25	)	)	PUNCT
iajs-3451	57	1	0.0021	0.0021	NUM
iajs-3451	58	1	*	*	PUNCT
iajs-3451	58	2	*	*	PUNCT
iajs-3451	58	3	p	p	X
iajs-3451	58	4	-	-	PUNCT
iajs-3451	58	5	value	value	NOUN
iajs-3451	58	6	-0.071	-0.071	PUNCT
iajs-3451	58	7	ns	ns	NUM
iajs-3451	58	8	0.502	0.502	NUM
iajs-3451	58	9	ns	ns	NUM
iajs-3451	58	10	1.00	1.00	NUM
iajs-3451	58	11	ns	ns	NUM
iajs-3451	58	12	0.328	0.328	NUM
iajs-3451	58	13	ns	ns	NUM
iajs-3451	58	14	--	--	PUNCT
iajs-3451	58	15	*	*	PUNCT
iajs-3451	58	16	*	*	PUNCT
iajs-3451	58	17	highly	highly	ADV
iajs-3451	58	18	significant	significant	ADJ
iajs-3451	58	19	at	at	ADP
iajs-3451	58	20	(	(	PUNCT
iajs-3451	58	21	p≤0.01	p≤0.01	NOUN
iajs-3451	58	22	)	)	PUNCT
iajs-3451	58	23	,	,	PUNCT
iajs-3451	58	24	ns=	ns=	ADJ
iajs-3451	58	25	non	non	ADJ
iajs-3451	58	26	-	-	ADJ
iajs-3451	58	27	significant	significant	ADJ
iajs-3451	58	28	.	.	PUNCT
iajs-3451	59	1	since	since	SCONJ
iajs-3451	59	2	blood	blood	NOUN
iajs-3451	59	3	type	type	NOUN
iajs-3451	59	4	o	o	NOUN
iajs-3451	59	5	is	be	AUX
iajs-3451	59	6	the	the	DET
iajs-3451	59	7	largest	large	ADJ
iajs-3451	59	8	proportion	proportion	NOUN
iajs-3451	59	9	in	in	ADP
iajs-3451	59	10	these	these	DET
iajs-3451	59	11	results	result	NOUN
iajs-3451	59	12	,	,	PUNCT
iajs-3451	59	13	this	this	PRON
iajs-3451	59	14	may	may	AUX
iajs-3451	59	15	be	be	AUX
iajs-3451	59	16	because	because	SCONJ
iajs-3451	59	17	the	the	DET
iajs-3451	59	18	majority	majority	NOUN
iajs-3451	59	19	of	of	ADP
iajs-3451	59	20	the	the	DET
iajs-3451	59	21	iraqi	iraqi	ADJ
iajs-3451	59	22	population	population	NOUN
iajs-3451	59	23	has	have	VERB
iajs-3451	59	24	blood	blood	NOUN
iajs-3451	59	25	group	group	NOUN
iajs-3451	59	26	o	o	NOUN
iajs-3451	59	27	,	,	PUNCT
iajs-3451	59	28	so	so	SCONJ
iajs-3451	59	29	the	the	DET
iajs-3451	59	30	results	result	NOUN
iajs-3451	59	31	showed	show	VERB
iajs-3451	59	32	that	that	SCONJ
iajs-3451	59	33	the	the	DET
iajs-3451	59	34	highest	high	ADJ
iajs-3451	59	35	incidence	incidence	NOUN
iajs-3451	59	36	of	of	ADP
iajs-3451	59	37	rheumatoid	rheumatoid	NOUN
iajs-3451	59	38	arthritis	arthritis	NOUN
iajs-3451	59	39	was	be	AUX
iajs-3451	59	40	in	in	ADP
iajs-3451	59	41	this	this	DET
iajs-3451	59	42	group	group	NOUN
iajs-3451	59	43	.	.	PUNCT
iajs-3451	60	1	this	this	DET
iajs-3451	60	2	result	result	NOUN
iajs-3451	60	3	conforms	conform	VERB
iajs-3451	60	4	to	to	ADP
iajs-3451	60	5	[	[	X
iajs-3451	60	6	24	24	NUM
iajs-3451	60	7	]	]	PUNCT
iajs-3451	60	8	.	.	PUNCT
iajs-3451	61	1	that	that	PRON
iajs-3451	61	2	showed	show	VERB
iajs-3451	61	3	the	the	DET
iajs-3451	61	4	study	study	NOUN
iajs-3451	61	5	a	a	DET
iajs-3451	61	6	result	result	NOUN
iajs-3451	61	7	:	:	PUNCT
iajs-3451	61	8	the	the	DET
iajs-3451	61	9	blood	blood	NOUN
iajs-3451	61	10	group	group	NOUN
iajs-3451	61	11	o	o	PROPN
iajs-3451	61	12	has	have	VERB
iajs-3451	61	13	the	the	DET
iajs-3451	61	14	greatest	great	ADJ
iajs-3451	61	15	percentage	percentage	NOUN
iajs-3451	61	16	of	of	ADP
iajs-3451	61	17	patients	patient	NOUN
iajs-3451	61	18	with	with	ADP
iajs-3451	61	19	rheumatoid	rheumatoid	NOUN
iajs-3451	61	20	arthritis	arthritis	NOUN
iajs-3451	61	21	disease	disease	NOUN
iajs-3451	61	22	.	.	PUNCT
iajs-3451	62	1	3.3	3.3	NUM
iajs-3451	62	2	.	.	PUNCT
iajs-3451	63	1	rheumatoid	rheumatoid	NOUN
iajs-3451	63	2	factor	factor	NOUN
iajs-3451	63	3	(	(	PUNCT
iajs-3451	63	4	rf	rf	NOUN
iajs-3451	63	5	)	)	PUNCT
iajs-3451	63	6	percentage	percentage	NOUN
iajs-3451	63	7	in	in	ADP
iajs-3451	63	8	rheumatoid	rheumatoid	NOUN
iajs-3451	63	9	arthritis	arthritis	NOUN
iajs-3451	63	10	patients	patient	NOUN
iajs-3451	63	11	and	and	CCONJ
iajs-3451	63	12	control	control	NOUN
iajs-3451	63	13	groups	group	NOUN
iajs-3451	63	14	the	the	DET
iajs-3451	63	15	study	study	NOUN
iajs-3451	63	16	results	result	NOUN
iajs-3451	63	17	showed	show	VERB
iajs-3451	63	18	a	a	DET
iajs-3451	63	19	highly	highly	ADV
iajs-3451	63	20	significant	significant	ADJ
iajs-3451	63	21	increase	increase	NOUN
iajs-3451	63	22	(	(	PUNCT
iajs-3451	63	23	p<0.01	p<0.01	PROPN
iajs-3451	63	24	)	)	PUNCT
iajs-3451	63	25	of	of	ADP
iajs-3451	63	26	the	the	DET
iajs-3451	63	27	rheumatoid	rheumatoid	NOUN
iajs-3451	63	28	factor	factor	NOUN
iajs-3451	63	29	influence	influence	NOUN
iajs-3451	63	30	in	in	ADP
iajs-3451	63	31	patients	patient	NOUN
iajs-3451	63	32	with	with	ADP
iajs-3451	63	33	rheumatoid	rheumatoid	NOUN
iajs-3451	63	34	arthritis	arthritis	NOUN
iajs-3451	63	35	;	;	PUNCT
iajs-3451	63	36	the	the	DET
iajs-3451	63	37	positive	positive	ADJ
iajs-3451	63	38	percentage	percentage	NOUN
iajs-3451	63	39	was	be	AUX
iajs-3451	63	40	in	in	ADP
iajs-3451	63	41	45	45	NUM
iajs-3451	63	42	(	(	PUNCT
iajs-3451	63	43	75.00	75.00	NUM
iajs-3451	63	44	%	%	NOUN
iajs-3451	63	45	)	)	PUNCT
iajs-3451	63	46	and	and	CCONJ
iajs-3451	63	47	the	the	DET
iajs-3451	63	48	negative	negative	ADJ
iajs-3451	63	49	in	in	ADP
iajs-3451	63	50	15	15	NUM
iajs-3451	63	51	(	(	PUNCT
iajs-3451	63	52	25.00	25.00	NUM
iajs-3451	63	53	%	%	NOUN
iajs-3451	63	54	)	)	PUNCT
iajs-3451	63	55	,	,	PUNCT
iajs-3451	63	56	while	while	SCONJ
iajs-3451	63	57	the	the	DET
iajs-3451	63	58	results	result	NOUN
iajs-3451	63	59	of	of	ADP
iajs-3451	63	60	the	the	DET
iajs-3451	63	61	control	control	NOUN
iajs-3451	63	62	group	group	NOUN
iajs-3451	63	63	were	be	AUX
iajs-3451	63	64	in	in	ADP
iajs-3451	63	65	the	the	DET
iajs-3451	63	66	positive	positive	ADJ
iajs-3451	63	67	percentage	percentage	NOUN
iajs-3451	63	68	(	(	PUNCT
iajs-3451	63	69	0.00	0.00	NUM
iajs-3451	63	70	%	%	NOUN
iajs-3451	63	71	)	)	PUNCT
iajs-3451	63	72	and	and	CCONJ
iajs-3451	63	73	the	the	DET
iajs-3451	63	74	negative	negative	ADJ
iajs-3451	63	75	in	in	ADP
iajs-3451	63	76	50	50	NUM
iajs-3451	63	77	(	(	PUNCT
iajs-3451	63	78	100	100	NUM
iajs-3451	63	79	%	%	NOUN
iajs-3451	63	80	)	)	PUNCT
iajs-3451	63	81	,	,	PUNCT
iajs-3451	63	82	as	as	SCONJ
iajs-3451	63	83	shown	show	VERB
iajs-3451	63	84	in	in	ADP
iajs-3451	63	85	tables	table	NOUN
iajs-3451	63	86	1–3	1–3	NOUN
iajs-3451	63	87	.	.	PUNCT
iajs-3451	63	88	ihjpas	ihjpas	PROPN
iajs-3451	63	89	.	.	PUNCT
iajs-3451	64	1	37	37	NUM
iajs-3451	64	2	(	(	PUNCT
iajs-3451	64	3	2	2	NUM
iajs-3451	64	4	)	)	PUNCT
iajs-3451	64	5	2024	2024	NUM
iajs-3451	64	6	131	131	NUM
iajs-3451	64	7	table	table	NOUN
iajs-3451	64	8	3	3	NUM
iajs-3451	64	9	.	.	PUNCT
iajs-3451	65	1	the	the	DET
iajs-3451	65	2	percentage	percentage	NOUN
iajs-3451	65	3	of	of	ADP
iajs-3451	65	4	rheumatoid	rheumatoid	NOUN
iajs-3451	65	5	factor	factor	NOUN
iajs-3451	65	6	in	in	ADP
iajs-3451	65	7	patients	patient	NOUN
iajs-3451	65	8	and	and	CCONJ
iajs-3451	65	9	control	control	NOUN
iajs-3451	65	10	groups	group	NOUN
iajs-3451	65	11	.	.	PUNCT
iajs-3451	66	1	group	group	NOUN
iajs-3451	67	1	no	no	INTJ
iajs-3451	67	2	positive+	positive+	NOUN
iajs-3451	67	3	no	no	INTJ
iajs-3451	67	4	.	.	PUNCT
iajs-3451	68	1	(	(	PUNCT
iajs-3451	68	2	%	%	INTJ
iajs-3451	68	3	)	)	PUNCT
iajs-3451	68	4	negative	negative	ADJ
iajs-3451	68	5	no	no	INTJ
iajs-3451	68	6	.	.	PUNCT
iajs-3451	69	1	(	(	PUNCT
iajs-3451	69	2	%	%	INTJ
iajs-3451	69	3	)	)	PUNCT
iajs-3451	69	4	p	p	X
iajs-3451	69	5	-	-	PUNCT
iajs-3451	69	6	value	value	NOUN
iajs-3451	69	7	patients	patient	NOUN
iajs-3451	69	8	60	60	NUM
iajs-3451	69	9	45	45	NUM
iajs-3451	69	10	(	(	PUNCT
iajs-3451	69	11	75.00	75.00	NUM
iajs-3451	69	12	%	%	NOUN
iajs-3451	69	13	)	)	PUNCT
iajs-3451	69	14	15	15	NUM
iajs-3451	69	15	(	(	PUNCT
iajs-3451	69	16	25.00	25.00	NUM
iajs-3451	69	17	%	%	NOUN
iajs-3451	69	18	)	)	PUNCT
iajs-3451	70	1	0.0001	0.0001	NUM
iajs-3451	70	2	*	*	PUNCT
iajs-3451	70	3	*	*	PUNCT
iajs-3451	70	4	control	control	NOUN
iajs-3451	70	5	50	50	NUM
iajs-3451	70	6	0	0	NUM
iajs-3451	70	7	(	(	PUNCT
iajs-3451	70	8	0.00	0.00	NUM
iajs-3451	70	9	%	%	NOUN
iajs-3451	70	10	)	)	PUNCT
iajs-3451	70	11	50	50	NUM
iajs-3451	70	12	(	(	PUNCT
iajs-3451	70	13	100	100	NUM
iajs-3451	70	14	%	%	NOUN
iajs-3451	70	15	)	)	PUNCT
iajs-3451	71	1	0.0001	0.0001	NUM
iajs-3451	71	2	*	*	PUNCT
iajs-3451	71	3	*	*	PUNCT
iajs-3451	71	4	p	p	NUM
iajs-3451	71	5	-	-	PUNCT
iajs-3451	71	6	value	value	NOUN
iajs-3451	71	7	-0.0001	-0.0001	NOUN
iajs-3451	72	1	*	*	PUNCT
iajs-3451	73	1	*	*	PUNCT
iajs-3451	73	2	0.0001	0.0001	NUM
iajs-3451	73	3	*	*	PUNCT
iajs-3451	73	4	*	*	PUNCT
iajs-3451	73	5	--	--	PUNCT
iajs-3451	73	6	*	*	PUNCT
iajs-3451	73	7	*	*	PUNCT
iajs-3451	73	8	highly	highly	ADV
iajs-3451	73	9	significant	significant	ADJ
iajs-3451	73	10	at	at	ADP
iajs-3451	73	11	(	(	PUNCT
iajs-3451	73	12	p≤0.01	p≤0.01	NOUN
iajs-3451	73	13	)	)	PUNCT
iajs-3451	73	14	.	.	PUNCT
iajs-3451	74	1	the	the	DET
iajs-3451	74	2	current	current	ADJ
iajs-3451	74	3	study	study	NOUN
iajs-3451	74	4	corresponds	correspond	VERB
iajs-3451	74	5	to	to	ADP
iajs-3451	74	6	[	[	X
iajs-3451	74	7	25	25	NUM
iajs-3451	74	8	]	]	PUNCT
iajs-3451	74	9	,	,	PUNCT
iajs-3451	74	10	where	where	SCONJ
iajs-3451	74	11	(	(	PUNCT
iajs-3451	74	12	76	76	NUM
iajs-3451	74	13	%	%	NOUN
iajs-3451	74	14	)	)	PUNCT
iajs-3451	74	15	were	be	AUX
iajs-3451	74	16	positive	positive	ADJ
iajs-3451	74	17	,	,	PUNCT
iajs-3451	74	18	(	(	PUNCT
iajs-3451	74	19	24	24	NUM
iajs-3451	74	20	%	%	NOUN
iajs-3451	74	21	)	)	PUNCT
iajs-3451	74	22	were	be	AUX
iajs-3451	74	23	negative	negative	ADJ
iajs-3451	74	24	,	,	PUNCT
iajs-3451	74	25	and	and	CCONJ
iajs-3451	74	26	the	the	DET
iajs-3451	74	27	control	control	NOUN
iajs-3451	74	28	group	group	NOUN
iajs-3451	74	29	was	be	AUX
iajs-3451	74	30	negative	negative	ADJ
iajs-3451	74	31	(	(	PUNCT
iajs-3451	74	32	100	100	NUM
iajs-3451	74	33	%	%	NOUN
iajs-3451	74	34	)	)	PUNCT
iajs-3451	74	35	.	.	PUNCT
iajs-3451	75	1	according	accord	VERB
iajs-3451	75	2	to	to	ADP
iajs-3451	75	3	the	the	DET
iajs-3451	75	4	results	result	NOUN
iajs-3451	75	5	,	,	PUNCT
iajs-3451	75	6	the	the	DET
iajs-3451	75	7	pathogenic	pathogenic	ADJ
iajs-3451	75	8	factor	factor	NOUN
iajs-3451	75	9	played	play	VERB
iajs-3451	75	10	a	a	DET
iajs-3451	75	11	significant	significant	ADJ
iajs-3451	75	12	role	role	NOUN
iajs-3451	75	13	in	in	ADP
iajs-3451	75	14	infections	infection	NOUN
iajs-3451	75	15	as	as	ADP
iajs-3451	75	16	a	a	DET
iajs-3451	75	17	result	result	NOUN
iajs-3451	75	18	of	of	ADP
iajs-3451	75	19	the	the	DET
iajs-3451	75	20	combination	combination	NOUN
iajs-3451	75	21	of	of	ADP
iajs-3451	75	22	antibodies	antibody	NOUN
iajs-3451	75	23	in	in	ADP
iajs-3451	75	24	the	the	DET
iajs-3451	75	25	inflammatory	inflammatory	ADJ
iajs-3451	75	26	position	position	NOUN
iajs-3451	75	27	,	,	PUNCT
iajs-3451	75	28	and	and	CCONJ
iajs-3451	75	29	this	this	PRON
iajs-3451	75	30	came	come	VERB
iajs-3451	75	31	in	in	ADP
iajs-3451	75	32	conformity	conformity	NOUN
iajs-3451	75	33	with	with	ADP
iajs-3451	75	34	[	[	X
iajs-3451	75	35	26	26	NUM
iajs-3451	75	36	]	]	PUNCT
iajs-3451	75	37	.	.	PUNCT
iajs-3451	76	1	therefore	therefore	ADV
iajs-3451	76	2	,	,	PUNCT
iajs-3451	76	3	the	the	DET
iajs-3451	76	4	rf	rf	ADJ
iajs-3451	76	5	-	-	ADJ
iajs-3451	76	6	positive	positive	ADJ
iajs-3451	76	7	percentage	percentage	NOUN
iajs-3451	76	8	in	in	ADP
iajs-3451	76	9	patients	patient	NOUN
iajs-3451	76	10	is	be	AUX
iajs-3451	76	11	higher	high	ADJ
iajs-3451	76	12	than	than	ADP
iajs-3451	76	13	the	the	DET
iajs-3451	76	14	rf	rf	NOUN
iajs-3451	76	15	-	-	PUNCT
iajs-3451	76	16	negative	negative	ADJ
iajs-3451	76	17	.	.	PUNCT
iajs-3451	77	1	patients	patient	NOUN
iajs-3451	77	2	with	with	ADP
iajs-3451	77	3	rheumatoid	rheumatoid	NOUN
iajs-3451	77	4	arthritis	arthritis	NOUN
iajs-3451	77	5	and	and	CCONJ
iajs-3451	77	6	many	many	ADJ
iajs-3451	77	7	other	other	ADJ
iajs-3451	77	8	non	non	ADJ
iajs-3451	77	9	-	-	ADJ
iajs-3451	77	10	rheumatic	rheumatic	ADJ
iajs-3451	77	11	disorders	disorder	NOUN
iajs-3451	77	12	,	,	PUNCT
iajs-3451	77	13	including	include	VERB
iajs-3451	77	14	infections	infection	NOUN
iajs-3451	77	15	and	and	CCONJ
iajs-3451	77	16	chronic	chronic	ADJ
iajs-3451	77	17	diseases	disease	NOUN
iajs-3451	77	18	,	,	PUNCT
iajs-3451	77	19	might	might	AUX
iajs-3451	77	20	show	show	VERB
iajs-3451	77	21	signs	sign	NOUN
iajs-3451	77	22	of	of	ADP
iajs-3451	77	23	the	the	DET
iajs-3451	77	24	immunoglobulin	immunoglobulin	NOUN
iajs-3451	77	25	class	class	NOUN
iajs-3451	77	26	known	know	VERB
iajs-3451	77	27	as	as	ADP
iajs-3451	77	28	rheumatoid	rheumatoid	NOUN
iajs-3451	77	29	factors	factor	NOUN
iajs-3451	77	30	[	[	X
iajs-3451	77	31	27	27	NUM
iajs-3451	77	32	,	,	PUNCT
iajs-3451	77	33	28	28	NUM
iajs-3451	77	34	]	]	PUNCT
iajs-3451	77	35	.	.	PUNCT
iajs-3451	78	1	according	accord	VERB
iajs-3451	78	2	to	to	ADP
iajs-3451	78	3	numerous	numerous	ADJ
iajs-3451	78	4	studies	study	NOUN
iajs-3451	78	5	,	,	PUNCT
iajs-3451	78	6	the	the	DET
iajs-3451	78	7	acuteness	acuteness	NOUN
iajs-3451	78	8	of	of	ADP
iajs-3451	78	9	rheumatoid	rheumatoid	VERB
iajs-3451	78	10	arthritis	arthritis	NOUN
iajs-3451	78	11	disease	disease	NOUN
iajs-3451	78	12	and	and	CCONJ
iajs-3451	78	13	the	the	DET
iajs-3451	78	14	rheumatic	rheumatic	ADJ
iajs-3451	78	15	component	component	NOUN
iajs-3451	78	16	are	be	AUX
iajs-3451	78	17	strongly	strongly	ADV
iajs-3451	78	18	correlated	correlate	VERB
iajs-3451	78	19	because	because	SCONJ
iajs-3451	78	20	this	this	DET
iajs-3451	78	21	factor	factor	NOUN
iajs-3451	78	22	is	be	AUX
iajs-3451	78	23	titer	titer	NOUN
iajs-3451	78	24	as	as	ADP
iajs-3451	78	25	a	a	DET
iajs-3451	78	26	measure	measure	NOUN
iajs-3451	78	27	of	of	ADP
iajs-3451	78	28	the	the	DET
iajs-3451	78	29	depth	depth	NOUN
iajs-3451	78	30	of	of	ADP
iajs-3451	78	31	medication	medication	NOUN
iajs-3451	78	32	response	response	NOUN
iajs-3451	78	33	rather	rather	ADV
iajs-3451	78	34	than	than	ADP
iajs-3451	78	35	a	a	DET
iajs-3451	78	36	prediction	prediction	NOUN
iajs-3451	78	37	of	of	ADP
iajs-3451	78	38	the	the	DET
iajs-3451	78	39	length	length	NOUN
iajs-3451	78	40	or	or	CCONJ
iajs-3451	78	41	severity	severity	NOUN
iajs-3451	78	42	of	of	ADP
iajs-3451	78	43	the	the	DET
iajs-3451	78	44	disease	disease	NOUN
iajs-3451	78	45	,	,	PUNCT
iajs-3451	78	46	so	so	SCONJ
iajs-3451	78	47	the	the	DET
iajs-3451	78	48	value	value	NOUN
iajs-3451	78	49	is	be	AUX
iajs-3451	78	50	lower	low	ADJ
iajs-3451	78	51	in	in	ADP
iajs-3451	78	52	cases	case	NOUN
iajs-3451	78	53	where	where	SCONJ
iajs-3451	78	54	the	the	DET
iajs-3451	78	55	clinical	clinical	ADJ
iajs-3451	78	56	symptoms	symptom	NOUN
iajs-3451	78	57	decrease	decrease	VERB
iajs-3451	78	58	in	in	ADP
iajs-3451	78	59	patients	patient	NOUN
iajs-3451	78	60	[	[	X
iajs-3451	78	61	29	29	NUM
iajs-3451	78	62	]	]	PUNCT
iajs-3451	78	63	.	.	PUNCT
iajs-3451	79	1	3.4	3.4	NUM
iajs-3451	79	2	.	.	PUNCT
iajs-3451	80	1	c	c	X
iajs-3451	80	2	-	-	PUNCT
iajs-3451	80	3	reactive	reactive	ADJ
iajs-3451	80	4	protein	protein	NOUN
iajs-3451	80	5	in	in	ADP
iajs-3451	80	6	rheumatoid	rheumatoid	ADJ
iajs-3451	80	7	arthritis	arthritis	NOUN
iajs-3451	80	8	patients	patient	NOUN
iajs-3451	80	9	and	and	CCONJ
iajs-3451	80	10	control	control	NOUN
iajs-3451	80	11	groups	group	NOUN
iajs-3451	80	12	the	the	DET
iajs-3451	80	13	results	result	NOUN
iajs-3451	80	14	of	of	ADP
iajs-3451	80	15	c	c	NOUN
iajs-3451	80	16	-	-	PUNCT
iajs-3451	80	17	reactive	reactive	ADJ
iajs-3451	80	18	protein	protein	NOUN
iajs-3451	80	19	showed	show	VERB
iajs-3451	80	20	non	non	ADJ
iajs-3451	80	21	-	-	ADJ
iajs-3451	80	22	significant	significant	ADJ
iajs-3451	80	23	differences	difference	NOUN
iajs-3451	80	24	;	;	PUNCT
iajs-3451	80	25	the	the	DET
iajs-3451	80	26	positive	positive	ADJ
iajs-3451	80	27	percentage	percentage	NOUN
iajs-3451	80	28	was	be	AUX
iajs-3451	80	29	in	in	ADP
iajs-3451	80	30	26	26	NUM
iajs-3451	80	31	patients	patient	NOUN
iajs-3451	80	32	(	(	PUNCT
iajs-3451	80	33	43.33	43.33	NUM
iajs-3451	80	34	%	%	NOUN
iajs-3451	80	35	)	)	PUNCT
iajs-3451	80	36	,	,	PUNCT
iajs-3451	80	37	and	and	CCONJ
iajs-3451	80	38	the	the	DET
iajs-3451	80	39	negative	negative	ADJ
iajs-3451	80	40	was	be	AUX
iajs-3451	80	41	in	in	ADP
iajs-3451	80	42	34	34	NUM
iajs-3451	80	43	(	(	PUNCT
iajs-3451	80	44	56.67	56.67	NUM
iajs-3451	80	45	%	%	NOUN
iajs-3451	80	46	)	)	PUNCT
iajs-3451	80	47	.	.	PUNCT
iajs-3451	81	1	while	while	SCONJ
iajs-3451	81	2	it	it	PRON
iajs-3451	81	3	was	be	AUX
iajs-3451	81	4	not	not	PART
iajs-3451	81	5	expressed	express	VERB
iajs-3451	81	6	in	in	ADP
iajs-3451	81	7	the	the	DET
iajs-3451	81	8	healthy	healthy	ADJ
iajs-3451	81	9	group	group	NOUN
iajs-3451	81	10	(	(	PUNCT
iajs-3451	81	11	0.00	0.00	NUM
iajs-3451	81	12	%	%	NOUN
iajs-3451	81	13	)	)	PUNCT
iajs-3451	81	14	,	,	PUNCT
iajs-3451	81	15	as	as	SCONJ
iajs-3451	81	16	shown	show	VERB
iajs-3451	81	17	in	in	ADP
iajs-3451	81	18	table	table	NOUN
iajs-3451	81	19	1	1	NUM
iajs-3451	81	20	-	-	SYM
iajs-3451	81	21	4	4	NUM
iajs-3451	81	22	.	.	PUNCT
iajs-3451	81	23	table	table	NOUN
iajs-3451	81	24	4	4	NUM
iajs-3451	81	25	.	.	PUNCT
iajs-3451	82	1	the	the	DET
iajs-3451	82	2	percentage	percentage	NOUN
iajs-3451	82	3	of	of	ADP
iajs-3451	82	4	c	c	NOUN
iajs-3451	82	5	reactive	reactive	ADJ
iajs-3451	82	6	protein	protein	NOUN
iajs-3451	82	7	in	in	ADP
iajs-3451	82	8	patients	patient	NOUN
iajs-3451	82	9	and	and	CCONJ
iajs-3451	82	10	control	control	NOUN
iajs-3451	82	11	groups	group	NOUN
iajs-3451	82	12	.	.	PUNCT
iajs-3451	83	1	group	group	NOUN
iajs-3451	83	2	no	no	DET
iajs-3451	83	3	positive	positive	ADJ
iajs-3451	83	4	no	no	NOUN
iajs-3451	83	5	.	.	PUNCT
iajs-3451	84	1	(	(	PUNCT
iajs-3451	84	2	%	%	INTJ
iajs-3451	84	3	)	)	PUNCT
iajs-3451	84	4	negative	negative	ADJ
iajs-3451	84	5	no	no	INTJ
iajs-3451	84	6	.	.	PUNCT
iajs-3451	85	1	(	(	PUNCT
iajs-3451	85	2	%	%	INTJ
iajs-3451	85	3	)	)	PUNCT
iajs-3451	85	4	p	p	X
iajs-3451	85	5	-	-	PUNCT
iajs-3451	85	6	value	value	NOUN
iajs-3451	85	7	patients	patient	NOUN
iajs-3451	85	8	60	60	NUM
iajs-3451	85	9	26	26	NUM
iajs-3451	85	10	(	(	PUNCT
iajs-3451	85	11	43.33	43.33	NUM
iajs-3451	85	12	%	%	NOUN
iajs-3451	85	13	)	)	PUNCT
iajs-3451	85	14	34	34	NUM
iajs-3451	85	15	(	(	PUNCT
iajs-3451	85	16	56.67	56.67	NUM
iajs-3451	85	17	%	%	NOUN
iajs-3451	85	18	)	)	PUNCT
iajs-3451	85	19	0.302	0.302	NUM
iajs-3451	85	20	ns	ns	NUM
iajs-3451	85	21	control	control	NOUN
iajs-3451	85	22	50	50	NUM
iajs-3451	85	23	0	0	NUM
iajs-3451	85	24	(	(	PUNCT
iajs-3451	85	25	0.00	0.00	NUM
iajs-3451	85	26	%	%	NOUN
iajs-3451	85	27	)	)	PUNCT
iajs-3451	85	28	50	50	NUM
iajs-3451	85	29	(	(	PUNCT
iajs-3451	85	30	100	100	NUM
iajs-3451	85	31	%	%	NOUN
iajs-3451	85	32	)	)	PUNCT
iajs-3451	85	33	0.0001	0.0001	NUM
iajs-3451	86	1	*	*	PUNCT
iajs-3451	86	2	*	*	PUNCT
iajs-3451	86	3	p	p	NUM
iajs-3451	86	4	-	-	PUNCT
iajs-3451	86	5	value	value	NOUN
iajs-3451	86	6	-0.0001	-0.0001	NOUN
iajs-3451	87	1	*	*	PUNCT
iajs-3451	88	1	*	*	PUNCT
iajs-3451	89	1	0.0037	0.0037	NUM
iajs-3451	89	2	*	*	PUNCT
iajs-3451	89	3	*	*	PUNCT
iajs-3451	89	4	--	--	PUNCT
iajs-3451	90	1	*	*	PUNCT
iajs-3451	90	2	*	*	PUNCT
iajs-3451	90	3	highly	highly	ADV
iajs-3451	90	4	significant	significant	ADJ
iajs-3451	90	5	at	at	ADP
iajs-3451	90	6	(	(	PUNCT
iajs-3451	90	7	p≤0.01	p≤0.01	NOUN
iajs-3451	90	8	)	)	PUNCT
iajs-3451	90	9	,	,	PUNCT
iajs-3451	90	10	ns=	ns=	ADJ
iajs-3451	90	11	non	non	ADJ
iajs-3451	90	12	-	-	ADJ
iajs-3451	90	13	significant	significant	ADJ
iajs-3451	90	14	.	.	PUNCT
iajs-3451	91	1	creactive	creactive	ADJ
iajs-3451	91	2	protein	protein	NOUN
iajs-3451	91	3	and	and	CCONJ
iajs-3451	91	4	serum	serum	NOUN
iajs-3451	91	5	ferritin	ferritin	X
iajs-3451	91	6	are	be	AUX
iajs-3451	91	7	two	two	NUM
iajs-3451	91	8	of	of	ADP
iajs-3451	91	9	the	the	DET
iajs-3451	91	10	most	most	ADV
iajs-3451	91	11	widely	widely	ADV
iajs-3451	91	12	used	use	VERB
iajs-3451	91	13	acute	acute	NOUN
iajs-3451	91	14	phase	phase	NOUN
iajs-3451	91	15	indicators	indicator	NOUN
iajs-3451	91	16	and	and	CCONJ
iajs-3451	91	17	have	have	VERB
iajs-3451	91	18	great	great	ADJ
iajs-3451	91	19	value	value	NOUN
iajs-3451	91	20	for	for	ADP
iajs-3451	91	21	monitoring	monitor	VERB
iajs-3451	91	22	disease	disease	NOUN
iajs-3451	91	23	activity	activity	NOUN
iajs-3451	91	24	;	;	PUNCT
iajs-3451	91	25	therefore	therefore	ADV
iajs-3451	91	26	,	,	PUNCT
iajs-3451	91	27	crp	crp	PROPN
iajs-3451	91	28	was	be	AUX
iajs-3451	91	29	detected	detect	VERB
iajs-3451	91	30	in	in	ADP
iajs-3451	91	31	some	some	DET
iajs-3451	91	32	samples	sample	NOUN
iajs-3451	91	33	of	of	ADP
iajs-3451	91	34	patients	patient	NOUN
iajs-3451	91	35	with	with	ADP
iajs-3451	91	36	rheumatoid	rheumatoid	NOUN
iajs-3451	91	37	arthritis	arthritis	NOUN
iajs-3451	91	38	[	[	X
iajs-3451	91	39	30,31	30,31	PROPN
iajs-3451	91	40	]	]	PUNCT
iajs-3451	91	41	.	.	PUNCT
iajs-3451	92	1	other	other	ADJ
iajs-3451	92	2	studies	study	NOUN
iajs-3451	92	3	indicated	indicate	VERB
iajs-3451	92	4	that	that	SCONJ
iajs-3451	92	5	an	an	DET
iajs-3451	92	6	increase	increase	NOUN
iajs-3451	92	7	in	in	ADP
iajs-3451	92	8	its	its	PRON
iajs-3451	92	9	concentration	concentration	NOUN
iajs-3451	92	10	is	be	AUX
iajs-3451	92	11	associated	associate	VERB
iajs-3451	92	12	with	with	ADP
iajs-3451	92	13	the	the	DET
iajs-3451	92	14	severity	severity	NOUN
iajs-3451	92	15	of	of	ADP
iajs-3451	92	16	rheumatoid	rheumatoid	VERB
iajs-3451	92	17	arthritis	arthritis	NOUN
iajs-3451	92	18	disease	disease	NOUN
iajs-3451	92	19	,	,	PUNCT
iajs-3451	92	20	and	and	CCONJ
iajs-3451	92	21	this	this	PRON
iajs-3451	92	22	illustrated	illustrate	VERB
iajs-3451	92	23	the	the	DET
iajs-3451	92	24	expression	expression	NOUN
iajs-3451	92	25	result	result	NOUN
iajs-3451	92	26	in	in	ADP
iajs-3451	92	27	some	some	DET
iajs-3451	92	28	infected	infected	ADJ
iajs-3451	92	29	patients	patient	NOUN
iajs-3451	92	30	without	without	ADP
iajs-3451	92	31	the	the	DET
iajs-3451	92	32	other	other	ADJ
iajs-3451	92	33	samples	sample	NOUN
iajs-3451	92	34	[	[	X
iajs-3451	92	35	32	32	NUM
iajs-3451	92	36	]	]	PUNCT
iajs-3451	92	37	.	.	PUNCT
iajs-3451	93	1	4	4	X
iajs-3451	93	2	.	.	X
iajs-3451	93	3	conclusion	conclusion	VERB
iajs-3451	93	4	the	the	DET
iajs-3451	93	5	high	high	ADJ
iajs-3451	93	6	levels	level	NOUN
iajs-3451	93	7	of	of	ADP
iajs-3451	93	8	esr	esr	PROPN
iajs-3451	93	9	in	in	ADP
iajs-3451	93	10	(	(	PUNCT
iajs-3451	93	11	ra	ra	NOUN
iajs-3451	93	12	)	)	PUNCT
iajs-3451	93	13	patients	patient	NOUN
iajs-3451	93	14	were	be	AUX
iajs-3451	93	15	higher	high	ADJ
iajs-3451	93	16	than	than	ADP
iajs-3451	93	17	the	the	DET
iajs-3451	93	18	control	control	NOUN
iajs-3451	93	19	,	,	PUNCT
iajs-3451	93	20	but	but	CCONJ
iajs-3451	93	21	no	no	DET
iajs-3451	93	22	differences	difference	NOUN
iajs-3451	93	23	were	be	AUX
iajs-3451	93	24	observed	observe	VERB
iajs-3451	93	25	in	in	ADP
iajs-3451	93	26	the	the	DET
iajs-3451	93	27	numbers	number	NOUN
iajs-3451	93	28	of	of	ADP
iajs-3451	93	29	wbc	wbc	PROPN
iajs-3451	93	30	,	,	PUNCT
iajs-3451	93	31	rbc	rbc	PROPN
iajs-3451	93	32	,	,	PUNCT
iajs-3451	93	33	and	and	CCONJ
iajs-3451	93	34	plt	plt	NOUN
iajs-3451	93	35	in	in	ADP
iajs-3451	93	36	these	these	DET
iajs-3451	93	37	patients	patient	NOUN
iajs-3451	93	38	,	,	PUNCT
iajs-3451	93	39	and	and	CCONJ
iajs-3451	93	40	there	there	PRON
iajs-3451	93	41	were	be	VERB
iajs-3451	93	42	significant	significant	ADJ
iajs-3451	93	43	differences	difference	NOUN
iajs-3451	93	44	in	in	ADP
iajs-3451	93	45	the	the	DET
iajs-3451	93	46	levels	level	NOUN
iajs-3451	93	47	of	of	ADP
iajs-3451	93	48	rf	rf	NOUN
iajs-3451	93	49	,	,	PUNCT
iajs-3451	93	50	and	and	CCONJ
iajs-3451	93	51	crp	crp	PROPN
iajs-3451	93	52	for	for	ADP
iajs-3451	93	53	patients	patient	NOUN
iajs-3451	93	54	compared	compare	VERB
iajs-3451	93	55	with	with	ADP
iajs-3451	93	56	the	the	DET
iajs-3451	93	57	control	control	NOUN
iajs-3451	93	58	.	.	PUNCT
iajs-3451	94	1	ihjpas	ihjpas	PROPN
iajs-3451	94	2	.	.	PUNCT
iajs-3451	95	1	37	37	NUM
iajs-3451	95	2	(	(	PUNCT
iajs-3451	95	3	2	2	NUM
iajs-3451	95	4	)	)	PUNCT
iajs-3451	95	5	2024	2024	NUM
iajs-3451	95	6	132	132	NUM
iajs-3451	95	7	acknowledgment	acknowledgment	NOUN
iajs-3451	95	8	in	in	ADP
iajs-3451	95	9	the	the	DET
iajs-3451	95	10	name	name	NOUN
iajs-3451	95	11	of	of	ADP
iajs-3451	95	12	god	god	PROPN
iajs-3451	95	13	,	,	PUNCT
iajs-3451	95	14	the	the	DET
iajs-3451	95	15	most	most	ADV
iajs-3451	95	16	gracious	gracious	ADJ
iajs-3451	95	17	,	,	PUNCT
iajs-3451	95	18	the	the	DET
iajs-3451	95	19	most	most	ADV
iajs-3451	95	20	merciful	merciful	ADJ
iajs-3451	95	21	,	,	PUNCT
iajs-3451	95	22	and	and	CCONJ
iajs-3451	95	23	in	in	ADP
iajs-3451	95	24	the	the	DET
iajs-3451	95	25	salutations	salutation	NOUN
iajs-3451	95	26	and	and	CCONJ
iajs-3451	95	27	blessings	blessing	NOUN
iajs-3451	95	28	of	of	ADP
iajs-3451	95	29	muhammad	muhammad	PROPN
iajs-3451	95	30	,	,	PUNCT
iajs-3451	95	31	his	his	PRON
iajs-3451	95	32	servant	servant	NOUN
iajs-3451	95	33	and	and	CCONJ
iajs-3451	95	34	messenger	messenger	NOUN
iajs-3451	95	35	,	,	PUNCT
iajs-3451	95	36	and	and	CCONJ
iajs-3451	95	37	his	his	PRON
iajs-3451	95	38	pure	pure	ADJ
iajs-3451	95	39	and	and	CCONJ
iajs-3451	95	40	pure	pure	ADJ
iajs-3451	95	41	family	family	NOUN
iajs-3451	95	42	,	,	PUNCT
iajs-3451	95	43	acknowledge	acknowledge	VERB
iajs-3451	95	44	the	the	DET
iajs-3451	95	45	immeasurable	immeasurable	ADJ
iajs-3451	95	46	thanksgiving	thanksgiving	NOUN
iajs-3451	95	47	to	to	ADP
iajs-3451	95	48	the	the	DET
iajs-3451	95	49	ever	ever	ADV
iajs-3451	95	50	-	-	PUNCT
iajs-3451	95	51	great	great	ADJ
iajs-3451	95	52	god	god	PROPN
iajs-3451	95	53	.	.	PUNCT
iajs-3451	96	1	i	i	PRON
iajs-3451	96	2	extend	extend	VERB
iajs-3451	96	3	my	my	PRON
iajs-3451	96	4	sincere	sincere	ADJ
iajs-3451	96	5	gratitude	gratitude	NOUN
iajs-3451	96	6	to	to	ADP
iajs-3451	96	7	my	my	PRON
iajs-3451	96	8	supervisor	supervisor	NOUN
iajs-3451	96	9	,	,	PUNCT
iajs-3451	96	10	assistant	assistant	NOUN
iajs-3451	96	11	professor	professor	PROPN
iajs-3451	96	12	dr	dr	PROPN
iajs-3451	96	13	.	.	PROPN
iajs-3451	96	14	wasan	wasan	PROPN
iajs-3451	96	15	addai	addai	PROPN
iajs-3451	96	16	mahdi	mahdi	PROPN
iajs-3451	96	17	.	.	PUNCT
iajs-3451	97	1	many	many	ADJ
iajs-3451	97	2	thanks	thank	NOUN
iajs-3451	97	3	to	to	ADP
iajs-3451	97	4	the	the	DET
iajs-3451	97	5	staff	staff	NOUN
iajs-3451	97	6	of	of	ADP
iajs-3451	97	7	baghdad	baghdad	PROPN
iajs-3451	97	8	teaching	teaching	NOUN
iajs-3451	97	9	hospital	hospital	NOUN
iajs-3451	97	10	,	,	PUNCT
iajs-3451	97	11	to	to	ADP
iajs-3451	97	12	dr	dr	PROPN
iajs-3451	97	13	.	.	PROPN
iajs-3451	97	14	adnan	adnan	PROPN
iajs-3451	97	15	sedkhan	sedkhan	PROPN
iajs-3451	97	16	,	,	PUNCT
iajs-3451	97	17	to	to	ADP
iajs-3451	97	18	the	the	DET
iajs-3451	97	19	martyr	martyr	NOUN
iajs-3451	97	20	al	al	PROPN
iajs-3451	97	21	-	-	PUNCT
iajs-3451	97	22	sadr	sadr	PROPN
iajs-3451	97	23	general	general	ADJ
iajs-3451	97	24	hospital	hospital	NOUN
iajs-3451	97	25	,	,	PUNCT
iajs-3451	97	26	and	and	CCONJ
iajs-3451	97	27	to	to	ADP
iajs-3451	97	28	the	the	DET
iajs-3451	97	29	department	department	NOUN
iajs-3451	97	30	of	of	ADP
iajs-3451	97	31	biology	biology	NOUN
iajs-3451	97	32	,	,	PUNCT
iajs-3451	97	33	college	college	NOUN
iajs-3451	97	34	of	of	ADP
iajs-3451	97	35	science	science	NOUN
iajs-3451	97	36	for	for	ADP
iajs-3451	97	37	women	woman	NOUN
iajs-3451	97	38	,	,	PUNCT
iajs-3451	97	39	university	university	NOUN
iajs-3451	97	40	of	of	ADP
iajs-3451	97	41	baghdad	baghdad	PROPN
iajs-3451	97	42	.	.	PUNCT
iajs-3451	98	1	conflict	conflict	NOUN
iajs-3451	98	2	of	of	ADP
iajs-3451	98	3	interest	interest	NOUN
iajs-3451	98	4	there	there	PRON
iajs-3451	98	5	are	be	VERB
iajs-3451	98	6	no	no	DET
iajs-3451	98	7	conflicts	conflict	NOUN
iajs-3451	98	8	of	of	ADP
iajs-3451	98	9	interest	interest	NOUN
iajs-3451	98	10	.	.	PUNCT
iajs-3451	99	1	funding	funding	NOUN
iajs-3451	99	2	there	there	PRON
iajs-3451	99	3	is	be	VERB
iajs-3451	99	4	no	no	DET
iajs-3451	99	5	funding	funding	NOUN
iajs-3451	99	6	for	for	ADP
iajs-3451	99	7	the	the	DET
iajs-3451	99	8	article	article	NOUN
iajs-3451	99	9	.	.	PUNCT
iajs-3451	100	1	ethical	ethical	ADJ
iajs-3451	100	2	clearance	clearance	NOUN
iajs-3451	100	3	the	the	DET
iajs-3451	100	4	samples	sample	NOUN
iajs-3451	100	5	were	be	AUX
iajs-3451	100	6	gained	gain	VERB
iajs-3451	100	7	according	accord	VERB
iajs-3451	100	8	to	to	ADP
iajs-3451	100	9	local	local	ADJ
iajs-3451	100	10	research	research	NOUN
iajs-3451	100	11	ethics	ethic	NOUN
iajs-3451	100	12	committee	committee	PROPN
iajs-3451	100	13	approval	approval	NOUN
iajs-3451	100	14	in	in	ADP
iajs-3451	100	15	iraqi	iraqi	ADJ
iajs-3451	100	16	ministry	ministry	PROPN
iajs-3451	100	17	of	of	ADP
iajs-3451	100	18	health	health	PROPN
iajs-3451	100	19	no	no	PROPN
iajs-3451	100	20	.	.	PROPN
iajs-3451	100	21	135857i	135857i	NOUN
iajs-3451	100	22	on	on	ADP
iajs-3451	100	23	6	6	NUM
iajs-3451	100	24	/10/2022	/10/2022	SYM
iajs-3451	100	25	.	.	PUNCT
iajs-3451	101	1	references	reference	NOUN
iajs-3451	101	2	1	1	NUM
iajs-3451	101	3	.	.	PUNCT
iajs-3451	102	1	yap	yap	PROPN
iajs-3451	102	2	,	,	PUNCT
iajs-3451	102	3	h.y	h.y	PROPN
iajs-3451	102	4	.	.	PROPN
iajs-3451	102	5	;	;	PUNCT
iajs-3451	102	6	tee	tee	NOUN
iajs-3451	102	7	,	,	PUNCT
iajs-3451	102	8	s.z	s.z	PROPN
iajs-3451	102	9	.	.	PROPN
iajs-3451	102	10	;	;	PUNCT
iajs-3451	102	11	wong	wong	PROPN
iajs-3451	102	12	,	,	PUNCT
iajs-3451	102	13	m.m	m.m	PROPN
iajs-3451	102	14	.	.	PROPN
iajs-3451	102	15	;	;	PUNCT
iajs-3451	102	16	chow	chow	PROPN
iajs-3451	102	17	,	,	PUNCT
iajs-3451	102	18	s.k	s.k	PROPN
iajs-3451	102	19	.	.	PROPN
iajs-3451	102	20	;	;	PUNCT
iajs-3451	102	21	peh	peh	PROPN
iajs-3451	102	22	,	,	PUNCT
iajs-3451	102	23	s.c	s.c	PROPN
iajs-3451	102	24	.	.	PROPN
iajs-3451	102	25	;	;	PUNCT
iajs-3451	102	26	teow	teow	PROPN
iajs-3451	102	27	,	,	PUNCT
iajs-3451	102	28	s.y	s.y	PROPN
iajs-3451	102	29	.	.	PROPN
iajs-3451	102	30	pathogenic	pathogenic	ADJ
iajs-3451	102	31	role	role	NOUN
iajs-3451	102	32	of	of	ADP
iajs-3451	102	33	immune	immune	ADJ
iajs-3451	102	34	cells	cell	NOUN
iajs-3451	102	35	in	in	ADP
iajs-3451	102	36	rheumatoid	rheumatoid	NOUN
iajs-3451	102	37	arthritis	arthritis	NOUN
iajs-3451	102	38	:	:	PUNCT
iajs-3451	102	39	implications	implication	NOUN
iajs-3451	102	40	in	in	ADP
iajs-3451	102	41	clinical	clinical	ADJ
iajs-3451	102	42	treatment	treatment	NOUN
iajs-3451	102	43	and	and	CCONJ
iajs-3451	102	44	biomarker	biomarker	NOUN
iajs-3451	102	45	development	development	NOUN
iajs-3451	102	46	.	.	PUNCT
iajs-3451	103	1	cells	cell	NOUN
iajs-3451	103	2	2018	2018	NUM
iajs-3451	103	3	,	,	PUNCT
iajs-3451	103	4	7(10	7(10	NUM
iajs-3451	103	5	)	)	PUNCT
iajs-3451	103	6	,	,	PUNCT
iajs-3451	103	7	161	161	NUM
iajs-3451	103	8	.	.	PUNCT
iajs-3451	104	1	doi	doi	NOUN
iajs-3451	104	2	:	:	PUNCT
iajs-3451	104	3	https://doi.org/10.3390/cells7100161	https://doi.org/10.3390/cells7100161	ADJ
iajs-3451	104	4	.	.	PUNCT
iajs-3451	105	1	2	2	X
iajs-3451	105	2	.	.	X
iajs-3451	105	3	rija	rija	NOUN
iajs-3451	105	4	,	,	PUNCT
iajs-3451	105	5	f.f	f.f	PROPN
iajs-3451	105	6	.	.	PROPN
iajs-3451	105	7	,	,	PUNCT
iajs-3451	105	8	hussein	hussein	PROPN
iajs-3451	105	9	,	,	PUNCT
iajs-3451	105	10	s.z	s.z	PROPN
iajs-3451	105	11	.	.	PROPN
iajs-3451	105	12	;	;	PUNCT
iajs-3451	105	13	abdalla	abdalla	PROPN
iajs-3451	105	14	,	,	PUNCT
iajs-3451	105	15	m.a	m.a	PROPN
iajs-3451	105	16	.	.	PROPN
iajs-3451	105	17	,	,	PUNCT
iajs-3451	105	18	2021	2021	NUM
iajs-3451	105	19	.	.	PUNCT
iajs-3451	106	1	physiological	physiological	ADJ
iajs-3451	106	2	and	and	CCONJ
iajs-3451	106	3	immunological	immunological	ADJ
iajs-3451	106	4	disturbance	disturbance	NOUN
iajs-3451	106	5	in	in	ADP
iajs-3451	106	6	rheumatoid	rheumatoid	NOUN
iajs-3451	106	7	arthritis	arthritis	NOUN
iajs-3451	106	8	patients	patient	NOUN
iajs-3451	106	9	.	.	PUNCT
iajs-3451	107	1	baghdad	baghdad	PROPN
iajs-3451	107	2	science	science	PROPN
iajs-3451	107	3	journal	journal	PROPN
iajs-3451	107	4	2021	2021	NUM
iajs-3451	107	5	,	,	PUNCT
iajs-3451	107	6	18(2	18(2	NUM
iajs-3451	107	7	)	)	PUNCT
iajs-3451	107	8	,	,	PUNCT
iajs-3451	107	9	0247	0247	NUM
iajs-3451	107	10	-	-	SYM
iajs-3451	107	11	0247	0247	NUM
iajs-3451	107	12	.	.	PUNCT
iajs-3451	108	1	doi	doi	NOUN
iajs-3451	108	2	:	:	PUNCT
iajs-3451	108	3	https://doi.org/10.21123/bsj.2021.18.2.0247	https://doi.org/10.21123/bsj.2021.18.2.0247	PROPN
iajs-3451	108	4	.	.	NOUN
iajs-3451	109	1	3	3	X
iajs-3451	109	2	.	.	X
iajs-3451	109	3	faiq	faiq	PROPN
iajs-3451	109	4	,	,	PUNCT
iajs-3451	109	5	m.k	m.k	PROPN
iajs-3451	109	6	.	.	PUNCT
iajs-3451	109	7	;	;	PUNCT
iajs-3451	110	1	kadhim	kadhim	PROPN
iajs-3451	110	2	,	,	PUNCT
iajs-3451	110	3	d.j	d.j	PROPN
iajs-3451	110	4	.	.	PROPN
iajs-3451	110	5	;	;	PUNCT
iajs-3451	110	6	gorial	gorial	ADJ
iajs-3451	110	7	,	,	PUNCT
iajs-3451	110	8	f.i	f.i	PROPN
iajs-3451	110	9	.	.	PUNCT
iajs-3451	111	1	the	the	DET
iajs-3451	111	2	belief	belief	NOUN
iajs-3451	111	3	about	about	ADP
iajs-3451	111	4	medicines	medicine	NOUN
iajs-3451	111	5	among	among	ADP
iajs-3451	111	6	a	a	DET
iajs-3451	111	7	sample	sample	NOUN
iajs-3451	111	8	of	of	ADP
iajs-3451	111	9	iraqi	iraqi	ADJ
iajs-3451	111	10	patients	patient	NOUN
iajs-3451	111	11	with	with	ADP
iajs-3451	111	12	rheumatoid	rheumatoid	NOUN
iajs-3451	111	13	arthritis	arthritis	NOUN
iajs-3451	111	14	.	.	PUNCT
iajs-3451	112	1	iraqi	iraqi	ADJ
iajs-3451	112	2	journal	journal	PROPN
iajs-3451	112	3	of	of	ADP
iajs-3451	112	4	pharmaceutical	pharmaceutical	ADJ
iajs-3451	112	5	sciences	science	NOUN
iajs-3451	112	6	2019	2019	NUM
iajs-3451	112	7	,	,	PUNCT
iajs-3451	112	8	1683	1683	NUM
iajs-3451	112	9	-	-	SYM
iajs-3451	112	10	28(2	28(2	NUM
iajs-3451	112	11	)	)	PUNCT
iajs-3451	112	12	,	,	PUNCT
iajs-3451	112	13	134141	134141	NUM
iajs-3451	112	14	.	.	PUNCT
iajs-3451	113	1	doi	doi	NOUN
iajs-3451	113	2	:	:	PUNCT
iajs-3451	113	3	https://doi.org/10.31351/vol28iss2pp134-141	https://doi.org/10.31351/vol28iss2pp134-141	NOUN
iajs-3451	113	4	4	4	NUM
iajs-3451	113	5	.	.	PUNCT
iajs-3451	113	6	lucchino	lucchino	PROPN
iajs-3451	113	7	,	,	PUNCT
iajs-3451	113	8	b.	b.	PROPN
iajs-3451	113	9	;	;	PUNCT
iajs-3451	113	10	spinelli	spinelli	PROPN
iajs-3451	113	11	,	,	PUNCT
iajs-3451	113	12	f.r	f.r	PROPN
iajs-3451	113	13	;	;	PUNCT
iajs-3451	113	14	iannuccelli	iannuccelli	PROPN
iajs-3451	113	15	,	,	PUNCT
iajs-3451	113	16	a.	a.	NOUN
iajs-3451	113	17	guzzo	guzzo	PROPN
iajs-3451	113	18	,	,	PUNCT
iajs-3451	113	19	m.p	m.p	PROPN
iajs-3451	113	20	.	.	PROPN
iajs-3451	113	21	;	;	PUNCT
iajs-3451	113	22	conti	conti	X
iajs-3451	113	23	,	,	PUNCT
iajs-3451	113	24	f.	f.	PROPN
iajs-3451	113	25	;	;	PUNCT
iajs-3451	113	26	franco	franco	PROPN
iajs-3451	113	27	,	,	PUNCT
iajs-3451	113	28	m.d	m.d	PROPN
iajs-3451	113	29	.	.	PROPN
iajs-3451	113	30	mucosa	mucosa	PROPN
iajs-3451	113	31	–	–	PUNCT
iajs-3451	113	32	environment	environment	NOUN
iajs-3451	113	33	interactions	interaction	NOUN
iajs-3451	113	34	in	in	ADP
iajs-3451	113	35	the	the	DET
iajs-3451	113	36	pathogenesis	pathogenesis	NOUN
iajs-3451	113	37	of	of	ADP
iajs-3451	113	38	rheumatoid	rheumatoid	NOUN
iajs-3451	113	39	arthritis	arthritis	NOUN
iajs-3451	113	40	.	.	PUNCT
iajs-3451	114	1	cells	cell	NOUN
iajs-3451	114	2	2019	2019	NUM
iajs-3451	114	3	,	,	PUNCT
iajs-3451	114	4	8(7	8(7	NUM
iajs-3451	114	5	)	)	PUNCT
iajs-3451	114	6	,	,	PUNCT
iajs-3451	114	7	700	700	NUM
iajs-3451	114	8	.	.	PUNCT
iajs-3451	115	1	doi	doi	NOUN
iajs-3451	115	2	:	:	PUNCT
iajs-3451	115	3	https://doi.org/10.3390/cells8070700	https://doi.org/10.3390/cells8070700	PROPN
iajs-3451	115	4	5	5	NUM
iajs-3451	115	5	.	.	PUNCT
iajs-3451	115	6	targońska	targońska	PROPN
iajs-3451	115	7	-	-	PUNCT
iajs-3451	115	8	stępniak	stępniak	PROPN
iajs-3451	115	9	,	,	PUNCT
iajs-3451	115	10	b.	b.	PROPN
iajs-3451	115	11	;	;	PUNCT
iajs-3451	115	12	zwolak	zwolak	ADV
iajs-3451	115	13	,	,	PUNCT
iajs-3451	115	14	r.	r.	PROPN
iajs-3451	115	15	;	;	PUNCT
iajs-3451	115	16	piotrowski	piotrowski	NOUN
iajs-3451	115	17	,	,	PUNCT
iajs-3451	115	18	m.	m.	NOUN
iajs-3451	115	19	;	;	PUNCT
iajs-3451	115	20	grzechnik	grzechnik	X
iajs-3451	115	21	,	,	PUNCT
iajs-3451	115	22	k.	k.	PROPN
iajs-3451	115	23	;	;	PUNCT
iajs-3451	115	24	majdan	majdan	PROPN
iajs-3451	115	25	,	,	PUNCT
iajs-3451	115	26	m.	m.	VERB
iajs-3451	115	27	the	the	DET
iajs-3451	115	28	relationship	relationship	NOUN
iajs-3451	115	29	between	between	ADP
iajs-3451	115	30	hematological	hematological	ADJ
iajs-3451	115	31	markers	marker	NOUN
iajs-3451	115	32	of	of	ADP
iajs-3451	115	33	systemic	systemic	ADJ
iajs-3451	115	34	inflammation	inflammation	NOUN
iajs-3451	115	35	(	(	PUNCT
iajs-3451	115	36	neutrophil	neutrophil	NOUN
iajs-3451	115	37	-	-	PUNCT
iajs-3451	115	38	to	to	ADP
iajs-3451	115	39	-	-	PUNCT
iajs-3451	115	40	lymphocyte	lymphocyte	ADJ
iajs-3451	115	41	,	,	PUNCT
iajs-3451	115	42	platelet	platelet	NOUN
iajs-3451	115	43	-	-	PUNCT
iajs-3451	115	44	tolymphocyte	tolymphocyte	NOUN
iajs-3451	115	45	,	,	PUNCT
iajs-3451	115	46	lymphocyte	lymphocyte	NOUN
iajs-3451	115	47	-	-	PUNCT
iajs-3451	115	48	to	to	ADP
iajs-3451	115	49	-	-	PUNCT
iajs-3451	115	50	monocyte	monocyte	NOUN
iajs-3451	115	51	ratios	ratio	NOUN
iajs-3451	115	52	)	)	PUNCT
iajs-3451	115	53	and	and	CCONJ
iajs-3451	115	54	ultrasound	ultrasound	NOUN
iajs-3451	115	55	disease	disease	NOUN
iajs-3451	115	56	activity	activity	NOUN
iajs-3451	115	57	parameters	parameter	NOUN
iajs-3451	115	58	in	in	ADP
iajs-3451	115	59	patients	patient	NOUN
iajs-3451	115	60	with	with	ADP
iajs-3451	115	61	rheumatoid	rheumatoid	NOUN
iajs-3451	115	62	arthritis	arthritis	NOUN
iajs-3451	115	63	.	.	PUNCT
iajs-3451	116	1	journal	journal	NOUN
iajs-3451	116	2	of	of	ADP
iajs-3451	116	3	clinical	clinical	ADJ
iajs-3451	116	4	medicine	medicine	NOUN
iajs-3451	116	5	.	.	PUNCT
iajs-3451	117	1	2020	2020	NUM
iajs-3451	117	2	,	,	PUNCT
iajs-3451	117	3	9(9	9(9	NUM
iajs-3451	117	4	)	)	PUNCT
iajs-3451	117	5	,	,	PUNCT
iajs-3451	117	6	2760	2760	NUM
iajs-3451	117	7	.	.	PUNCT
iajs-3451	118	1	doi	doi	NOUN
iajs-3451	118	2	:	:	PUNCT
iajs-3451	118	3	https://doi.org/10.3390/jcm9092760	https://doi.org/10.3390/jcm9092760	NOUN
iajs-3451	118	4	6	6	NUM
iajs-3451	118	5	.	.	PUNCT
iajs-3451	119	1	jassim	jassim	PROPN
iajs-3451	119	2	,	,	PUNCT
iajs-3451	119	3	h.h	h.h	PROPN
iajs-3451	119	4	.	.	PROPN
iajs-3451	119	5	;	;	PUNCT
iajs-3451	119	6	alnassiri	alnassiri	PROPN
iajs-3451	119	7	,	,	PUNCT
iajs-3451	119	8	s.h	s.h	PROPN
iajs-3451	119	9	.	.	PROPN
iajs-3451	119	10	;	;	PUNCT
iajs-3451	119	11	mawlood	mawlood	PROPN
iajs-3451	119	12	,	,	PUNCT
iajs-3451	119	13	a.f	a.f	PROPN
iajs-3451	119	14	.	.	PROPN
iajs-3451	119	15	;	;	PUNCT
iajs-3451	119	16	shnak	shnak	PROPN
iajs-3451	119	17	,	,	PUNCT
iajs-3451	119	18	q.a	q.a	PROPN
iajs-3451	119	19	.	.	PROPN
iajs-3451	119	20	relationship	relationship	NOUN
iajs-3451	119	21	of	of	ADP
iajs-3451	119	22	erythrocyte	erythrocyte	PROPN
iajs-3451	119	23	sedimentation	sedimentation	NOUN
iajs-3451	119	24	rate	rate	NOUN
iajs-3451	119	25	with	with	ADP
iajs-3451	119	26	the	the	DET
iajs-3451	119	27	activity	activity	NOUN
iajs-3451	119	28	of	of	ADP
iajs-3451	119	29	prolidase	prolidase	NOUN
iajs-3451	119	30	and	and	CCONJ
iajs-3451	119	31	liver	liver	NOUN
iajs-3451	119	32	enzyme	enzyme	NOUN
iajs-3451	119	33	in	in	ADP
iajs-3451	119	34	serum	serum	NOUN
iajs-3451	119	35	of	of	ADP
iajs-3451	119	36	patients	patient	NOUN
iajs-3451	119	37	with	with	ADP
iajs-3451	119	38	rheumatoid	rheumatoid	NOUN
iajs-3451	119	39	arthritis	arthritis	NOUN
iajs-3451	119	40	.	.	PUNCT
iajs-3451	120	1	materials	material	NOUN
iajs-3451	120	2	today	today	NOUN
iajs-3451	120	3	:	:	PUNCT
iajs-3451	120	4	proceedings	proceeding	NOUN
iajs-3451	120	5	2021	2021	NUM
iajs-3451	120	6	,	,	PUNCT
iajs-3451	120	7	43	43	NUM
iajs-3451	120	8	,	,	PUNCT
iajs-3451	120	9	2069	2069	NUM
iajs-3451	120	10	-	-	SYM
iajs-3451	120	11	2075	2075	NUM
iajs-3451	120	12	.	.	PUNCT
iajs-3451	121	1	7	7	X
iajs-3451	121	2	.	.	NOUN
iajs-3451	121	3	buzatu	buzatu	NOUN
iajs-3451	121	4	,	,	PUNCT
iajs-3451	121	5	c.	c.	NOUN
iajs-3451	121	6	;	;	PUNCT
iajs-3451	121	7	moots	moot	NOUN
iajs-3451	121	8	,	,	PUNCT
iajs-3451	121	9	r.j	r.j	PROPN
iajs-3451	121	10	.	.	NOUN
iajs-3451	121	11	measuring	measure	VERB
iajs-3451	121	12	disease	disease	NOUN
iajs-3451	121	13	activity	activity	NOUN
iajs-3451	121	14	and	and	CCONJ
iajs-3451	121	15	response	response	NOUN
iajs-3451	121	16	to	to	ADP
iajs-3451	121	17	treatment	treatment	NOUN
iajs-3451	121	18	in	in	ADP
iajs-3451	121	19	rheumatoid	rheumatoid	NOUN
iajs-3451	121	20	arthritis	arthritis	NOUN
iajs-3451	121	21	.	.	PUNCT
iajs-3451	122	1	expert	expert	NOUN
iajs-3451	122	2	review	review	NOUN
iajs-3451	122	3	of	of	ADP
iajs-3451	122	4	clinical	clinical	ADJ
iajs-3451	122	5	immunology	immunology	NOUN
iajs-3451	122	6	2019	2019	NUM
iajs-3451	122	7	,	,	PUNCT
iajs-3451	122	8	15(2	15(2	NUM
iajs-3451	122	9	)	)	PUNCT
iajs-3451	122	10	,	,	PUNCT
iajs-3451	122	11	135	135	NUM
iajs-3451	122	12	-	-	SYM
iajs-3451	122	13	45	45	NUM
iajs-3451	122	14	.	.	PUNCT
iajs-3451	123	1	doi	doi	PROPN
iajs-3451	123	2	:	:	PUNCT
iajs-3451	123	3	https://doi.org/10.1080/1744666x.2019.1559050	https://doi.org/10.1080/1744666x.2019.1559050	PROPN
iajs-3451	123	4	8	8	NUM
iajs-3451	123	5	.	.	PUNCT
iajs-3451	124	1	hale	hale	PROPN
iajs-3451	124	2	,	,	PUNCT
iajs-3451	124	3	a.j	a.j	PROPN
iajs-3451	124	4	.	.	PROPN
iajs-3451	124	5	;	;	PUNCT
iajs-3451	124	6	ricotta	ricotta	NOUN
iajs-3451	124	7	,	,	PUNCT
iajs-3451	124	8	d.n	d.n	PROPN
iajs-3451	124	9	.	.	PROPN
iajs-3451	124	10	;	;	PUNCT
iajs-3451	124	11	freed	free	VERB
iajs-3451	124	12	,	,	PUNCT
iajs-3451	124	13	j.a	j.a	PROPN
iajs-3451	124	14	.	.	PROPN
iajs-3451	124	15	evaluating	evaluate	VERB
iajs-3451	124	16	the	the	DET
iajs-3451	124	17	erythrocyte	erythrocyte	PROPN
iajs-3451	124	18	sedimentation	sedimentation	NOUN
iajs-3451	124	19	rate	rate	NOUN
iajs-3451	124	20	.	.	PUNCT
iajs-3451	125	1	jama	jama	PROPN
iajs-3451	125	2	diagnostic	diagnostic	ADJ
iajs-3451	125	3	test	test	NOUN
iajs-3451	125	4	interpretation	interpretation	NOUN
iajs-3451	125	5	2019	2019	NUM
iajs-3451	125	6	,	,	PUNCT
iajs-3451	125	7	321(14	321(14	NUM
iajs-3451	125	8	)	)	PUNCT
iajs-3451	125	9	,	,	PUNCT
iajs-3451	125	10	1404	1404	NUM
iajs-3451	125	11	-	-	SYM
iajs-3451	125	12	1405	1405	NUM
iajs-3451	125	13	.	.	PUNCT
iajs-3451	126	1	doi	doi	NOUN
iajs-3451	126	2	:	:	PUNCT
iajs-3451	126	3	10.1001	10.1001	NUM
iajs-3451	126	4	/	/	SYM
iajs-3451	127	1	jama.2019.1178	jama.2019.1178	NOUN
iajs-3451	127	2	.	.	PUNCT
iajs-3451	128	1	9	9	X
iajs-3451	128	2	.	.	X
iajs-3451	128	3	tishkowski	tishkowski	PROPN
iajs-3451	128	4	,	,	PUNCT
iajs-3451	128	5	k	k	NOUN
iajs-3451	128	6	;	;	PUNCT
iajs-3451	128	7	gupta	gupta	PROPN
iajs-3451	128	8	,	,	PUNCT
iajs-3451	128	9	v.	v.	CCONJ
iajs-3451	128	10	erythrocyte	erythrocyte	PROPN
iajs-3451	128	11	sedimentation	sedimentation	NOUN
iajs-3451	128	12	rate	rate	NOUN
iajs-3451	128	13	.	.	PUNCT
iajs-3451	129	1	in	in	ADP
iajs-3451	129	2	statpearls	statpearl	NOUN
iajs-3451	130	1	[	[	X
iajs-3451	130	2	internet	internet	NOUN
iajs-3451	130	3	]	]	PUNCT
iajs-3451	130	4	.	.	PUNCT
iajs-3451	131	1	statpearls	statpearl	NOUN
iajs-3451	131	2	publishing	publish	VERB
iajs-3451	131	3	2022	2022	NUM
iajs-3451	131	4	.	.	PUNCT
iajs-3451	132	1	https://pubmed.ncbi.nlm.nih.gov/32491417/	https://pubmed.ncbi.nlm.nih.gov/32491417/	ADJ
iajs-3451	132	2	https://doi.org/10.3390/cells7100161	https://doi.org/10.3390/cells7100161	NOUN
iajs-3451	132	3	https://doi.org/10.21123/bsj.2021.18.2.0247	https://doi.org/10.21123/bsj.2021.18.2.0247	VERB
iajs-3451	132	4	https://doi.org/10.31351/vol28iss2pp134-141	https://doi.org/10.31351/vol28iss2pp134-141	NOUN
iajs-3451	132	5	https://doi.org/10.3390/cells8070700	https://doi.org/10.3390/cells8070700	PROPN
iajs-3451	133	1	https://doi.org/10.3390/jcm9092760	https://doi.org/10.3390/jcm9092760	NOUN
iajs-3451	133	2	https://doi.org/10.1080/1744666x.2019.1559050	https://doi.org/10.1080/1744666x.2019.1559050	VERB
iajs-3451	133	3	https://pubmed.ncbi.nlm.nih.gov/32491417/	https://pubmed.ncbi.nlm.nih.gov/32491417/	PROPN
iajs-3451	133	4	ihjpas	ihjpa	NOUN
iajs-3451	133	5	.	.	PUNCT
iajs-3451	134	1	37	37	NUM
iajs-3451	134	2	(	(	PUNCT
iajs-3451	134	3	2	2	NUM
iajs-3451	134	4	)	)	PUNCT
iajs-3451	134	5	2024	2024	NUM
iajs-3451	134	6	133	133	NUM
iajs-3451	134	7	10	10	NUM
iajs-3451	134	8	.	.	PUNCT
iajs-3451	135	1	atere	atere	ADV
iajs-3451	135	2	,	,	PUNCT
iajs-3451	135	3	a.d	a.d	PROPN
iajs-3451	135	4	.	.	PROPN
iajs-3451	135	5	;	;	PUNCT
iajs-3451	135	6	oseni	oseni	ADJ
iajs-3451	135	7	,	,	PUNCT
iajs-3451	135	8	b.s	b.s	PROPN
iajs-3451	135	9	.	.	PROPN
iajs-3451	135	10	;	;	PUNCT
iajs-3451	136	1	adebua	adebua	PROPN
iajs-3451	136	2	,	,	PUNCT
iajs-3451	136	3	i.p	i.p	PROPN
iajs-3451	136	4	.	.	PROPN
iajs-3451	136	5	;	;	PUNCT
iajs-3451	136	6	fapohunda	fapohunda	PROPN
iajs-3451	136	7	,	,	PUNCT
iajs-3451	136	8	j.s	j.s	PROPN
iajs-3451	136	9	.	.	PROPN
iajs-3451	136	10	;	;	PUNCT
iajs-3451	136	11	aigbokheo	aigbokheo	PROPN
iajs-3451	136	12	,	,	PUNCT
iajs-3451	136	13	i.f	i.f	PROPN
iajs-3451	136	14	.	.	PUNCT
iajs-3451	136	15	prognostic	prognostic	ADJ
iajs-3451	136	16	roles	role	NOUN
iajs-3451	136	17	of	of	ADP
iajs-3451	136	18	c	c	NOUN
iajs-3451	136	19	-	-	PUNCT
iajs-3451	136	20	reactive	reactive	ADJ
iajs-3451	136	21	protein	protein	NOUN
iajs-3451	136	22	and	and	CCONJ
iajs-3451	136	23	erythrocyte	erythrocyte	NOUN
iajs-3451	136	24	sedimentation	sedimentation	NOUN
iajs-3451	136	25	rate	rate	NOUN
iajs-3451	136	26	as	as	ADP
iajs-3451	136	27	acute	acute	ADJ
iajs-3451	136	28	phase	phase	NOUN
iajs-3451	136	29	reactants	reactant	VERB
iajs-3451	136	30	in	in	ADP
iajs-3451	136	31	mentally	mentally	ADV
iajs-3451	136	32	challenged	challenge	VERB
iajs-3451	136	33	subjects	subject	NOUN
iajs-3451	136	34	.	.	PUNCT
iajs-3451	137	1	sudan	sudan	PROPN
iajs-3451	137	2	journal	journal	PROPN
iajs-3451	137	3	of	of	ADP
iajs-3451	137	4	medical	medical	ADJ
iajs-3451	137	5	sciences	science	NOUN
iajs-3451	137	6	2018	2018	NUM
iajs-3451	137	7	,	,	PUNCT
iajs-3451	137	8	13(4	13(4	NUM
iajs-3451	137	9	)	)	PUNCT
iajs-3451	137	10	,	,	PUNCT
iajs-3451	137	11	311	311	NUM
iajs-3451	137	12	-	-	SYM
iajs-3451	137	13	323	323	NUM
iajs-3451	137	14	.	.	PUNCT
iajs-3451	138	1	doi:10.18502	doi:10.18502	VERB
iajs-3451	138	2	/	/	SYM
iajs-3451	138	3	sjms.v13i4.3641	sjms.v13i4.3641	PROPN
iajs-3451	138	4	.	.	PUNCT
iajs-3451	139	1	11	11	NUM
iajs-3451	139	2	.	.	PUNCT
iajs-3451	140	1	assasi	assasi	ADJ
iajs-3451	140	2	,	,	PUNCT
iajs-3451	140	3	n.	n.	NOUN
iajs-3451	140	4	;	;	PUNCT
iajs-3451	140	5	blackhouse	blackhouse	PROPN
iajs-3451	140	6	,	,	PUNCT
iajs-3451	140	7	g.	g.	PROPN
iajs-3451	140	8	;	;	PUNCT
iajs-3451	140	9	campbell	campbell	PROPN
iajs-3451	140	10	,	,	PUNCT
iajs-3451	140	11	k.	k.	PROPN
iajs-3451	140	12	;	;	PUNCT
iajs-3451	140	13	hopkins	hopkins	PROPN
iajs-3451	140	14	,	,	PUNCT
iajs-3451	140	15	r.b	r.b	PROPN
iajs-3451	140	16	.	.	PROPN
iajs-3451	140	17	;	;	PUNCT
iajs-3451	140	18	levine	levine	PROPN
iajs-3451	140	19	,	,	PUNCT
iajs-3451	140	20	m.	m.	NOUN
iajs-3451	140	21	;	;	PUNCT
iajs-3451	140	22	richter	richter	PROPN
iajs-3451	140	23	,	,	PUNCT
iajs-3451	140	24	t.	t.	PROPN
iajs-3451	140	25	;	;	PUNCT
iajs-3451	140	26	budden	budden	PROPN
iajs-3451	140	27	,	,	PUNCT
iajs-3451	140	28	a.	a.	NOUN
iajs-3451	140	29	2015	2015	NUM
iajs-3451	140	30	.	.	PUNCT
iajs-3451	141	1	comparative	comparative	ADJ
iajs-3451	141	2	value	value	NOUN
iajs-3451	141	3	of	of	ADP
iajs-3451	141	4	erythrocyte	erythrocyte	PROPN
iajs-3451	141	5	sedimentation	sedimentation	NOUN
iajs-3451	141	6	rate	rate	NOUN
iajs-3451	141	7	(	(	PUNCT
iajs-3451	141	8	esr	esr	PROPN
iajs-3451	141	9	)	)	PUNCT
iajs-3451	141	10	and	and	CCONJ
iajs-3451	141	11	c	c	NOUN
iajs-3451	141	12	-	-	PUNCT
iajs-3451	141	13	reactive	reactive	ADJ
iajs-3451	141	14	protein	protein	NOUN
iajs-3451	141	15	(	(	PUNCT
iajs-3451	141	16	crp	crp	NOUN
iajs-3451	141	17	)	)	PUNCT
iajs-3451	141	18	testing	testing	NOUN
iajs-3451	141	19	in	in	ADP
iajs-3451	141	20	combination	combination	NOUN
iajs-3451	141	21	versus	versus	ADP
iajs-3451	141	22	individually	individually	ADV
iajs-3451	141	23	for	for	ADP
iajs-3451	141	24	the	the	DET
iajs-3451	141	25	diagnosis	diagnosis	NOUN
iajs-3451	141	26	of	of	ADP
iajs-3451	141	27	undifferentiated	undifferentiated	ADJ
iajs-3451	141	28	patients	patient	NOUN
iajs-3451	141	29	with	with	ADP
iajs-3451	141	30	suspected	suspect	VERB
iajs-3451	141	31	inflammatory	inflammatory	ADJ
iajs-3451	141	32	disease	disease	NOUN
iajs-3451	141	33	or	or	CCONJ
iajs-3451	141	34	serious	serious	ADJ
iajs-3451	141	35	infection	infection	NOUN
iajs-3451	141	36	:	:	PUNCT
iajs-3451	141	37	a	a	DET
iajs-3451	141	38	systematic	systematic	ADJ
iajs-3451	141	39	review	review	NOUN
iajs-3451	141	40	and	and	CCONJ
iajs-3451	141	41	economic	economic	ADJ
iajs-3451	141	42	analysis	analysis	NOUN
iajs-3451	141	43	.	.	PUNCT
iajs-3451	142	1	canadian	canadian	ADJ
iajs-3451	142	2	agency	agency	NOUN
iajs-3451	142	3	for	for	ADP
iajs-3451	142	4	drugs	drug	NOUN
iajs-3451	142	5	and	and	CCONJ
iajs-3451	142	6	technologies	technology	NOUN
iajs-3451	142	7	in	in	ADP
iajs-3451	142	8	health	health	NOUN
iajs-3451	142	9	2015	2015	NUM
iajs-3451	142	10	,	,	PUNCT
iajs-3451	142	11	(	(	PUNCT
iajs-3451	142	12	internet	internet	NOUN
iajs-3451	142	13	)	)	PUNCT
iajs-3451	142	14	.	.	PUNCT
iajs-3451	143	1	12	12	NUM
iajs-3451	143	2	.	.	PUNCT
iajs-3451	143	3	lapić	lapić	PROPN
iajs-3451	143	4	,	,	PUNCT
iajs-3451	143	5	i.	i.	NOUN
iajs-3451	143	6	;	;	PUNCT
iajs-3451	143	7	padoan	padoan	NOUN
iajs-3451	143	8	,	,	PUNCT
iajs-3451	143	9	a.	a.	NOUN
iajs-3451	143	10	;	;	PUNCT
iajs-3451	143	11	bozzato	bozzato	PROPN
iajs-3451	143	12	,	,	PUNCT
iajs-3451	143	13	d.	d.	PROPN
iajs-3451	143	14	;	;	PUNCT
iajs-3451	143	15	plebani	plebani	PROPN
iajs-3451	143	16	,	,	PUNCT
iajs-3451	143	17	m.	m.	NOUN
iajs-3451	143	18	erythrocyte	erythrocyte	PROPN
iajs-3451	143	19	sedimentation	sedimentation	NOUN
iajs-3451	143	20	rate	rate	NOUN
iajs-3451	143	21	and	and	CCONJ
iajs-3451	143	22	c	c	NOUN
iajs-3451	143	23	-	-	PUNCT
iajs-3451	143	24	reactive	reactive	ADJ
iajs-3451	143	25	protein	protein	NOUN
iajs-3451	143	26	in	in	ADP
iajs-3451	143	27	acute	acute	ADJ
iajs-3451	143	28	inflammation	inflammation	NOUN
iajs-3451	143	29	:	:	PUNCT
iajs-3451	143	30	meta	meta	ADJ
iajs-3451	143	31	-	-	PUNCT
iajs-3451	143	32	analysis	analysis	NOUN
iajs-3451	143	33	of	of	ADP
iajs-3451	143	34	diagnostic	diagnostic	ADJ
iajs-3451	143	35	accuracy	accuracy	NOUN
iajs-3451	143	36	studies	study	NOUN
iajs-3451	143	37	.	.	PUNCT
iajs-3451	144	1	american	american	PROPN
iajs-3451	144	2	journal	journal	PROPN
iajs-3451	144	3	of	of	ADP
iajs-3451	144	4	clinical	clinical	ADJ
iajs-3451	144	5	pathology	pathology	NOUN
iajs-3451	144	6	2020	2020	NUM
iajs-3451	144	7	,	,	PUNCT
iajs-3451	144	8	153(1	153(1	NUM
iajs-3451	144	9	)	)	PUNCT
iajs-3451	144	10	,	,	PUNCT
iajs-3451	144	11	14	14	NUM
iajs-3451	144	12	-	-	SYM
iajs-3451	144	13	29	29	NUM
iajs-3451	144	14	.	.	PUNCT
iajs-3451	145	1	doi	doi	NOUN
iajs-3451	145	2	:	:	PUNCT
iajs-3451	145	3	10.1093	10.1093	NUM
iajs-3451	145	4	/	/	SYM
iajs-3451	145	5	ajcp	ajcp	PROPN
iajs-3451	145	6	/	/	SYM
iajs-3451	145	7	aqz142	aqz142	PROPN
iajs-3451	145	8	.	.	PUNCT
iajs-3451	146	1	13	13	NUM
iajs-3451	146	2	.	.	PUNCT
iajs-3451	146	3	falkenburg	falkenburg	PROPN
iajs-3451	146	4	,	,	PUNCT
iajs-3451	146	5	w.j	w.j	PROPN
iajs-3451	146	6	.	.	PROPN
iajs-3451	146	7	;	;	PUNCT
iajs-3451	146	8	van	van	PROPN
iajs-3451	146	9	schaardenburg	schaardenburg	PROPN
iajs-3451	146	10	,	,	PUNCT
iajs-3451	146	11	d.	d.	PROPN
iajs-3451	146	12	;	;	PUNCT
iajs-3451	146	13	ooijevaar	ooijevaar	PROPN
iajs-3451	146	14	-	-	PUNCT
iajs-3451	146	15	de	de	X
iajs-3451	146	16	heer	heer	NOUN
iajs-3451	146	17	,	,	PUNCT
iajs-3451	146	18	p.	p.	NOUN
iajs-3451	146	19	;	;	PUNCT
iajs-3451	146	20	bultink	bultink	NOUN
iajs-3451	146	21	i.e.	i.e.	X
iajs-3451	146	22	;	;	PUNCT
iajs-3451	146	23	voskuyl	voskuyl	NOUN
iajs-3451	146	24	,	,	PUNCT
iajs-3451	146	25	a.	a.	PROPN
iajs-3451	146	26	e.	e.	PROPN
iajs-3451	146	27	;	;	PUNCT
iajs-3451	146	28	bentlage	bentlage	NOUN
iajs-3451	146	29	,	,	PUNCT
iajs-3451	146	30	a.e	a.e	PROPN
iajs-3451	146	31	.	.	PROPN
iajs-3451	146	32	;	;	PUNCT
iajs-3451	146	33	vidarsson	vidarsson	PROPN
iajs-3451	146	34	,	,	PUNCT
iajs-3451	146	35	g.	g.	PROPN
iajs-3451	146	36	;	;	PUNCT
iajs-3451	146	37	wolbink	wolbink	NOUN
iajs-3451	146	38	,	,	PUNCT
iajs-3451	146	39	g.	g.	PROPN
iajs-3451	146	40	;	;	PUNCT
iajs-3451	146	41	rispens	rispen	NOUN
iajs-3451	146	42	,	,	PUNCT
iajs-3451	146	43	t.	t.	NOUN
iajs-3451	146	44	anti	anti	ADJ
iajs-3451	146	45	-	-	ADJ
iajs-3451	146	46	hinge	hinge	ADJ
iajs-3451	146	47	antibodies	antibody	NOUN
iajs-3451	146	48	recognize	recognize	VERB
iajs-3451	146	49	igg	igg	PROPN
iajs-3451	146	50	subclass	subclass	NOUN
iajs-3451	146	51	–	–	PUNCT
iajs-3451	146	52	and	and	CCONJ
iajs-3451	146	53	protease	protease	NOUN
iajs-3451	146	54	-	-	PUNCT
iajs-3451	146	55	restricted	restrict	VERB
iajs-3451	146	56	neoepitopes	neoepitope	NOUN
iajs-3451	146	57	.	.	PUNCT
iajs-3451	147	1	the	the	DET
iajs-3451	147	2	journal	journal	NOUN
iajs-3451	147	3	of	of	ADP
iajs-3451	147	4	immunology	immunology	NOUN
iajs-3451	147	5	2017	2017	NUM
iajs-3451	147	6	,	,	PUNCT
iajs-3451	147	7	198(1	198(1	NUM
iajs-3451	147	8	)	)	PUNCT
iajs-3451	147	9	,	,	PUNCT
iajs-3451	147	10	82	82	NUM
iajs-3451	147	11	-	-	SYM
iajs-3451	147	12	93	93	NUM
iajs-3451	147	13	.	.	PUNCT
iajs-3451	148	1	https://doi.org/10.4049/jimmunol.1601096	https://doi.org/10.4049/jimmunol.1601096	NOUN
iajs-3451	148	2	.	.	PUNCT
iajs-3451	149	1	14	14	NUM
iajs-3451	149	2	.	.	PUNCT
iajs-3451	150	1	motta	motta	PROPN
iajs-3451	150	2	,	,	PUNCT
iajs-3451	150	3	f.	f.	PROPN
iajs-3451	150	4	;	;	PUNCT
iajs-3451	150	5	bizzaro	bizzaro	PROPN
iajs-3451	150	6	,	,	PUNCT
iajs-3451	150	7	n.	n.	NOUN
iajs-3451	150	8	;	;	PUNCT
iajs-3451	150	9	giavarina	giavarina	PROPN
iajs-3451	150	10	,	,	PUNCT
iajs-3451	150	11	d.	d.	PROPN
iajs-3451	150	12	;	;	PUNCT
iajs-3451	150	13	franceschini	franceschini	PROPN
iajs-3451	150	14	,	,	PUNCT
iajs-3451	150	15	f.	f.	PROPN
iajs-3451	150	16	;	;	PUNCT
iajs-3451	150	17	infantino	infantino	PROPN
iajs-3451	150	18	,	,	PUNCT
iajs-3451	150	19	m.	m.	NOUN
iajs-3451	150	20	;	;	PUNCT
iajs-3451	150	21	palterer	palterer	X
iajs-3451	150	22	,	,	PUNCT
iajs-3451	150	23	b.	b.	PROPN
iajs-3451	150	24	;	;	PUNCT
iajs-3451	150	25	sebastiani	sebastiani	PROPN
iajs-3451	150	26	,	,	PUNCT
iajs-3451	150	27	g.d	g.d	PROPN
iajs-3451	150	28	.	.	PROPN
iajs-3451	150	29	;	;	PUNCT
iajs-3451	150	30	selmi	selmi	PROPN
iajs-3451	150	31	,	,	PUNCT
iajs-3451	150	32	c.	c.	PROPN
iajs-3451	150	33	rheumatoid	rheumatoid	NOUN
iajs-3451	150	34	factor	factor	NOUN
iajs-3451	150	35	isotypes	isotype	NOUN
iajs-3451	150	36	in	in	ADP
iajs-3451	150	37	rheumatoid	rheumatoid	NOUN
iajs-3451	150	38	arthritis	arthritis	NOUN
iajs-3451	150	39	diagnosis	diagnosis	NOUN
iajs-3451	150	40	and	and	CCONJ
iajs-3451	150	41	prognosis	prognosis	NOUN
iajs-3451	150	42	:	:	PUNCT
iajs-3451	150	43	a	a	DET
iajs-3451	150	44	systematic	systematic	ADJ
iajs-3451	150	45	review	review	NOUN
iajs-3451	150	46	and	and	CCONJ
iajs-3451	150	47	meta	meta	ADJ
iajs-3451	150	48	-	-	PUNCT
iajs-3451	150	49	analysis	analysis	NOUN
iajs-3451	150	50	.	.	PUNCT
iajs-3451	151	1	rmd	rmd	PROPN
iajs-3451	151	2	open	open	VERB
iajs-3451	151	3	.	.	PUNCT
iajs-3451	152	1	2023	2023	NUM
iajs-3451	152	2	,	,	PUNCT
iajs-3451	152	3	9(3	9(3	NUM
iajs-3451	152	4	)	)	PUNCT
iajs-3451	152	5	,	,	PUNCT
iajs-3451	153	1	e002817	e002817	PROPN
iajs-3451	153	2	.	.	PUNCT
iajs-3451	153	3	doi	doi	PROPN
iajs-3451	153	4	:	:	PUNCT
iajs-3451	153	5	10.1136	10.1136	NUM
iajs-3451	153	6	/	/	SYM
iajs-3451	153	7	rmdopen-2022	rmdopen-2022	NOUN
iajs-3451	153	8	-	-	PUNCT
iajs-3451	153	9	002817	002817	NUM
iajs-3451	153	10	.	.	PUNCT
iajs-3451	154	1	15	15	NUM
iajs-3451	154	2	.	.	PUNCT
iajs-3451	155	1	van	van	NOUN
iajs-3451	155	2	hoovels	hoovel	NOUN
iajs-3451	155	3	,	,	PUNCT
iajs-3451	155	4	l.	l.	PROPN
iajs-3451	155	5	;	;	PUNCT
iajs-3451	155	6	vander	vander	PROPN
iajs-3451	155	7	cruyssen	cruyssen	PROPN
iajs-3451	155	8	,	,	PUNCT
iajs-3451	155	9	b.	b.	PROPN
iajs-3451	155	10	;	;	PUNCT
iajs-3451	155	11	sieghart	sieghart	PROPN
iajs-3451	155	12	,	,	PUNCT
iajs-3451	155	13	d.	d.	PROPN
iajs-3451	155	14	;	;	PUNCT
iajs-3451	155	15	bonroy	bonroy	PROPN
iajs-3451	155	16	,	,	PUNCT
iajs-3451	155	17	c.	c.	PROPN
iajs-3451	155	18	;	;	PUNCT
iajs-3451	155	19	nagy	nagy	PROPN
iajs-3451	155	20	,	,	PUNCT
iajs-3451	155	21	e.	e.	PROPN
iajs-3451	155	22	;	;	PUNCT
iajs-3451	155	23	pullerits	pullerit	NOUN
iajs-3451	155	24	,	,	PUNCT
iajs-3451	155	25	r.	r.	PROPN
iajs-3451	155	26	;	;	PUNCT
iajs-3451	155	27	čučnik	čučnik	X
iajs-3451	155	28	,	,	PUNCT
iajs-3451	155	29	s.	s.	PROPN
iajs-3451	155	30	;	;	PUNCT
iajs-3451	155	31	dahle	dahle	PROPN
iajs-3451	155	32	,	,	PUNCT
iajs-3451	155	33	c.	c.	PROPN
iajs-3451	155	34	;	;	PUNCT
iajs-3451	155	35	heijnen	heijnen	PROPN
iajs-3451	155	36	,	,	PUNCT
iajs-3451	155	37	i.	i.	PROPN
iajs-3451	155	38	;	;	PUNCT
iajs-3451	155	39	bernasconi	bernasconi	PROPN
iajs-3451	155	40	,	,	PUNCT
iajs-3451	155	41	l.	l.	PROPN
iajs-3451	155	42	;	;	PUNCT
iajs-3451	155	43	benkhadra	benkhadra	PROPN
iajs-3451	155	44	,	,	PUNCT
iajs-3451	155	45	f.	f.	PROPN
iajs-3451	155	46	iga	iga	PROPN
iajs-3451	155	47	rheumatoid	rheumatoid	NOUN
iajs-3451	155	48	factor	factor	NOUN
iajs-3451	155	49	in	in	ADP
iajs-3451	155	50	rheumatoid	rheumatoid	NOUN
iajs-3451	155	51	arthritis	arthritis	NOUN
iajs-3451	155	52	.	.	PUNCT
iajs-3451	156	1	clinical	clinical	ADJ
iajs-3451	156	2	chemistry	chemistry	NOUN
iajs-3451	156	3	and	and	CCONJ
iajs-3451	156	4	laboratory	laboratory	NOUN
iajs-3451	156	5	medicine	medicine	NOUN
iajs-3451	156	6	(	(	PUNCT
iajs-3451	156	7	cclm	cclm	PROPN
iajs-3451	156	8	)	)	PUNCT
iajs-3451	156	9	.	.	PUNCT
iajs-3451	157	1	2022	2022	NUM
iajs-3451	157	2	,	,	PUNCT
iajs-3451	157	3	60(10	60(10	NUM
iajs-3451	157	4	)	)	PUNCT
iajs-3451	157	5	,	,	PUNCT
iajs-3451	157	6	1617	1617	NUM
iajs-3451	157	7	-	-	SYM
iajs-3451	157	8	1626	1626	NUM
iajs-3451	157	9	.	.	PUNCT
iajs-3451	158	1	doi	doi	NOUN
iajs-3451	158	2	:	:	PUNCT
iajs-3451	158	3	https://doi.org/10.1515/cclm-2022-0244	https://doi.org/10.1515/cclm-2022-0244	PROPN
iajs-3451	158	4	.	.	PROPN
iajs-3451	158	5	16	16	NUM
iajs-3451	158	6	.	.	PUNCT
iajs-3451	159	1	elshafie	elshafie	PROPN
iajs-3451	159	2	,	,	PUNCT
iajs-3451	159	3	a.i	a.i	PROPN
iajs-3451	159	4	.	.	PROPN
iajs-3451	159	5	;	;	PUNCT
iajs-3451	159	6	elbagir	elbagir	PROPN
iajs-3451	159	7	,	,	PUNCT
iajs-3451	159	8	s.	s.	PROPN
iajs-3451	159	9	;	;	PUNCT
iajs-3451	159	10	aledrissy	aledrissy	PROPN
iajs-3451	159	11	,	,	PUNCT
iajs-3451	159	12	m.i	m.i	PROPN
iajs-3451	159	13	.	.	PROPN
iajs-3451	159	14	;	;	PUNCT
iajs-3451	159	15	elagib	elagib	PROPN
iajs-3451	159	16	,	,	PUNCT
iajs-3451	159	17	e.m	e.m	PROPN
iajs-3451	159	18	.	.	PROPN
iajs-3451	159	19	;	;	PUNCT
iajs-3451	159	20	nur	nur	PROPN
iajs-3451	159	21	,	,	PUNCT
iajs-3451	159	22	m.a	m.a	PROPN
iajs-3451	159	23	.	.	PROPN
iajs-3451	159	24	;	;	PUNCT
iajs-3451	159	25	rönnelid	rönnelid	ADJ
iajs-3451	159	26	,	,	PUNCT
iajs-3451	159	27	j.	j.	PROPN
iajs-3451	159	28	occurrence	occurrence	PROPN
iajs-3451	159	29	of	of	ADP
iajs-3451	159	30	anticcp2	anticcp2	PROPN
iajs-3451	159	31	and	and	CCONJ
iajs-3451	159	32	rf	rf	PROPN
iajs-3451	159	33	isotypes	isotype	NOUN
iajs-3451	159	34	and	and	CCONJ
iajs-3451	159	35	their	their	PRON
iajs-3451	159	36	relation	relation	NOUN
iajs-3451	159	37	to	to	ADP
iajs-3451	159	38	age	age	NOUN
iajs-3451	159	39	and	and	CCONJ
iajs-3451	159	40	disease	disease	NOUN
iajs-3451	159	41	severity	severity	NOUN
iajs-3451	159	42	among	among	ADP
iajs-3451	159	43	sudanese	sudanese	ADJ
iajs-3451	159	44	patients	patient	NOUN
iajs-3451	159	45	with	with	ADP
iajs-3451	159	46	rheumatoid	rheumatoid	NOUN
iajs-3451	159	47	arthritis	arthritis	NOUN
iajs-3451	159	48	.	.	PUNCT
iajs-3451	160	1	clinical	clinical	ADJ
iajs-3451	160	2	rheumatology	rheumatology	NOUN
iajs-3451	160	3	2019	2019	NUM
iajs-3451	160	4	,	,	PUNCT
iajs-3451	160	5	1(38	1(38	NUM
iajs-3451	160	6	)	)	PUNCT
iajs-3451	160	7	,	,	PUNCT
iajs-3451	160	8	1545	1545	NUM
iajs-3451	160	9	-	-	SYM
iajs-3451	160	10	1553	1553	NUM
iajs-3451	160	11	.	.	PUNCT
iajs-3451	161	1	doi	doi	NOUN
iajs-3451	161	2	:	:	PUNCT
iajs-3451	161	3	https://doi.org/10.1007/s10067-019-04431-6	https://doi.org/10.1007/s10067-019-04431-6	NUM
iajs-3451	161	4	.	.	PUNCT
iajs-3451	162	1	17	17	NUM
iajs-3451	162	2	.	.	X
iajs-3451	162	3	shpatz	shpatz	PROPN
iajs-3451	162	4	,	,	PUNCT
iajs-3451	162	5	r.	r.	PROPN
iajs-3451	162	6	;	;	PUNCT
iajs-3451	162	7	braun	braun	NOUN
iajs-3451	162	8	-	-	PUNCT
iajs-3451	162	9	moscovici	moscovici	NOUN
iajs-3451	162	10	,	,	PUNCT
iajs-3451	162	11	y.	y.	PROPN
iajs-3451	162	12	;	;	PUNCT
iajs-3451	162	13	balbir	balbir	NOUN
iajs-3451	162	14	-	-	PUNCT
iajs-3451	162	15	gurman	gurman	NOUN
iajs-3451	162	16	,	,	PUNCT
iajs-3451	162	17	a.	a.	NOUN
iajs-3451	162	18	acpa	acpa	PROPN
iajs-3451	162	19	antibodies	antibodie	VERB
iajs-3451	162	20	titer	titer	NOUN
iajs-3451	162	21	at	at	ADP
iajs-3451	162	22	the	the	DET
iajs-3451	162	23	time	time	NOUN
iajs-3451	162	24	of	of	ADP
iajs-3451	162	25	rheumatoid	rheumatoid	NOUN
iajs-3451	162	26	arthritis	arthritis	NOUN
iajs-3451	162	27	diagnosis	diagnosis	NOUN
iajs-3451	162	28	is	be	AUX
iajs-3451	162	29	not	not	PART
iajs-3451	162	30	associated	associate	VERB
iajs-3451	162	31	with	with	ADP
iajs-3451	162	32	disease	disease	NOUN
iajs-3451	162	33	severity	severity	NOUN
iajs-3451	162	34	.	.	PUNCT
iajs-3451	163	1	the	the	DET
iajs-3451	163	2	israel	israel	PROPN
iajs-3451	163	3	medical	medical	PROPN
iajs-3451	163	4	association	association	PROPN
iajs-3451	163	5	journal	journal	PROPN
iajs-3451	163	6	:	:	PUNCT
iajs-3451	163	7	imaj	imaj	ADJ
iajs-3451	163	8	.	.	PUNCT
iajs-3451	163	9	2021	2021	NUM
iajs-3451	163	10	,	,	PUNCT
iajs-3451	163	11	23(10	23(10	NUM
iajs-3451	163	12	)	)	PUNCT
iajs-3451	163	13	,	,	PUNCT
iajs-3451	163	14	646	646	NUM
iajs-3451	163	15	-	-	SYM
iajs-3451	163	16	650	650	NUM
iajs-3451	163	17	.	.	PUNCT
iajs-3451	164	1	https://pubmed.ncbi.nlm.nih.gov/34672447/	https://pubmed.ncbi.nlm.nih.gov/34672447/	PROPN
iajs-3451	164	2	18	18	NUM
iajs-3451	164	3	.	.	PUNCT
iajs-3451	164	4	kamiya	kamiya	PROPN
iajs-3451	164	5	,	,	PUNCT
iajs-3451	164	6	h.	h.	PROPN
iajs-3451	164	7	;	;	PUNCT
iajs-3451	164	8	panlaqui	panlaqui	PROPN
iajs-3451	164	9	,	,	PUNCT
iajs-3451	164	10	o.m	o.m	PROPN
iajs-3451	164	11	.	.	PROPN
iajs-3451	164	12	systematic	systematic	ADJ
iajs-3451	164	13	review	review	NOUN
iajs-3451	164	14	and	and	CCONJ
iajs-3451	164	15	meta	meta	NOUN
iajs-3451	164	16	-	-	PUNCT
iajs-3451	164	17	analysis	analysis	NOUN
iajs-3451	164	18	of	of	ADP
iajs-3451	164	19	the	the	DET
iajs-3451	164	20	risk	risk	NOUN
iajs-3451	164	21	of	of	ADP
iajs-3451	164	22	rheumatoid	rheumatoid	NOUN
iajs-3451	164	23	arthritisassociated	arthritisassociate	VERB
iajs-3451	164	24	interstitial	interstitial	ADJ
iajs-3451	164	25	lung	lung	NOUN
iajs-3451	164	26	disease	disease	NOUN
iajs-3451	164	27	related	relate	VERB
iajs-3451	164	28	to	to	ADP
iajs-3451	164	29	anti	anti	ADJ
iajs-3451	164	30	-	-	ADJ
iajs-3451	164	31	cyclic	cyclic	ADJ
iajs-3451	164	32	citrullinated	citrullinate	VERB
iajs-3451	164	33	peptide	peptide	NOUN
iajs-3451	164	34	(	(	PUNCT
iajs-3451	164	35	ccp	ccp	PROPN
iajs-3451	164	36	)	)	PUNCT
iajs-3451	164	37	antibody	antibody	NOUN
iajs-3451	164	38	.	.	PUNCT
iajs-3451	165	1	bmj	bmj	PROPN
iajs-3451	165	2	open	open	ADJ
iajs-3451	165	3	2021	2021	NUM
iajs-3451	165	4	,	,	PUNCT
iajs-3451	165	5	11(3	11(3	NUM
iajs-3451	165	6	)	)	PUNCT
iajs-3451	165	7	,	,	PUNCT
iajs-3451	165	8	e040465	e040465	PROPN
iajs-3451	165	9	.	.	PROPN
iajs-3451	165	10	19	19	NUM
iajs-3451	165	11	.	.	PUNCT
iajs-3451	166	1	nagy	nagy	PROPN
iajs-3451	166	2	,	,	PUNCT
iajs-3451	166	3	g.	g.	PROPN
iajs-3451	166	4	;	;	PUNCT
iajs-3451	166	5	roodenrijs	roodenrijs	PROPN
iajs-3451	166	6	,	,	PUNCT
iajs-3451	166	7	n.m.;welsing	n.m.;welsing	NUM
iajs-3451	166	8	,	,	PUNCT
iajs-3451	166	9	p.m.	p.m.	NUM
iajs-3451	166	10	;	;	PUNCT
iajs-3451	166	11	kedves	kedve	NOUN
iajs-3451	166	12	,	,	PUNCT
iajs-3451	166	13	m.	m.	NOUN
iajs-3451	166	14	;	;	PUNCT
iajs-3451	166	15	hamar	hamar	PROPN
iajs-3451	166	16	,	,	PUNCT
iajs-3451	166	17	a.	a.	NOUN
iajs-3451	166	18	;	;	PUNCT
iajs-3451	166	19	van	van	PROPN
iajs-3451	166	20	der	der	NOUN
iajs-3451	166	21	goes	go	VERB
iajs-3451	166	22	,	,	PUNCT
iajs-3451	166	23	m.c	m.c	PROPN
iajs-3451	166	24	.	.	PROPN
iajs-3451	166	25	;	;	PUNCT
iajs-3451	167	1	kent	kent	PROPN
iajs-3451	167	2	,	,	PUNCT
iajs-3451	167	3	a.	a.	PROPN
iajs-3451	167	4	;	;	PUNCT
iajs-3451	167	5	bakkers	bakker	NOUN
iajs-3451	167	6	,	,	PUNCT
iajs-3451	167	7	m.	m.	NOUN
iajs-3451	167	8	;	;	PUNCT
iajs-3451	167	9	blaas	blaas	NOUN
iajs-3451	167	10	,	,	PUNCT
iajs-3451	167	11	e.	e.	PROPN
iajs-3451	167	12	;	;	PUNCT
iajs-3451	167	13	senolt	senolt	PROPN
iajs-3451	167	14	,	,	PUNCT
iajs-3451	167	15	l.	l.	PROPN
iajs-3451	167	16	;	;	PUNCT
iajs-3451	167	17	szekanecz	szekanecz	PROPN
iajs-3451	167	18	,	,	PUNCT
iajs-3451	167	19	z.	z.	PROPN
iajs-3451	167	20	eular	eular	ADJ
iajs-3451	167	21	definition	definition	NOUN
iajs-3451	167	22	of	of	ADP
iajs-3451	167	23	difficult	difficult	ADJ
iajs-3451	167	24	-	-	PUNCT
iajs-3451	167	25	to	to	PART
iajs-3451	167	26	-	-	PUNCT
iajs-3451	167	27	treat	treat	VERB
iajs-3451	167	28	rheumatoid	rheumatoid	NOUN
iajs-3451	167	29	arthritis	arthritis	NOUN
iajs-3451	167	30	.	.	PUNCT
iajs-3451	168	1	annals	annal	NOUN
iajs-3451	168	2	of	of	ADP
iajs-3451	168	3	the	the	DET
iajs-3451	168	4	rheumatic	rheumatic	ADJ
iajs-3451	168	5	diseases	disease	NOUN
iajs-3451	168	6	2021	2021	NUM
iajs-3451	168	7	,	,	PUNCT
iajs-3451	168	8	80(1	80(1	NUM
iajs-3451	168	9	)	)	PUNCT
iajs-3451	168	10	,	,	PUNCT
iajs-3451	168	11	31	31	NUM
iajs-3451	168	12	-	-	SYM
iajs-3451	168	13	35	35	NUM
iajs-3451	168	14	.	.	PUNCT
iajs-3451	169	1	doi	doi	NOUN
iajs-3451	169	2	:	:	PUNCT
iajs-3451	169	3	https://doi.org/10.1136/bmjopen2020-040465	https://doi.org/10.1136/bmjopen2020-040465	X
iajs-3451	169	4	.	.	PUNCT
iajs-3451	170	1	20	20	NUM
iajs-3451	170	2	.	.	X
iajs-3451	171	1	cleland	cleland	PROPN
iajs-3451	171	2	,	,	PUNCT
iajs-3451	171	3	d.a	d.a	PROPN
iajs-3451	171	4	.	.	PROPN
iajs-3451	171	5	;	;	PUNCT
iajs-3451	171	6	eranki	eranki	PROPN
iajs-3451	171	7	,	,	PUNCT
iajs-3451	171	8	a.p	a.p	PROPN
iajs-3451	171	9	.	.	PROPN
iajs-3451	171	10	procalcitonin	procalcitonin	PROPN
iajs-3451	171	11	.	.	PUNCT
iajs-3451	172	1	[	[	X
iajs-3451	172	2	updated	update	VERB
iajs-3451	172	3	2023	2023	NUM
iajs-3451	172	4	apr	apr	NOUN
iajs-3451	172	5	23	23	NUM
iajs-3451	172	6	]	]	PUNCT
iajs-3451	172	7	.	.	PUNCT
iajs-3451	173	1	in	in	ADP
iajs-3451	173	2	:	:	PUNCT
iajs-3451	173	3	statpearls	statpearl	NOUN
iajs-3451	174	1	[	[	X
iajs-3451	174	2	internet	internet	NOUN
iajs-3451	174	3	]	]	PUNCT
iajs-3451	174	4	.	.	PUNCT
iajs-3451	175	1	treasure	treasure	NOUN
iajs-3451	175	2	island	island	NOUN
iajs-3451	175	3	(	(	PUNCT
iajs-3451	175	4	fl	fl	PROPN
iajs-3451	175	5	):	):	PUNCT
iajs-3451	175	6	statpearls	statpearl	NOUN
iajs-3451	175	7	publishing	publish	VERB
iajs-3451	175	8	2024	2024	NUM
iajs-3451	175	9	.	.	PUNCT
iajs-3451	176	1	available	available	ADJ
iajs-3451	176	2	from	from	ADP
iajs-3451	176	3	:	:	PUNCT
iajs-3451	176	4	https://www.ncbi.nlm.nih.gov/books/nbk539794/.	https://www.ncbi.nlm.nih.gov/books/nbk539794/.	PROPN
iajs-3451	176	5	21	21	NUM
iajs-3451	176	6	.	.	PUNCT
iajs-3451	177	1	sproston	sproston	PROPN
iajs-3451	177	2	,	,	PUNCT
iajs-3451	177	3	n.r	n.r	PROPN
iajs-3451	177	4	.	.	PROPN
iajs-3451	177	5	;	;	PUNCT
iajs-3451	178	1	ashworth	ashworth	PROPN
iajs-3451	178	2	,	,	PUNCT
iajs-3451	178	3	j.j	j.j	PROPN
iajs-3451	178	4	.	.	PROPN
iajs-3451	178	5	role	role	NOUN
iajs-3451	178	6	of	of	ADP
iajs-3451	178	7	c	c	NOUN
iajs-3451	178	8	-	-	PUNCT
iajs-3451	178	9	reactive	reactive	ADJ
iajs-3451	178	10	protein	protein	NOUN
iajs-3451	178	11	at	at	ADP
iajs-3451	178	12	sites	site	NOUN
iajs-3451	178	13	of	of	ADP
iajs-3451	178	14	inflammation	inflammation	NOUN
iajs-3451	178	15	and	and	CCONJ
iajs-3451	178	16	infection	infection	NOUN
iajs-3451	178	17	.	.	PUNCT
iajs-3451	179	1	frontiers	frontier	NOUN
iajs-3451	179	2	in	in	ADP
iajs-3451	179	3	immunology	immunology	NOUN
iajs-3451	179	4	.	.	PUNCT
iajs-3451	180	1	2018	2018	NUM
iajs-3451	180	2	,	,	PUNCT
iajs-3451	180	3	9	9	NUM
iajs-3451	180	4	,	,	PUNCT
iajs-3451	180	5	342848	342848	NUM
iajs-3451	180	6	.	.	PUNCT
iajs-3451	181	1	doi	doi	NOUN
iajs-3451	181	2	:	:	PUNCT
iajs-3451	181	3	https://doi.org/10.3389/fimmu.2018.00754	https://doi.org/10.3389/fimmu.2018.00754	PROPN
iajs-3451	181	4	.	.	PROPN
iajs-3451	182	1	22	22	NUM
iajs-3451	182	2	.	.	PUNCT
iajs-3451	183	1	galeef	galeef	PROPN
iajs-3451	183	2	,	,	PUNCT
iajs-3451	183	3	e.r	e.r	PROPN
iajs-3451	183	4	;	;	PUNCT
iajs-3451	183	5	salloom	salloom	PROPN
iajs-3451	183	6	,	,	PUNCT
iajs-3451	183	7	d.f	d.f	PROPN
iajs-3451	183	8	.	.	PROPN
iajs-3451	183	9	hla	hla	PROPN
iajs-3451	183	10	-	-	PUNCT
iajs-3451	183	11	b	b	NOUN
iajs-3451	183	12	genotype	genotype	NOUN
iajs-3451	183	13	and	and	CCONJ
iajs-3451	183	14	escherichia	escherichia	NOUN
iajs-3451	183	15	coli	coli	NOUN
iajs-3451	183	16	association	association	NOUN
iajs-3451	183	17	in	in	ADP
iajs-3451	183	18	iraqi	iraqi	ADJ
iajs-3451	183	19	patients	patient	NOUN
iajs-3451	183	20	with	with	ADP
iajs-3451	183	21	reactive	reactive	ADJ
iajs-3451	183	22	arthritis	arthritis	NOUN
iajs-3451	183	23	.	.	PUNCT
iajs-3451	184	1	iraqi	iraqi	ADJ
iajs-3451	184	2	journal	journal	PROPN
iajs-3451	184	3	of	of	ADP
iajs-3451	184	4	science	science	PROPN
iajs-3451	184	5	2016	2016	NUM
iajs-3451	184	6	,	,	PUNCT
iajs-3451	184	7	1648	1648	NUM
iajs-3451	184	8	-	-	SYM
iajs-3451	184	9	1652	1652	NUM
iajs-3451	184	10	.	.	PUNCT
iajs-3451	185	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/7020	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/7020	PROPN
iajs-3451	185	2	.	.	PUNCT
iajs-3451	186	1	23	23	NUM
iajs-3451	186	2	.	.	PUNCT
iajs-3451	187	1	sultan	sultan	PROPN
iajs-3451	187	2	,	,	PUNCT
iajs-3451	187	3	m.	m.	NOUN
iajs-3451	187	4	biochemical	biochemical	NOUN
iajs-3451	187	5	and	and	CCONJ
iajs-3451	187	6	the	the	DET
iajs-3451	187	7	genetic	genetic	ADJ
iajs-3451	187	8	variations	variation	NOUN
iajs-3451	187	9	of	of	ADP
iajs-3451	187	10	apolipoprotein	apolipoprotein	ADJ
iajs-3451	187	11	e	e	PROPN
iajs-3451	187	12	levels	level	NOUN
iajs-3451	187	13	and	and	CCONJ
iajs-3451	187	14	correlation	correlation	NOUN
iajs-3451	187	15	with	with	ADP
iajs-3451	187	16	its	its	PRON
iajs-3451	187	17	isoforms	isoform	NOUN
iajs-3451	187	18	polymorphism	polymorphism	NOUN
iajs-3451	187	19	in	in	ADP
iajs-3451	187	20	patients	patient	NOUN
iajs-3451	187	21	with	with	ADP
iajs-3451	187	22	rheumatoid	rheumatoid	NOUN
iajs-3451	187	23	arthritis	arthritis	NOUN
iajs-3451	187	24	.	.	PUNCT
iajs-3451	188	1	msc	msc	PROPN
iajs-3451	188	2	thesis	thesis	PROPN
iajs-3451	188	3	,	,	PUNCT
iajs-3451	188	4	college	college	NOUN
iajs-3451	188	5	of	of	ADP
iajs-3451	188	6	medicine	medicine	NOUN
iajs-3451	188	7	,	,	PUNCT
iajs-3451	188	8	university	university	NOUN
iajs-3451	188	9	of	of	ADP
iajs-3451	188	10	babylon	babylon	PROPN
iajs-3451	188	11	2021	2021	NUM
iajs-3451	188	12	.	.	PUNCT
iajs-3451	189	1	24	24	NUM
iajs-3451	189	2	.	.	PUNCT
iajs-3451	189	3	baughman	baughman	PROPN
iajs-3451	189	4	,	,	PUNCT
iajs-3451	189	5	r.p	r.p	PROPN
iajs-3451	189	6	.	.	PROPN
iajs-3451	189	7	;	;	PUNCT
iajs-3451	189	8	cremers	cremer	NOUN
iajs-3451	189	9	,	,	PUNCT
iajs-3451	189	10	j.p	j.p	PROPN
iajs-3451	189	11	;	;	PUNCT
iajs-3451	189	12	harmon	harmon	PROPN
iajs-3451	189	13	,	,	PUNCT
iajs-3451	189	14	m.	m.	NOUN
iajs-3451	189	15	;	;	PUNCT
iajs-3451	189	16	lower	low	ADJ
iajs-3451	189	17	,	,	PUNCT
iajs-3451	189	18	e.e	e.e	PROPN
iajs-3451	189	19	;	;	PUNCT
iajs-3451	189	20	drent	drent	PROPN
iajs-3451	189	21	,	,	PUNCT
iajs-3451	189	22	m.	m.	NOUN
iajs-3451	189	23	methotrexate	methotrexate	NOUN
iajs-3451	189	24	in	in	ADP
iajs-3451	189	25	sarcoidosis	sarcoidosis	NOUN
iajs-3451	189	26	:	:	PUNCT
iajs-3451	189	27	hematologic	hematologic	NOUN
iajs-3451	189	28	and	and	CCONJ
iajs-3451	189	29	hepatic	hepatic	NOUN
iajs-3451	189	30	toxicity	toxicity	NOUN
iajs-3451	189	31	encountered	encounter	VERB
iajs-3451	189	32	in	in	ADP
iajs-3451	189	33	a	a	DET
iajs-3451	189	34	large	large	ADJ
iajs-3451	189	35	cohort	cohort	NOUN
iajs-3451	189	36	over	over	ADP
iajs-3451	189	37	a	a	DET
iajs-3451	189	38	six	six	NUM
iajs-3451	189	39	year	year	NOUN
iajs-3451	189	40	period	period	NOUN
iajs-3451	189	41	.	.	PUNCT
iajs-3451	190	1	sarcoidosis	sarcoidosis	NOUN
iajs-3451	190	2	,	,	PUNCT
iajs-3451	190	3	https://doi.org/10.18502/sjms.v13i4.3641	https://doi.org/10.18502/sjms.v13i4.3641	X
iajs-3451	190	4	https://doi.org/10.1093/ajcp/aqz142	https://doi.org/10.1093/ajcp/aqz142	PROPN
iajs-3451	190	5	https://doi.org/10.4049/jimmunol.1601096	https://doi.org/10.4049/jimmunol.1601096	NOUN
iajs-3451	190	6	https://doi.org/10.1136%2frmdopen-2022-002817	https://doi.org/10.1136%2frmdopen-2022-002817	X
iajs-3451	190	7	https://doi.org/10.1515/cclm-2022-0244	https://doi.org/10.1515/cclm-2022-0244	X
iajs-3451	190	8	https://doi.org/10.1007/s10067-019-04431-6	https://doi.org/10.1007/s10067-019-04431-6	NUM
iajs-3451	191	1	https://pubmed.ncbi.nlm.nih.gov/34672447/	https://pubmed.ncbi.nlm.nih.gov/34672447/	PROPN
iajs-3451	192	1	https://doi.org/10.1136/bmjopen-2020-040465	https://doi.org/10.1136/bmjopen-2020-040465	PROPN
iajs-3451	192	2	https://doi.org/10.1136/bmjopen-2020-040465	https://doi.org/10.1136/bmjopen-2020-040465	PROPN
iajs-3451	192	3	https://www.ncbi.nlm.nih.gov/books/nbk539794/	https://www.ncbi.nlm.nih.gov/books/nbk539794/	PROPN
iajs-3451	192	4	https://doi.org/10.3389/fimmu.2018.00754	https://doi.org/10.3389/fimmu.2018.00754	PROPN
iajs-3451	192	5	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/7020	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/7020	PROPN
iajs-3451	192	6	ihjpas	ihjpa	VERB
iajs-3451	192	7	.	.	PUNCT
iajs-3451	193	1	37	37	NUM
iajs-3451	193	2	(	(	PUNCT
iajs-3451	193	3	2	2	NUM
iajs-3451	193	4	)	)	PUNCT
iajs-3451	193	5	2024	2024	NUM
iajs-3451	193	6	134	134	NUM
iajs-3451	193	7	vasculitis	vasculiti	NOUN
iajs-3451	193	8	,	,	PUNCT
iajs-3451	193	9	and	and	CCONJ
iajs-3451	193	10	diffuse	diffuse	VERB
iajs-3451	193	11	lung	lung	NOUN
iajs-3451	193	12	diseases	disease	NOUN
iajs-3451	193	13	2020	2020	NUM
iajs-3451	193	14	,	,	PUNCT
iajs-3451	193	15	37(3	37(3	NUM
iajs-3451	193	16	)	)	PUNCT
iajs-3451	193	17	,	,	PUNCT
iajs-3451	193	18	e2020001	e2020001	PROPN
iajs-3451	193	19	.	.	PUNCT
iajs-3451	194	1	doi	doi	PROPN
iajs-3451	194	2	:	:	PUNCT
iajs-3451	194	3	https://doi.org/10.36141/svdld.v37i3.9362	https://doi.org/10.36141/svdld.v37i3.9362	NUM
iajs-3451	194	4	.	.	PUNCT
iajs-3451	195	1	25	25	NUM
iajs-3451	195	2	.	.	PUNCT
iajs-3451	196	1	salih	salih	PROPN
iajs-3451	196	2	,	,	PUNCT
iajs-3451	196	3	i.	i.	PROPN
iajs-3451	196	4	;	;	PUNCT
iajs-3451	196	5	omran	omran	PROPN
iajs-3451	196	6	,	,	PUNCT
iajs-3451	196	7	r.	r.	VERB
iajs-3451	196	8	the	the	DET
iajs-3451	196	9	effects	effect	NOUN
iajs-3451	196	10	of	of	ADP
iajs-3451	196	11	gene	gene	NOUN
iajs-3451	196	12	polymorphisms	polymorphism	NOUN
iajs-3451	196	13	in	in	ADP
iajs-3451	196	14	interleukin-4	interleukin-4	NUM
iajs-3451	196	15	on	on	ADP
iajs-3451	196	16	the	the	DET
iajs-3451	196	17	susceptibility	susceptibility	NOUN
iajs-3451	196	18	of	of	ADP
iajs-3451	196	19	rheumatoid	rheumatoid	NOUN
iajs-3451	196	20	arthritis	arthritis	NOUN
iajs-3451	196	21	in	in	ADP
iajs-3451	196	22	a	a	DET
iajs-3451	196	23	iraq	iraq	PROPN
iajs-3451	196	24	population	population	NOUN
iajs-3451	196	25	.	.	PUNCT
iajs-3451	197	1	journal	journal	PROPN
iajs-3451	197	2	of	of	ADP
iajs-3451	197	3	biotechnology	biotechnology	NOUN
iajs-3451	197	4	research	research	NOUN
iajs-3451	197	5	2018	2018	NUM
iajs-3451	197	6	,	,	PUNCT
iajs-3451	197	7	4(10	4(10	NUM
iajs-3451	197	8	)	)	PUNCT
iajs-3451	197	9	,	,	PUNCT
iajs-3451	197	10	76	76	NUM
iajs-3451	197	11	-	-	SYM
iajs-3451	197	12	79	79	NUM
iajs-3451	197	13	.	.	PUNCT
iajs-3451	198	1	doi	doi	NOUN
iajs-3451	198	2	:	:	PUNCT
iajs-3451	198	3	doi.org/10.32861/jbr.410.76.79	doi.org/10.32861/jbr.410.76.79	NOUN
iajs-3451	198	4	.	.	PUNCT
iajs-3451	199	1	26	26	NUM
iajs-3451	199	2	.	.	PUNCT
iajs-3451	200	1	mohammed	mohammed	PROPN
iajs-3451	200	2	,	,	PUNCT
iajs-3451	200	3	h.a	h.a	PROPN
iajs-3451	200	4	.	.	PROPN
iajs-3451	200	5	the	the	DET
iajs-3451	200	6	serum	serum	NOUN
iajs-3451	200	7	level	level	NOUN
iajs-3451	200	8	of	of	ADP
iajs-3451	200	9	dc	dc	PROPN
iajs-3451	200	10	-	-	PUNCT
iajs-3451	200	11	sign	sign	NOUN
iajs-3451	200	12	and	and	CCONJ
iajs-3451	200	13	mannose	mannose	NOUN
iajs-3451	200	14	receptor	receptor	NOUN
iajs-3451	200	15	in	in	ADP
iajs-3451	200	16	rheumatoid	rheumatoid	NOUN
iajs-3451	200	17	arthritis	arthritis	NOUN
iajs-3451	200	18	patients	patient	NOUN
iajs-3451	200	19	.	.	PUNCT
iajs-3451	201	1	msc	msc	PROPN
iajs-3451	201	2	.	.	PROPN
iajs-3451	202	1	thesis	thesis	PROPN
iajs-3451	202	2	college	college	PROPN
iajs-3451	202	3	of	of	ADP
iajs-3451	202	4	science	science	NOUN
iajs-3451	202	5	for	for	ADP
iajs-3451	202	6	women	woman	NOUN
iajs-3451	202	7	university	university	PROPN
iajs-3451	202	8	of	of	ADP
iajs-3451	202	9	baghdad	baghdad	PROPN
iajs-3451	202	10	2021	2021	NUM
iajs-3451	202	11	.	.	PUNCT
iajs-3451	203	1	27	27	NUM
iajs-3451	203	2	.	.	PUNCT
iajs-3451	204	1	wu	wu	PROPN
iajs-3451	204	2	,	,	PUNCT
iajs-3451	204	3	c.y	c.y	PROPN
iajs-3451	204	4	;	;	PUNCT
iajs-3451	204	5	yang	yang	PROPN
iajs-3451	204	6	,	,	PUNCT
iajs-3451	204	7	h.y	h.y	PROPN
iajs-3451	204	8	;	;	PUNCT
iajs-3451	204	9	luo	luo	PROPN
iajs-3451	204	10	,	,	PUNCT
iajs-3451	204	11	s.f	s.f	PROPN
iajs-3451	204	12	.	.	PROPN
iajs-3451	204	13	;	;	PUNCT
iajs-3451	205	1	lai	lai	PROPN
iajs-3451	205	2	,	,	PUNCT
iajs-3451	205	3	j.h	j.h	PROPN
iajs-3451	205	4	.	.	PROPN
iajs-3451	205	5	from	from	ADP
iajs-3451	205	6	rheumatoid	rheumatoid	NOUN
iajs-3451	205	7	factor	factor	NOUN
iajs-3451	205	8	to	to	ADP
iajs-3451	205	9	anti	anti	ADJ
iajs-3451	205	10	-	-	ADJ
iajs-3451	205	11	citrullinated	citrullinate	VERB
iajs-3451	205	12	protein	protein	NOUN
iajs-3451	205	13	antibodies	antibody	NOUN
iajs-3451	205	14	and	and	CCONJ
iajs-3451	205	15	anti	anti	ADJ
iajs-3451	205	16	-	-	ADJ
iajs-3451	205	17	carbamylated	carbamylated	ADJ
iajs-3451	205	18	protein	protein	NOUN
iajs-3451	205	19	antibodies	antibodie	VERB
iajs-3451	205	20	for	for	ADP
iajs-3451	205	21	diagnosis	diagnosis	NOUN
iajs-3451	205	22	and	and	CCONJ
iajs-3451	205	23	prognosis	prognosis	NOUN
iajs-3451	205	24	prediction	prediction	NOUN
iajs-3451	205	25	in	in	ADP
iajs-3451	205	26	patients	patient	NOUN
iajs-3451	205	27	with	with	ADP
iajs-3451	205	28	rheumatoid	rheumatoid	NOUN
iajs-3451	205	29	arthritis	arthritis	NOUN
iajs-3451	205	30	.	.	PUNCT
iajs-3451	206	1	international	international	ADJ
iajs-3451	206	2	journal	journal	NOUN
iajs-3451	206	3	of	of	ADP
iajs-3451	206	4	molecular	molecular	ADJ
iajs-3451	206	5	sciences	science	NOUN
iajs-3451	206	6	.	.	PUNCT
iajs-3451	206	7	2021	2021	NUM
iajs-3451	206	8	,	,	PUNCT
iajs-3451	206	9	22(2	22(2	NUM
iajs-3451	206	10	)	)	PUNCT
iajs-3451	206	11	,	,	PUNCT
iajs-3451	206	12	686	686	NUM
iajs-3451	206	13	.	.	PUNCT
iajs-3451	207	1	doi	doi	NOUN
iajs-3451	207	2	:	:	PUNCT
iajs-3451	207	3	https://doi.org/10.3390/ijms22020686	https://doi.org/10.3390/ijms22020686	ADJ
iajs-3451	207	4	.	.	PUNCT
iajs-3451	208	1	28	28	NUM
iajs-3451	208	2	.	.	PUNCT
iajs-3451	209	1	van	van	PROPN
iajs-3451	209	2	delft	delft	PROPN
iajs-3451	209	3	ma	ma	PROPN
iajs-3451	209	4	,	,	PUNCT
iajs-3451	209	5	huizinga	huizinga	PROPN
iajs-3451	209	6	tw	tw	NOUN
iajs-3451	209	7	.	.	PUNCT
iajs-3451	210	1	an	an	DET
iajs-3451	210	2	overview	overview	NOUN
iajs-3451	210	3	of	of	ADP
iajs-3451	210	4	autoantibodies	autoantibody	NOUN
iajs-3451	210	5	in	in	ADP
iajs-3451	210	6	rheumatoid	rheumatoid	NOUN
iajs-3451	210	7	arthritis	arthritis	NOUN
iajs-3451	210	8	.	.	PUNCT
iajs-3451	211	1	journal	journal	NOUN
iajs-3451	211	2	of	of	ADP
iajs-3451	211	3	autoimmunity	autoimmunity	NOUN
iajs-3451	211	4	.	.	PUNCT
iajs-3451	212	1	2020	2020	NUM
iajs-3451	212	2	,	,	PUNCT
iajs-3451	212	3	110	110	NUM
iajs-3451	212	4	,	,	PUNCT
iajs-3451	212	5	102392	102392	NUM
iajs-3451	212	6	.	.	PUNCT
iajs-3451	213	1	doi	doi	NOUN
iajs-3451	213	2	:	:	PUNCT
iajs-3451	213	3	https://doi.org/10.1016/j.jaut.2019.102392	https://doi.org/10.1016/j.jaut.2019.102392	NOUN
iajs-3451	213	4	.	.	PROPN
iajs-3451	214	1	29	29	NUM
iajs-3451	214	2	.	.	X
iajs-3451	215	1	ramdan	ramdan	PROPN
iajs-3451	215	2	,	,	PUNCT
iajs-3451	215	3	i.m	i.m	PROPN
iajs-3451	215	4	.	.	PROPN
iajs-3451	215	5	;	;	PUNCT
iajs-3451	216	1	candra	candra	PROPN
iajs-3451	216	2	,	,	PUNCT
iajs-3451	216	3	k.p	k.p	PROPN
iajs-3451	216	4	.	.	PROPN
iajs-3451	216	5	;	;	PUNCT
iajs-3451	216	6	lusiana	lusiana	PROPN
iajs-3451	216	7	,	,	PUNCT
iajs-3451	216	8	d.	d.	PROPN
iajs-3451	216	9	;	;	PUNCT
iajs-3451	216	10	duma	duma	PROPN
iajs-3451	216	11	,	,	PUNCT
iajs-3451	216	12	k.	k.	PROPN
iajs-3451	216	13	redesign	redesign	NOUN
iajs-3451	216	14	of	of	ADP
iajs-3451	216	15	the	the	DET
iajs-3451	216	16	traditional	traditional	ADJ
iajs-3451	216	17	handloom	handloom	NOUN
iajs-3451	216	18	for	for	ADP
iajs-3451	216	19	sarong	sarong	ADJ
iajs-3451	216	20	female	female	NOUN
iajs-3451	216	21	-	-	PUNCT
iajs-3451	216	22	weavers	weaver	NOUN
iajs-3451	216	23	based	base	VERB
iajs-3451	216	24	on	on	ADP
iajs-3451	216	25	anthropometric	anthropometric	ADJ
iajs-3451	216	26	data	datum	NOUN
iajs-3451	216	27	.	.	PUNCT
iajs-3451	217	1	indian	indian	PROPN
iajs-3451	217	2	journal	journal	PROPN
iajs-3451	217	3	of	of	ADP
iajs-3451	217	4	public	public	ADJ
iajs-3451	217	5	health	health	NOUN
iajs-3451	217	6	research	research	PROPN
iajs-3451	217	7	&	&	CCONJ
iajs-3451	217	8	development	development	PROPN
iajs-3451	217	9	2019	2019	NUM
iajs-3451	217	10	,	,	PUNCT
iajs-3451	217	11	1(10	1(10	NUM
iajs-3451	217	12	)	)	PUNCT
iajs-3451	217	13	,	,	PUNCT
iajs-3451	217	14	10	10	NUM
iajs-3451	217	15	.	.	PUNCT
iajs-3451	218	1	doi	doi	NOUN
iajs-3451	218	2	:	:	PUNCT
iajs-3451	218	3	https://doi.org/10.5958/0976-5506.2019.02950	https://doi.org/10.5958/0976-5506.2019.02950	PROPN
iajs-3451	218	4	.	.	PUNCT
iajs-3451	219	1	30	30	NUM
iajs-3451	219	2	.	.	PUNCT
iajs-3451	220	1	abdullah	abdullah	PROPN
iajs-3451	220	2	,	,	PUNCT
iajs-3451	220	3	h.	h.	PROPN
iajs-3451	220	4	evaluation	evaluation	NOUN
iajs-3451	220	5	of	of	ADP
iajs-3451	220	6	some	some	DET
iajs-3451	220	7	immunogenetic	immunogenetic	ADJ
iajs-3451	220	8	markers	marker	NOUN
iajs-3451	220	9	of	of	ADP
iajs-3451	220	10	rheumatoid	rheumatoid	NOUN
iajs-3451	220	11	arthritis	arthritis	NOUN
iajs-3451	220	12	in	in	ADP
iajs-3451	220	13	samples	sample	NOUN
iajs-3451	220	14	of	of	ADP
iajs-3451	220	15	iraqi	iraqi	ADJ
iajs-3451	220	16	patients	patient	NOUN
iajs-3451	220	17	.	.	PUNCT
iajs-3451	221	1	a	a	DET
iajs-3451	221	2	thesis	thesis	NOUN
iajs-3451	221	3	institute	institute	NOUN
iajs-3451	221	4	of	of	ADP
iajs-3451	221	5	genetic	genetic	ADJ
iajs-3451	221	6	engineering	engineering	NOUN
iajs-3451	221	7	and	and	CCONJ
iajs-3451	221	8	biotechnology	biotechnology	NOUN
iajs-3451	221	9	for	for	ADP
iajs-3451	221	10	postgraduate	postgraduate	ADJ
iajs-3451	221	11	studies	study	NOUN
iajs-3451	221	12	at	at	ADP
iajs-3451	221	13	baghdad	baghdad	PROPN
iajs-3451	221	14	university	university	PROPN
iajs-3451	221	15	2010	2010	NUM
iajs-3451	221	16	.	.	PUNCT
iajs-3451	222	1	31	31	NUM
iajs-3451	222	2	.	.	PUNCT
iajs-3451	223	1	bray	bray	PROPN
iajs-3451	223	2	c.	c.	PROPN
iajs-3451	223	3	;	;	PUNCT
iajs-3451	223	4	bell	bell	NOUN
iajs-3451	223	5	,	,	PUNCT
iajs-3451	223	6	l.n	l.n	PROPN
iajs-3451	223	7	.	.	PROPN
iajs-3451	223	8	;	;	PUNCT
iajs-3451	223	9	liang	liang	PROPN
iajs-3451	223	10	,	,	PUNCT
iajs-3451	223	11	h.	h.	PROPN
iajs-3451	223	12	;	;	PUNCT
iajs-3451	223	13	haykal	haykal	PROPN
iajs-3451	223	14	,	,	PUNCT
iajs-3451	223	15	r.	r.	PROPN
iajs-3451	223	16	;	;	PUNCT
iajs-3451	223	17	kaiksow	kaiksow	PROPN
iajs-3451	223	18	,	,	PUNCT
iajs-3451	223	19	f.	f.	PROPN
iajs-3451	223	20	;	;	PUNCT
iajs-3451	223	21	mazza	mazza	PROPN
iajs-3451	223	22	,	,	PUNCT
iajs-3451	223	23	j.j	j.j	PROPN
iajs-3451	223	24	.	.	PROPN
iajs-3451	223	25	yale	yale	PROPN
iajs-3451	223	26	,	,	PUNCT
iajs-3451	223	27	s.h	s.h	PROPN
iajs-3451	223	28	.	.	PROPN
iajs-3451	223	29	erythrocyte	erythrocyte	PROPN
iajs-3451	223	30	sedimentation	sedimentation	NOUN
iajs-3451	223	31	rate	rate	NOUN
iajs-3451	223	32	and	and	CCONJ
iajs-3451	223	33	c	c	NOUN
iajs-3451	223	34	-	-	PUNCT
iajs-3451	223	35	reactive	reactive	ADJ
iajs-3451	223	36	protein	protein	NOUN
iajs-3451	223	37	measurements	measurement	NOUN
iajs-3451	223	38	and	and	CCONJ
iajs-3451	223	39	their	their	PRON
iajs-3451	223	40	relevance	relevance	NOUN
iajs-3451	223	41	in	in	ADP
iajs-3451	223	42	clinical	clinical	ADJ
iajs-3451	223	43	medicine	medicine	NOUN
iajs-3451	223	44	.	.	PUNCT
iajs-3451	224	1	wmj	wmj	PROPN
iajs-3451	224	2	:	:	PUNCT
iajs-3451	224	3	official	official	ADJ
iajs-3451	224	4	publication	publication	NOUN
iajs-3451	224	5	of	of	ADP
iajs-3451	224	6	the	the	DET
iajs-3451	224	7	state	state	PROPN
iajs-3451	224	8	medical	medical	ADJ
iajs-3451	224	9	society	society	NOUN
iajs-3451	224	10	of	of	ADP
iajs-3451	224	11	wisconsin	wisconsin	PROPN
iajs-3451	224	12	2016	2016	NUM
iajs-3451	224	13	,	,	PUNCT
iajs-3451	224	14	115(6	115(6	NUM
iajs-3451	224	15	)	)	PUNCT
iajs-3451	224	16	,	,	PUNCT
iajs-3451	224	17	317	317	NUM
iajs-3451	224	18	-	-	SYM
iajs-3451	224	19	21	21	NUM
iajs-3451	224	20	.	.	PUNCT
iajs-3451	225	1	doi	doi	NOUN
iajs-3451	225	2	:	:	PUNCT
iajs-3451	225	3	10.18773	10.18773	NUM
iajs-3451	225	4	/	/	SYM
iajs-3451	225	5	austprescr.2015.034	austprescr.2015.034	NOUN
iajs-3451	225	6	.	.	PUNCT
iajs-3451	226	1	32	32	NUM
iajs-3451	226	2	.	.	PUNCT
iajs-3451	227	1	farag	farag	PROPN
iajs-3451	227	2	,	,	PUNCT
iajs-3451	227	3	m.r	m.r	PROPN
iajs-3451	227	4	;	;	PUNCT
iajs-3451	227	5	alagawany	alagawany	NOUN
iajs-3451	227	6	,	,	PUNCT
iajs-3451	227	7	m.	m.	NOUN
iajs-3451	227	8	physiological	physiological	ADJ
iajs-3451	227	9	alterations	alteration	NOUN
iajs-3451	227	10	of	of	ADP
iajs-3451	227	11	poultry	poultry	NOUN
iajs-3451	227	12	to	to	ADP
iajs-3451	227	13	the	the	DET
iajs-3451	227	14	high	high	ADJ
iajs-3451	227	15	environmental	environmental	ADJ
iajs-3451	227	16	temperature	temperature	NOUN
iajs-3451	227	17	.	.	PUNCT
iajs-3451	228	1	journal	journal	NOUN
iajs-3451	228	2	of	of	ADP
iajs-3451	228	3	thermal	thermal	ADJ
iajs-3451	228	4	biology	biology	NOUN
iajs-3451	228	5	.	.	PUNCT
iajs-3451	229	1	2018	2018	NUM
iajs-3451	229	2	,	,	PUNCT
iajs-3451	229	3	1(76	1(76	NUM
iajs-3451	229	4	)	)	PUNCT
iajs-3451	229	5	,	,	PUNCT
iajs-3451	229	6	101	101	NUM
iajs-3451	229	7	-	-	SYM
iajs-3451	229	8	106	106	NUM
iajs-3451	229	9	.	.	PUNCT
iajs-3451	230	1	doi	doi	NOUN
iajs-3451	230	2	:	:	PUNCT
iajs-3451	230	3	https://doi.org/10.1016/j.jtherbio.2018.07.012	https://doi.org/10.1016/j.jtherbio.2018.07.012	PROPN
iajs-3451	230	4	.	.	PUNCT
iajs-3451	231	1	https://doi.org/10.36141/svdld.v37i3.9362	https://doi.org/10.36141/svdld.v37i3.9362	VERB
iajs-3451	232	1	https://doi.org/10.32861/jbr.410.76.79	https://doi.org/10.32861/jbr.410.76.79	ADP
iajs-3451	232	2	https://doi.org/10.3390/ijms22020686	https://doi.org/10.3390/ijms22020686	ADJ
iajs-3451	232	3	https://doi.org/10.1016/j.jaut.2019.102392	https://doi.org/10.1016/j.jaut.2019.102392	NOUN
iajs-3451	232	4	https://doi.org/	https://doi.org/	NOUN
iajs-3451	232	5	https://doi.org/10.18773%2faustprescr.2015.034	https://doi.org/10.18773%2faustprescr.2015.034	X
iajs-3451	232	6	https://doi.org/10.1016/j.jtherbio.2018.07.012	https://doi.org/10.1016/j.jtherbio.2018.07.012	NOUN